<SEC-DOCUMENT>0001193125-26-015344.txt : 20260116
<SEC-HEADER>0001193125-26-015344.hdr.sgml : 20260116
<ACCEPTANCE-DATETIME>20260116160536
ACCESSION NUMBER:		0001193125-26-015344
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20260116
DATE AS OF CHANGE:		20260116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioAtla, Inc.
		CENTRAL INDEX KEY:			0001826892
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				851922320
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-292784
		FILM NUMBER:		26539479

	BUSINESS ADDRESS:	
		STREET 1:		11085 TORREYANA ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-558-0708

	MAIL ADDRESS:	
		STREET 1:		11085 TORREYANA ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>d31173ds3.htm
<DESCRIPTION>S-3
<TEXT>
<HTML><HEAD>
<TITLE>S-3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on January&nbsp;16, 2026 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="right"><B><U></U>Registration No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-&#8194;&#8194;&#8194;&#8194;&#8194;</FONT> </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-3</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>BIOATLA, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
Name of Registrant as Specified in Its Charter) </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">85-1922320</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Incorporation or Organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>11085 Torreyana Road </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>San Diego, California 92121 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(858) <FONT STYLE="white-space:nowrap">558-0708</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices) </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Jay M. Short, Ph.D.</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">Co-Founder,</FONT> Chief Executive Officer and Chairman </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>BioAtla, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>11085 Torreyana Road </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>San Diego, California 92121 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(858) <FONT STYLE="white-space:nowrap">558-0708</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>David
Schulman, Esq. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Niki Fang, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Orrick, Herrington&nbsp;&amp; Sutcliffe LLP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>405 Howard Street </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>San
Francisco, California 94105</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: (415) <FONT STYLE="white-space:nowrap">773-5700</FONT></B> </P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public</B>: From time to time after the effective date of this registration
statement. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans,
please check the following box.&#8194;&#9744; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.&#8194;&#9746; </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this
Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following
box.&#8194;&#9744; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed
to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.&#8194;&#9744; </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
<FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting
company&#8221; and &#8220;emerging growth company&#8221; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&#8194;&#9744; </P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall
file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act or until the registration statement shall become effective on such date
as the Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This registration statement is a new registration statement being filed pursuant to Rule 415(a)(6) under the Securities Act of 1933, as amended, or the
Securities Act, with respect to $195.95&nbsp;million of securities which remain unsold by the registrant, or the Unsold Securities, under the registration statement on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;S-3&nbsp;(File&nbsp;No.&nbsp;333-269148),&nbsp;which</FONT></FONT> was declared effective on January&nbsp;17, 2023, or the Prior Registration Statement. Filing fees of
$195.95&nbsp;million were previously paid with respect to the Unsold Securities (calculated at the filing fee rate in effect at the time of the filing of the Prior Registration Statement). Pursuant to Rule&nbsp;415(a)(5)(ii) under the Securities
Act, by filing this registration statement, the registrant may issue and sell securities under the Prior Registration Statement until the earlier of (i)&nbsp;the effective date of this registration statement and (ii)&nbsp;July 16, 2026, which is 180
days after the third anniversary of the initial effective date of the Prior Registration Statement, the earlier being the Expiration Date. Until the Expiration Date, the registrant may continue to use the Prior Registration Statement and related
prospectus supplements for its offerings thereunder. All offers and sales by the registrant under the Prior Registration Statement will be deemed terminated on the Expiration Date, except to the extent covered by this registration statement.
Pursuant to Rule 415(a)(6), on or before the Expiration Date, the registrant may file a <FONT STYLE="white-space:nowrap">pre-effective</FONT> amendment to this Registration Statement to update the amount of unsold securities previously registered by
the Prior Registration Statement being registered hereby, and continue to offer and sell such unsold securities under this Registration Statement, including without limitation by continuing to conduct the sales of shares pursuant to the Agreements
referenced below. If applicable, such <FONT STYLE="white-space:nowrap">pre-effective</FONT> amendment shall identify such unsold securities to be included in this Registration Statement, and the amount of any new securities to be registered on this
Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This registration statement contains two prospectuses: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a base prospectus, which covers the offering, issuance and sale by the registrant of up to a maximum aggregate
offering price of $200,000,000 of the registrant&#8217;s common stock, preferred stock, debt securities, warrants and units; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a prospectus supplement covering the offering, issuance and sale by the registrant of up to $18.75&nbsp;million
of shares of the registrant&#8217;s common stock that may be issued and sold to YA II PN, Ltd., a Cayman Islands exempt limited company (&#8220;Yorkville&#8221;), Anson Investments Master Fund LP, a Cayman Islands exempted limited partnership
(&#8220;Anson Investments Master Fund&#8221;), and Anson East Master Fund LP, a Cayman Islands exempted limited partnership (&#8220;Anson East Master Fund&#8221; and, collectively with Yorkville and Anson Investments Master Fund, the
&#8220;Investors&#8221;), in connection with the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements that the registrant entered into with the Investors on November&nbsp;20, 2025 (the
<FONT STYLE="white-space:nowrap">&#8220;Pre-Paid</FONT> Advance Agreements&#8221;) and (ii)&nbsp;the Standby Equity Purchase Agreement that the registrant entered into with Yorkville on November&nbsp;20, 2025 (the &#8220;Standby Equity Purchase
Agreement&#8221; and together with the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements, the &#8220;Agreements&#8221;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The base prospectus immediately follows this explanatory note. The specific terms of any securities to be offered pursuant to the base prospectus, other than
the shares under the Agreements, will be specified in a prospectus supplement to the base prospectus. The prospectus supplement covering the shares that may be issued and sold pursuant to the Agreements immediately follows the base prospectus. The
common stock that may be offered, issued and sold by the registrant under the prospectus supplement relating to the Agreements is included in the $200,000,000 of securities that may be offered, issued and sold by the registrant under the base
prospectus. Upon any termination of the Agreements, any portion of the $18.75&nbsp;million included in the prospectus supplement that has not been sold pursuant to the Agreements will become available for sale in other offerings pursuant to the base
prospectus and a corresponding prospectus supplement, and if none of the $18.75&nbsp;million of shares of common stock are sold under the Agreements, the full $18.75&nbsp;million of securities may be sold in other offerings pursuant to the base
prospectus and a corresponding prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;21, 2025, the Company filed a prospectus supplement, or the Prior Prospectus
Supplement, covering the offering, issuance and sale of up to $22.5&nbsp;million of shares of our common stock directly to the Investors in connection with the Agreements. As of immediately prior to the filing of this registration statement,
$195.95&nbsp;million of shares of common stock remained available for sale under the Prior Prospectus Supplement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV STYLE="position:relative; overflow:visible; width:675pt; height:30pt; transform-origin:bottom left; transform: rotate(-90deg) translate(-100%, 100%) translateX(30pt);">
<P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:10.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#ff4338"><B>The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities
until&nbsp;the U.S. Securities and Exchange Commission declares our registration statement effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any state or
jurisdiction where the offer or sale is not permitted. </B></FONT></P></DIV><DIV STYLE="position:relative; overflow:visible; margin-left:48pt; margin-right:48pt; transform: translateY(-30pt);">
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:3.0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>SUBJECT TO COMPLETION, DATED
JANUARY&nbsp;16, 2026 </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>$200,000,000 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g31173g03a03.jpg" ALT="LOGO" STYLE="width:1.47222in;height:0.742361in;">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preferred Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt
Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">From time to time, we may offer and sell up to $200,000,000 in the aggregate of any combination of the securities described in this prospectus
in one or more offerings. The securities we may offer may be convertible into or exercisable or exchangeable for other securities. We may offer the securities separately or together, in separate classes, series and in amounts, at prices and on terms
that will be determined at the time the securities are offered. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">This prospectus describes some of the general terms that may apply to
these securities. Each time securities are sold, the specific terms and amounts of the securities being offered, and any other information relating to the specific offering will be set forth in a supplement to this prospectus. We may also authorize
one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus. You should
carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents incorporated by reference, before you invest in any of the securities being offered. This prospectus may not be
used to sell our securities unless accompanied by a prospectus supplement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">As of January&nbsp;16, 2026, the aggregate market value of our
outstanding common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> was approximately $74.4&nbsp;million, which we calculated based on 63,464,322 shares of outstanding common stock as of December&nbsp;31, 2025, of which
60,967,643 shares were held by <FONT STYLE="white-space:nowrap">non-affiliates,</FONT> and a price per share of $1.22, which was the closing price of our common stock on November&nbsp;18, 2025. We have not offered any securities pursuant to General
Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> during the prior <FONT STYLE="white-space:nowrap">12-calendar-month</FONT> period that ends on and includes the date of this prospectus, other than $22.8&nbsp;million pursuant to
the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements and the Standby Equity Purchase Agreement. Pursuant to General Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3,</FONT> in no event will we sell, pursuant to the
registration statement of which this prospectus forms a part, securities with a value exceeding <FONT STYLE="white-space:nowrap">one-third</FONT> of the aggregate market value of our outstanding common stock held by
<FONT STYLE="white-space:nowrap">non-affiliates</FONT> in any <FONT STYLE="white-space:nowrap">12-month</FONT> period, so long as the aggregate market value of our outstanding common stock held by
<FONT STYLE="white-space:nowrap">non-affiliates</FONT> remains below $75.0&nbsp;million. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">Our common stock is traded on the Nasdaq Capital
Market under the symbol &#8220;BCAB&#8221;. On January&nbsp;15, 2026, the closing price for our common stock, as reported on the Nasdaq Capital Market, was $0.3196 per share. The applicable prospectus supplement will contain information, where
applicable, as to any other listing, if any, of the securities covered by the applicable prospectus supplement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">We may offer and sell our
securities to or through one or more underwriters, dealers and agents, or directly to purchasers, on an immediate, continuous or delayed basis. The names of any underwriters, dealers or agents and the terms of the arrangements with such entities
will be stated in the accompanying prospectus supplement. See the sections of this prospectus entitled &#8220;About this Prospectus&#8221; and &#8220;Plan of Distribution&#8221; for more information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties referenced under the
heading &#8220;<A HREF="#toc31173_3">RISK FACTORS</A>&#8221; on page 3 of this prospectus as well as those contained in the applicable prospectus supplement and any related free writing prospectus, and in the other documents that are incorporated by
reference into this prospectus or the applicable prospectus supplement. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any
state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is &#8195;&#8195;&#8195;&#8195;, 2026 </B></P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P></DIV> <p STYLE="clear:both; font-size:1pt; height:0">&nbsp;</p>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_2">BIOATLA, INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_4">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_6">DESCRIPTION OF OUR CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_7">DESCRIPTION OF OUR DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_8">DESCRIPTION OF OUR WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_9">DESCRIPTION OF OUR UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_13">WHERE YOU CAN FIND ADDITIONAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc31173_14">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are responsible for the information contained and incorporated by reference in this prospectus, in any accompanying prospectus supplement,
and in any related free writing prospectus we prepare or authorize. We have not authorized anyone to give you any other information, and we take no responsibility for any other information that others may give you. If you are in a jurisdiction where
offers to sell, or solicitations of offers to purchase, the securities offered by this documentation are unlawful, or if you are a person to whom it is unlawful to direct these types of activities, then the offer presented in this document does not
extend to you. The information contained in this document speaks only as of the date of this document, unless the information specifically indicates that another date applies. Neither the delivery of this prospectus or any accompanying prospectus
supplement, nor any sale of securities made under these documents, will, under any circumstances, create any implication that there has been no change in our affairs since the date of this prospectus, any accompanying prospectus supplement or any
free writing prospectus we may provide you in connection with an offering or that the information contained or incorporated by reference is correct as of any time subsequent to the date of such information. You should assume that the information in
this prospectus or any accompanying prospectus supplement, as well as the information incorporated by reference in this prospectus or any accompanying prospectus supplement, is accurate only as of the date of the documents containing the
information, unless the information specifically indicates that another date applies. Our business, financial condition, results of operations and prospects may have changed since those dates. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement we filed with the Securities and Exchange Commission (&#8220;SEC&#8221;), using a
&#8220;shelf&#8221; registration process. Under this shelf registration process, we may sell any combination of the securities described in this prospectus from time to time in one or more offerings in an amount not to exceed $200,000,000 in the
aggregate. Before purchasing any securities, you should read this prospectus and any applicable prospectus supplement together with the additional information described under the headings &#8220;Where You Can Find Additional Information&#8221; and
&#8220;Incorporation of Certain Information by Reference.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus only provides you with a general description of the
securities we may offer. Each time we offer securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about the terms of the offering, including, among other things, the specific amounts,
prices and terms of the securities offered. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. This prospectus may not be used to sell our securities
unless accompanied by a prospectus supplement. Each such prospectus supplement and any free writing prospectus that we may authorize to be provided to you may also add, update or change information contained in this prospectus or in documents
incorporated by reference into this prospectus. If this prospectus is inconsistent with any prospectus supplement, you should rely upon the prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as
exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &#8220;Where You Can Find Additional Information.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus incorporates by reference, and any prospectus supplement or free writing prospectus may contain and incorporate by reference,
market data and industry statistics and forecasts that are based on independent industry publications and other publicly available information. Although we believe these sources are reliable, we do not guarantee the accuracy or completeness of this
information and we have not independently verified this information. In addition, the market and industry data and forecasts that may be included or incorporated by reference in this prospectus, any prospectus supplement or any applicable free
writing prospectus may involve estimates, assumptions and other risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#8220;Risk Factors&#8221; contained in this prospectus, the
applicable prospectus supplement and any applicable free writing prospectus, and under similar headings in other documents that are incorporated by reference into this prospectus. Accordingly, investors should not place undue reliance on this
information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise mentioned or unless the context requires otherwise, throughout this prospectus, any applicable prospectus
supplement and any related free writing prospectus, the words &#8220;BioAtla&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, &#8220;our company&#8221; or similar references refer to BioAtla, Inc.; and the term &#8220;securities&#8221;
refers collectively to our common stock, preferred stock, warrants, debt securities, or any combination of the foregoing securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have obtained a registered trademark for BioAtla<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> in the United States. This prospectus and documents incorporated by reference into this prospectus contains references to our trademarks and
to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus and the documents incorporated by reference into this prospectus, including logos, artwork and other visual displays, may
appear without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> or TM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights
of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_2"></A>BIOATLA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biopharmaceutical company developing our novel class of highly specific and selective antibody-based therapeutics for
the treatment of solid tumor cancer. Our CABs capitalize on our proprietary discoveries with respect to tumor biology, enabling us to target known and widely validated tumor antigens that have previously been difficult or impossible to target. Our
novel CAB therapeutic candidates exploit characteristic pH differences between the tumor microenvironment and healthy tissue. Unlike healthy tissue, the tumor microenvironment is acidic, and we have designed our antibodies to selectively bind to
their targets on tumor cells under acidic pH conditions but not on targets in normal tissues. Our approach is to identify the necessary targeting and potency required for cancer cell destruction, while aiming to eliminate or greatly reduce <FONT
STYLE="white-space:nowrap">on-target,</FONT> <FONT STYLE="white-space:nowrap">off-tumor</FONT> toxicity&#8212;one of the fundamental challenges of existing cancer therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a United States-based company with facilities in San Diego, California. Since the commencement of our operations, we have focused
substantially all of our resources on conducting research and development activities, including drug discovery, preclinical studies and clinical trials of our product candidates, including the ongoing Phase 2 clinical trials of mecbotamab vedotin
(BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and our Phase 1 clinical trial of BA3182 <FONT STYLE="white-space:nowrap">(CAB-EpCAM</FONT> x <FONT STYLE="white-space:nowrap">CAB-CD3),</FONT> establishing and maintaining our
intellectual property portfolio, manufacturing clinical and research material through third parties, hiring personnel, establishing product development and commercialization collaborations with third parties, raising capital and providing general
and administrative support for these operations. Since 2014, such research and development activities have exclusively related to the research, development, manufacture and Phase 1 and Phase&nbsp;2 clinical testing of our CAB antibody-based product
candidates and the strengthening of our proprietary CAB technology platform and pipeline. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CHANNELS FOR DISCLOSURE OF INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investors and others should note that we routinely announce material information to investors and the marketplace using filings with
the SEC, press releases, public conference calls, presentations, webcasts and our investor relations website. While not all of the information that we post to our investor relations website is of a material nature, some information could be deemed
to be material. Accordingly, we encourage investors, the media, and others interested in our company to review the information that we share at the &#8220;Investors&#8221; link located at the top of our webpage at www.ir.bioatla.com. Users may
automatically receive email alerts and other information about our company when enrolling an email address by visiting Email Alerts in the Resources section of our website at https://ir.bioatla.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our securities involves a high degree of risk. Before making a decision to invest in our securities, you should carefully
consider the risks described under the heading &#8220;Risk Factors&#8221; in the applicable prospectus supplement and any related free writing prospectus, and discussed under &#8220;Part I, Item 1A. Risk Factors&#8221; contained in our most recent
annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and in &#8220;Part II, Item 1A. Risk Factors&#8221; in our most recent quarterly report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed subsequent to such Form <FONT
STYLE="white-space:nowrap">10-K,</FONT> as well as any amendments thereto, which are incorporated by reference into this prospectus and the applicable prospectus supplement in their entirety, together with other information in this prospectus and
the applicable prospectus supplement, the documents incorporated by reference herein and therein, and any free writing prospectus that we may authorize for use in connection with a specific offering. See &#8220;Where You Can Find Additional
Information.&#8221; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_4"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, any prospectus supplement and any related free writing prospectus, including the information incorporated by
reference herein and therein, contain forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, or the Securities Act, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, or the
Exchange Act. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through the use of
words or phrases such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221;
&#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these words or other comparable
terminology. Accordingly, these statements involve estimates, assumptions and uncertainties which could cause actual results to differ materially from those expressed in them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given these uncertainties, you should not place undue reliance on these forward-looking statements as actual events or results may differ
materially from those projected in the forward-looking statements due to various factors, including, but not limited to, those set forth under the heading &#8220;Risk Factors&#8221; in any applicable prospectus supplement, the documents incorporated
by reference therein or any free writing prospectus that we authorized. Our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements contained in this prospectus, in the documents
incorporated by reference herein and in any prospectus supplement by these cautionary statements. These forward-looking statements speak only as of the date on which the statements were made and are not guarantees of future performance. Although we
undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to review any additional disclosures we make in the documents we subsequently file with
the SEC that are incorporated by reference in this prospectus and any prospectus supplement. See &#8220;Where You Can Find Additional Information.&#8221; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in a prospectus supplement, we intend to use the net proceeds from the sale of securities offered by this
prospectus and any applicable prospectus supplement for general corporate purposes. Until we apply the proceeds from a sale of securities to their intended purposes, we may invest those proceeds in short-term, interest-bearing, investment-grade
securities or hold as cash. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_6"></A>DESCRIPTION OF OUR CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have one class of securities registered under Section&nbsp;12 of the Exchange Act: our common stock. The following summary of the terms of
our common stock is based upon our amended and restated certificate of incorporation and our amended and restated bylaws. This summary does not purport to be complete and is subject to, and is qualified in its entirety by express reference to, the
applicable provisions of our amended and restated certificate of incorporation and our amended and restated bylaws, which are filed as exhibits to our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and are incorporated by
reference herein. We encourage you to read our amended and restated certificate of incorporation, our amended and restated bylaws and the applicable provisions of the Delaware General Corporation Law for more information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common stock and class B common stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
are authorized to issue up to a total of 350,000,000 shares of common stock, par value $0.0001 per share, and up to a total of 15,368,569 shares of Class&nbsp;B common stock, par value $0.0001 per share. No Class&nbsp;B common stock is outstanding
as of December&nbsp;31, 2025. The holders of our common stock and Class&nbsp;B common stock have identical rights, provided that (i)&nbsp;except as otherwise expressly provided in our amended and restated certificate of incorporation or as required
by applicable law, on any matter that is submitted to a vote by our stockholders, holders of our common stock are entitled to one vote per share of common stock, and holders of our Class&nbsp;B common stock are not entitled to any votes per share of
Class&nbsp;B common stock, including for the election of directors and (ii)&nbsp;holders of our common stock have no conversion rights, while holders of our Class&nbsp;B common stock shall have the right to convert each share of our Class&nbsp;B
common stock into one share of common stock at such holder&#8217;s election, provided that as a result of such conversion, such holder would not beneficially own in excess of 4.99% of any class of our securities registered under the Exchange Act,
unless otherwise as expressly provided for in our amended and restated certificate of incorporation. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class&nbsp;B common stock upon
61 days&#8217; notice to us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock and Class&nbsp;B common stock have no preemptive rights or other subscription rights or
redemption or sinking fund provisions. Upon our liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> holders of our common stock and Class&nbsp;B common stock are entitled to share ratably in all assets remaining after
payment of all liabilities and the liquidation preferences of any of our outstanding shares of preferred stock. Subject to preferences that may be applicable to any outstanding shares of preferred stock, holders of our common stock and Class&nbsp;B
common stock are entitled to receive dividends only if declared from time to time by our board of directors out of assets which are legally available. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our amended and
restated certificate of incorporation, our board of directors has the authority, without further action by the stockholders, to issue up to 200,000,000 shares of preferred stock in one or more series, to establish from time to time the number of
shares to be included in each such series, to fix the rights, preferences and privileges of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon and to increase or decrease the number of shares of any
such series, but not below the number of shares of such series then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors may authorize the issuance of
preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions
and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control that may otherwise benefit holders of our common stock and may adversely affect the market price of the common
stock and the voting and other rights of the holders of common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Series A Junior Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;9, 2026, our board of directors authorized the issuance of one (1)&nbsp;share of Series A Junior Preferred Stock, par value
$0.0001 per share (the &#8220;Super-Voting Share&#8221;), to Jay M. Short, Ph.D., the Company&#8217;s Chairman, Chief Executive Officer and <FONT STYLE="white-space:nowrap">co-founder,</FONT> and the Company filed a Certificate of Designation of
Series&nbsp;A Junior Preferred Stock (the &#8220;Certificate of Designation&#8221;) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights, preferences and privileges of the Super-Voting Share are set forth in the Certificate of Designation. The Super-Voting Share
entitles the holder thereof to vote together with the holders of the Company&#8217;s common stock as a single class on any proposal to approve (i)&nbsp;an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation to
reclassify by combining the issued shares of Common Stock into a lesser number of issued shares of common stock and (ii)&nbsp;an adjournment of any meeting at which such a proposal is submitted to stockholders or (iii)&nbsp;any other matter that the
board of directors determines (in its sole discretion) is related to a such a proposal (each a &#8220;Voting Proposal&#8221;). The Super-Voting Share allows the holder to cast a number of votes, in person or by proxy, equal to the number of shares
of common stock outstanding on the record date for determining stockholders entitled to vote at the meeting at which such Voting Proposal will be submitted, provided that the holder of the Super-Voting Share is required to cast all votes
&#8220;for&#8221; the Voting Proposal if at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> (2/3) of the voting power of the common stock present and entitled to vote approve the Voting Proposal, and &#8220;against&#8221; the Voting
Proposal if less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> (2/3) of the voting power of the common stock present and entitled to vote approve such Voting Proposal. Except as required by law or as otherwise provided in the Certificate
of Designation, the Super-Voting Share does not entitle the holder to vote on any other matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holder of the Super-Voting Share is
not entitled to receive dividends. Subject to the prior rights of any other class or series of capital stock of the Company, upon a liquidation, dissolution or winding up of the Company, the holder of the Super-Voting Share will be entitled to $0.01
(payable out of funds legally available therefor) before any distribution or payment shall be made to the holders of common stock. The Super-Voting Share may be redeemed at any time at the option of the board of directors for $0.01 in cash out of
funds legally available therefor. In the event of a merger or consolidation of the Company with or into another entity, the Super-Voting Share will not entitle the holder to receive any consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holder of the Super-Voting Share may not transfer such share or any interest in such share to any other person or entity without the prior
consent of the board of directors, except for the provision of a proxy to a person designated by the Company in connection with any Voting Proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;20, 2024, in
connection with a registered direct offering, we issued warrants (the &#8220;Warrants&#8221;) which may be exercised to acquire our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>General Terms of the Warrants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2025, the outstanding Warrants represent the rights to purchase up to an aggregate of 9,679,158 shares of common stock
at an initial exercise price of $1.19 per share. The Warrants became exercisable on June&nbsp;20, 2025 and will expire five years from the date of initial exercisability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Duration and Exercise Price </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Warrant has an initial exercise price per share equal to $1.19. Each Warrant became exercisable beginning June&nbsp;20, 2025 at an
exercise price of $1.19 per share and will expire June&nbsp;20, 2030. The exercise price is subject to adjustment in the event of stock dividends, stock splits, rights offerings or other distributions to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
holders of common stock, reorganizations or similar events affecting our common stock and the exercise price. In the event of a reverse stock split, the number of shares of common stock issuable
upon the exercise of our outstanding Warrants and the exercise price of the Warrants will increase in proportion to the reverse stock split ratio. Furthermore, if the lowest volume weighted average price (&#8220;VWAP&#8221;) of the common stock
during the eleven (11)&nbsp;trading days (the &#8220;Adjustment Period&#8221;) commencing five (5)&nbsp;trading days immediately preceding the reverse stock split and ending five (5)&nbsp;trading days immediately following the reverse stock split is
less than the Warrant&#8217;s adjusted exercise price, then the exercise price of the Warrant will be reduced to match that lowest VWAP, as adjusted for the reverse stock split. This adjustment is applied retroactively to the first trading day of
the Adjustment Period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Exercisability and Exercise Limitations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice
accompanied by payment in full for the number of shares of our common stock purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of such
holder&#8217;s Warrant to the extent that the holder would own more than 9.99% of the outstanding shares of common stock immediately after exercise, as such percentage ownership is determined in accordance with the terms of the Warrants. No
fractional shares of common stock will be issued in connection with the exercise of a Warrant. In lieu of fractional shares, we will either pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up
to the next whole share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Cashless Exercise </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, at the time a holder exercises its Warrants, a registration statement registering the issuance of the shares of common stock underlying the
Warrants under the Securities Act is not then effective or available, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to
receive upon such exercise (either in whole or in part) the net number of shares of common stock determined according to a formula set forth in the Warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Fundamental Transaction </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any fundamental transaction, as described in the Warrants and generally including any merger with or into another entity, sale
of all or substantially all of our assets, tender offer or exchange offer, or reclassification of our shares of common stock, then upon any subsequent exercise of a Warrant, the holder will have the right to receive as alternative consideration, for
each share of common stock that would have been issuable upon such exercise immediately prior to the occurrence of such fundamental transaction, the number of shares of common stock of the successor or acquiring corporation of our company, if it is
the surviving corporation, and any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of common stock for which the Warrant is exercisable immediately prior to such event. Notwithstanding
the foregoing, in the event of a fundamental transaction, the holders of the Warrants have the right to require us or a successor entity to redeem the Warrants for cash in the amount of the Black-Scholes Value (as defined in each Warrant) of the
unexercised portion of the Warrants concurrently with or within 30 days following the consummation of a fundamental transaction. However, in the event of a fundamental transaction which is not in our control, including a fundamental transaction not
approved by our board of directors, the holders of the Warrants will only be entitled to receive from us or our successor entity, as of the date of consummation of such fundamental transaction the same type or form of consideration (and in the same
proportion), at the Black Scholes Value of the unexercised portion of the Warrant that is being offered and paid to the holders of our common stock in connection with the fundamental transaction, whether that consideration is in the form of cash,
stock or any combination of cash and stock, or whether the holders of our common stock are given the choice to receive alternative forms of consideration in connection with the fundamental transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Transferability </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable laws, a Warrant may be transferred at the option of the holder upon surrender of the Warrant to us together with the
appropriate instruments of transfer and payment of funds sufficient to pay any transfer taxes (if applicable). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Exchange Listing
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no trading market available for the Warrants on any securities exchange or nationally recognized trading system. We do
not plan on applying to list the Warrants on The Nasdaq Capital Market, any other national securities exchange or any other nationally recognized trading system. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>No Rights as a Stockholder </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in the Warrants or by virtue of such holder&#8217;s ownership of shares of our common stock, the holder of a
Warrant does not have the rights or privileges of a holder of our common stock, including any voting rights or the rights to receive dividends, until the holder exercises the Warrant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Resale Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Purchase Agreement, we have agreed to use our best efforts to maintain the effectiveness of a registration statement covering the
resale of the shares issuable upon exercise of the Warrants for as long as the holder continues to hold the Warrants or until the Warrants have expired. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-takeover effects of provisions of our certificate of incorporation, our bylaws and Delaware law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of Delaware law and certain provisions included in our amended and restated certificate of incorporation and amended and
restated bylaws, summarized below, may be deemed to have an anti-takeover effect and may delay or discourage transactions involving an actual or potential change in our control or change in our management, including transactions in which
stockholders might otherwise receive a premium for their shares or transactions that our stockholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Delaware anti-takeover law </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to Section&nbsp;203 of the Delaware General Corporation Law, or Section&nbsp;203. Section&nbsp;203 generally prohibits a public
Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the date of the transaction, the board of directors of the corporation approved either the business
combination or the transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding upon
consummation of the transaction, excluding for purposes of determining the number of shares outstanding (a)&nbsp;shares owned by persons who are directors and also officers and (b)&nbsp;shares owned by employee stock plans in which employee
participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on or subsequent to the consummation of the transaction, the business combination is approved by the board and
authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 defines a business combination to include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any merger or consolidation involving the corporation and the interested stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sale, transfer, pledge or other disposition involving the interested stockholder of 10% or more of the assets
of the corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction involving the corporation that has the effect of increasing the
proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock
of the corporation to the interested stockholder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other
financial benefits provided by or through the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines an interested
stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Preferred stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation contains provisions that permit our board of directors to issue, without any further vote
or action by the stockholders, shares of preferred stock in one or more series and, with respect to each such series, to fix the number of shares constituting the series and the designation of the series, the voting rights (if any) of the shares of
the series and the powers, preferences or relative, participation, optional and other special rights, if any, and any qualifications, limitations or restrictions, of the shares of such series. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Classified board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that our board of directors is divided into three classes, designated
Class&nbsp;I, Class&nbsp;II and Class&nbsp;III. Each class will be an equal number of directors, as nearly as possible, consisting of one third of the total number of directors constituting the entire board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Removal of directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that stockholders may only remove a director for cause by a vote of at least 66
2/3% of the voting power of all of our then outstanding common stock and that the authorized number of directors may be changed only by resolution adopted by a majority of the board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Director vacancies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that all vacancies, including newly created directorships, may, except as
otherwise required by law or subject to the rights of holders of preferred stock as designated from time to time, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Special meetings of stockholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and our amended and restated bylaws provide that, except as otherwise required by law,
special meetings of our stockholders may be called only by the chairman of the board, our Chief Executive Officer or by the board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors (whether or not
there exists any vacancies). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Advance notice procedures for director nominations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated bylaws provide that stockholders seeking to nominate candidates
for election as directors at an annual or special meeting of stockholders must provide timely notice thereof in writing and also specify requirements as to the form and content of a stockholder&#8217;s notice. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Action by written consent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated bylaws require that any action to be taken by our stockholders
must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Cumulative voting
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides for cumulative voting rights (therefore allowing the holders of a
majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Amending our certificate of incorporation and bylaws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amendment of any of the provisions in our amended and restated certificate of incorporation, with the exception of the ability of our board
of directors to issue shares of preferred stock and designate any rights, preferences and privileges thereto, would require the affirmative vote of the holders of at least 66 2/3% of the voting power of all of our then outstanding common stock.
Additionally, our amended and restated certificate of incorporation provides that our bylaws may be amended, altered or repealed by the board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Exclusive forum provision </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the
Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware does not have jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for the following types of
proceedings: (i)&nbsp;any derivative action or proceeding brought on behalf of our company, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, employees or stockholders to our company or our
stockholders, (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware or as to which the General Corporation Law of the State of Delaware confers jurisdiction on the Court of
Chancery of the State of Delaware or (iv)&nbsp;any action asserting a claim arising pursuant to any provision of our amended and restated certificate of incorporation or amended and restated bylaws (in each case, as they may be amended from time to
time) or governed by the internal affairs doctrine. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction.
Furthermore, Section&nbsp;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. Our amended
and restated bylaws further provide that the federal district courts of the United States of America will be the exclusive forum to the fullest extent permitted by law, for resolving any complaint asserting a cause of action arising under the
Securities Act. This choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such
lawsuits against us and our directors, officers and employees. Alternatively, if a court were to find these provisions of our amended and restated certificate of incorporation and amended and restated bylaws inapplicable to, or unenforceable in
respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition. Any person or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of and to have consented to the provisions of our amended and restated
certificate of incorporation and amended and restated bylaws described above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nasdaq Capital Market </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The Nasdaq Capital Market under the symbol &#8220;BCAB.&#8221; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer agent and registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
transfer agent and registrar for our common stock and Class&nbsp;B common stock is Pacific Stock Transfer Company. The transfer agent and registrar&#8217;s address is 6725 Via Austi Pkwy, Suite 300, Las Vegas, NV 89119. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_7"></A>DESCRIPTION OF OUR DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue debt securities from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated
convertible debt. While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in the
applicable prospectus supplement. The terms of any debt securities offered under a prospectus supplement may differ from the terms described below. Unless the context requires otherwise, whenever we refer to the indenture, we also are referring to
any supplemental indentures that specify the terms of a particular series of debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will issue the debt securities under one
or more separate indentures that we will enter into with the trustee named in the indenture. The indenture will be qualified under the Trust Indenture Act of 1939, as amended, or the Trust Indenture Act. We have filed a form of indenture under which
debt securities may be issued from time to time as an exhibit to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will
be filed as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we file with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary of material provisions of the debt securities and the indenture is subject to, and qualified in its entirety by
reference to, all of the provisions of the indenture applicable to a particular series of debt securities. We urge you to read the applicable prospectus supplements and any related free writing prospectuses related to the debt securities that we may
offer under this prospectus, as well as the complete indenture that contains the terms of the debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt securities will
represent unsecured general obligations of the Company, unless otherwise provided in the applicable offering material. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this section of
the prospectus, the term &#8220;the Company&#8221; refers only to BioAtla, Inc. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture does not limit the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal
amount that we may authorize and may be in any currency or currency unit that we may designate. The prospectus supplement, documents incorporated by reference, or free writing prospectus with respect to any debt securities will set forth the
following terms of the debt securities offered pursuant thereto as applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title and series of such debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the principal amount being offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the total amount authorized and the total amount outstanding as of the most recent practicable date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit upon the aggregate principal amount of such debt securities of such series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such debt securities will be in global or other form; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates and method or methods by which principal and any premium on such debt securities is payable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interest rate or rates (or method by which such rate will be determined), if any; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates on which any such interest will start accruing and become payable, record dates for interest payments
and the method of payment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether and under what circumstances any additional amounts are payable with respect to such debt securities;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the notice, if any, to holders of such debt securities regarding the determination of interest on a floating rate
debt security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the basis upon which interest on such debt securities shall be calculated, if other than that of a 360 day year
of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where the principal of and interest or additional amounts, if any, on such debt securities
will be payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any redemption or sinking fund provisions, or the terms of any repurchase at the option of the holder of the debt
securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations of such debt securities, if other than $1,000 and integral multiples thereof;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any rights of the holders of such debt securities to convert the debt securities into and/or exchange the debt
securities for, other securities, cash or other property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, on which payment of principal or any premium, interest or additional amounts on such debt
securities will be payable in a currency other than U.S. dollars; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, by which the amount of payments of principal or any premium, interest or additional amounts on
such debt securities may be determined by reference to an index, formula, financial or economic measure or other methods; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than the principal amount thereof, the portion of the principal amount of such debt securities that will
be payable upon declaration of acceleration of the maturity thereof or the method by which such portion is to be determined; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any events of default or covenants in addition to or in lieu of those described herein and remedies therefor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such debt securities will be subject to defeasance or covenant defeasance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, upon which such debt securities are to be issuable upon the exercise of warrants, units or
rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">name of any trustees and any authenticating or paying agents or registrars or depositaries or any other agents
with respect to such debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities rank as senior debt, senior subordinated debt, subordinated debt or any combination
thereof, and the terms of any subordination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such debt securities will be guaranteed and the terms thereof; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such debt securities will be secured by collateral and the terms of such security; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other specific terms of such debt securities and any other deletions from or additions to or modifications of
the indenture with respect to such debt securities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Debt securities may be presented for exchange, conversion or
transfer in the manner, at the places and subject to the restrictions set forth in the debt securities and the applicable offering material. Such services will be provided without charge, other than any tax or other governmental charge payable in
connection therewith, but subject to the limitations provided in the indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture does not contain any covenant or other
specific provision affording protection to holders of the debt securities in the event of a highly leveraged transaction or a change in control of the Company, except to the limited extent described below under &#8220;&#8212;Consolidation, Merger
and Sale of Assets.&#8221; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that supplements to the indenture may be made by the Company and the trustee for the purpose of adding any provisions to
or changing in any manner or eliminating any of the provisions of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indenture or of modifying in any manner the rights of the holders of debt securities of a series under the indenture or the debt securities of such series, with the consent of the holders of a
majority (or such greater amount as is provided for a particular series of debt securities) in principal amount of the outstanding debt securities issued under such indenture that are affected by the supplemental indenture, voting as a single class;
provided that no such supplemental indenture may, without the consent of the holder of each such debt security affected thereby, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">change the stated maturity of the principal of, or any premium, interest or additional amounts on, such debt
securities, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest or any additional amounts thereon, or reduce any premium payable on redemption thereof or otherwise, or change the obligation to pay
additional amounts pursuant to the indenture, or reduce the amount of the principal of debt securities issued with original issue discount that would be due and payable upon an acceleration of the maturity thereof or the amount thereof provable in
bankruptcy, or change the redemption provisions or adversely affect the right of repayment at the option of the holder, or change the place of payment or currency in which the principal of, or any premium, interest or additional amounts with respect
to any debt security is payable, or impair the right of any holder of debt securities to institute suit for the payment after such payment is due (or, in the case of redemption, on or after such redemption date or, in the case of repayment at the
option of the holder, on or after such payment is due); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reduce the percentage in principal amount of outstanding debt securities of any series, the consent of the
holders of which is required for any such supplemental indenture, or the consent of whose holders is required for any waiver provided for in the indenture, or reduce the requirements for quorum or voting; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">modify any of the provisions of the sections of such indenture relating to supplemental indentures with the
consent of the holders, waivers of past defaults or waivers of certain provisions or covenants, except to increase any such percentage or to provide that certain other provisions of such indenture cannot be modified or waived without the consent of
each holder affected thereby; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make any change that adversely affects the right to convert or exchange any security into or for common stock
or other securities, cash or other property in accordance with the terms of the applicable debt security. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture
provides that a supplemental indenture that changes or eliminates any covenant or other provision of the indenture that has expressly been included solely for the benefit of one or more particular series of debt securities, or that modifies the
rights of the holders of such series with respect to such covenant or other provision, shall be deemed not to affect the rights under the indenture of the holders of debt securities of any other series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that the Company and the trustee may, without the consent of the holders of any series of debt securities issued
thereunder, enter into additional supplemental indentures for one of the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to evidence the succession of another corporation to the Company and the assumption by any such successor of
the covenants of the Company in such indenture and in the debt securities issued thereunder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add to the covenants of the Company for the benefit of the holders of any series of debt securities issued
thereunder or to surrender any right or power conferred on the Company pursuant to the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to establish the form and terms of debt securities issued thereunder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to evidence and provide for the acceptance of an appointment of a successor trustee under such indenture with
respect to one or more series of debt securities issued thereunder and to add to or change </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
any of the provisions of the indenture as necessary to provide for or facilitate the administration of the trusts under such indenture by more than one trustee pursuant to the indenture;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to cure any ambiguity, to correct or supplement any provision in the indenture that may be defective or
inconsistent with any other provision of the indenture or to make any other provisions with respect to matters or questions arising under such indenture; provided that no such action pursuant to this clause (e)&nbsp;shall adversely affect the
interests of the holders of any series of outstanding debt securities issued thereunder in any material respect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add to, delete from or revise the conditions, limitations and restrictions on the authorized amount, terms
or purposes of issue, authentication and delivery of securities under the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add any additional events of default with respect to all or any series of debt securities (as shall be
specified in such supplemental indenture); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to supplement any of the provisions of the indenture as may be necessary to permit or facilitate the defeasance
and discharge of any series of debt securities, provided that such action does not adversely affect the interests of any holder of an outstanding debt security of such series or any other security in any material respect; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to make provisions with respect to the conversion or exchange rights of holders of debt securities of any
series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add guarantees in respect of the debt securities of one or more series and to provide for the terms and
conditions of release thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to convey, transfer, assign, mortgage or pledge to the trustee as security for the debt securities of any
series any property or assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to change or eliminate any of the provisions of the indenture, provided that any such change or elimination
become effective only when there is no security of any series outstanding created prior to the execution of such supplemental indenture which is entitled to the benefit of such provision; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to provide for certificated securities in addition to or in place of global securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to qualify such indenture under the Trust Indenture Act of 1939, as amended; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">with respect to the debt securities of any series, to conform the text of the indenture or the debt securities
of such series to any provision of the description thereof in the Company&#8217;s offering memorandum or prospectus relating to the initial offering of such debt securities, to the extent that such provision, in the good faith judgment of the
Company, was intended to be a verbatim recitation of a provision of the indenture or such securities; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to make any other change that does not adversely affect the rights of holders of any series of debt securities
issued thereunder in any material respect. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in any applicable prospectus supplement, documents incorporated by reference or free writing prospectus, the
following will be events of default under the indenture with respect to each series of debt securities issued thereunder: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">default for 30 days in the payment when due of interest on, or any additional amount in respect of, any series
of debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">default in the payment of principal of or any premium on any series of the debt securities outstanding under
the indenture when due and payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">default in the deposit, if any, of any sinking fund payment when and as due by the terms of any debt security
of such series, subject to any cure period that may be specified in any debt security of such series; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">failure by the Company for 60 days after receipt by written notice from the trustee upon instruction from
holders of at least 25% in principal amount of the debt securities outstanding of such series to observe or perform any of the other covenants or agreements in the indenture and stating that such notice is a &#8220;Notice of Default&#8221; pursuant
to the indenture; provided, that if such failure cannot be cured within such <FONT STYLE="white-space:nowrap">60-day</FONT> period, such period shall be automatically extended by another 60 days so long as (i)&nbsp;such failure is subject to cure
and (ii)&nbsp;the Company is using commercially reasonable efforts to cure such failure; and provided, further, that a failure to comply with any such other agreement in the indenture that results from a change in U.S. generally accepted accounting
principles shall not be deemed to be an event of default; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">certain events of bankruptcy, insolvency, reorganization or other similar action of the Company; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other event of default provided in the indenture with respect to a particular series of debt securities,
provided that any such event of default that results from a change in U.S. generally accepted accounting principles shall not be deemed to be an event of default. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case an event of default specified in clause (a)&nbsp;or (b) above shall occur and be continuing with respect to any series of debt
securities, holders of at least 25%, and in case an event of default specified in any clause other than clause (a), (b) or (e)&nbsp;above shall occur and be continuing with respect to any series of debt securities, holders of at least a majority in
aggregate principal amount of the debt securities of such series then outstanding may declare the principal (or, in the case of discounted debt securities, the amount specified in the terms thereof) of such series to be due and payable. If an event
of default described in (e)&nbsp;above shall occur and be continuing then the principal amount (or, in the case of discounted debt securities, the amount specified in the terms thereof) of all the debt securities outstanding shall be and become due
and payable immediately, without notice or other action by any holder or the trustee, to the full extent permitted by law. Any past or existing default or event of default with respect to a particular series of debt securities under such indenture
may be waived by the holders of a majority in aggregate principal amount of the outstanding debt securities of such series, except in each case a continuing default (1)&nbsp;in the payment of the principal of, any premium or interest on, or any
additional amounts with respect to, any debt security of such series, or (2)&nbsp;in respect of a covenant or provision which cannot be modified or amended without the consent of each holder affected thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that the Company must periodically furnish the trustee with a written statement as to the Company&#8217;s compliance
with the covenants contained in the indenture and as to the absence of default under the indenture terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that the
trustee may withhold notice to the holders of any default with respect to any series of debt securities (except in payment of principal of or interest or premium on, or sinking fund payment in respect of, the debt securities) if and so long as the
board of directors, the executive committee or a trust committee of directors of the trustee and/or responsible officers of the trustee in good faith determine that the withholding of such notice is in the best interest of the holders of securities
of such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture contains a provision entitling the trustee to be indemnified by the holders before proceeding to exercise
any trust or power under the indenture at the request of such holders. The indenture provides that the holders of a majority in aggregate principal amount of the then outstanding debt securities of any series may direct the time, method and place of
conducting any proceedings for any remedy available to the trustee or of exercising any trust or power conferred upon the trustee with respect to the debt securities of such series; provided, however, that the trustee may decline to follow any such
direction if, among other reasons, the trustee determines in good faith that the actions or proceedings as directed may not lawfully be taken or would be unduly prejudicial to the holders of the debt securities of such series not joining in such
direction. The right of a holder to institute a proceeding with respect to a series of debt securities will be subject to certain conditions precedent including, without limitation, that in case of an event of default specified in clause (a), (b) or
(e)&nbsp;of the first paragraph above under &#8220;&#8212;Events of Default,&#8221; holders of at least 25%, or in case of an event of default other than specified in clause (a), (b) or (e)&nbsp;of the first paragraph above under
&#8220;&#8212;Events of Default&#8221;, holders of at least a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
majority, in aggregate principal amount of the debt securities of such series then outstanding make a written request upon the trustee to exercise its powers under such indenture, indemnify the
trustee and afford the trustee reasonable opportunity to act. Notwithstanding the foregoing, the holder has an absolute right to receipt of the principal of, premium, if any, and interest when due on the debt securities, to require conversion of
debt securities if such indenture provides for convertibility at the option of the holder and to institute suit for the enforcement thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger and Sale of Assets</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that the Company may not directly or indirectly consolidate with or merge with or into, or sell, assign, transfer,
lease, convey or otherwise dispose of all or substantially all of its assets and properties and the assets and properties of its subsidiaries (taken as a whole) to another person in one or more related transactions unless the successor person is a
person organized under the laws of any domestic jurisdiction and assumes the Company&#8217;s obligations on the debt securities issued thereunder, and under the indenture, and after giving effect thereto no event of default, and no event that, after
notice or lapse of time or both, would become an event of default, shall have occurred and be continuing, and that certain other conditions are met. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Covenants</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Payment of Principal, any Premium,
Interest or Additional Amounts. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will duly and punctually pay the principal of, and premium and interest on or any
additional amounts payable with respect to, any debt securities of any series in accordance with their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Maintenance of Office or Agency.
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will be required to maintain an office or agency in each place of payment for each series of debt securities for notice
and demand purposes and for the purposes of presenting or surrendering debt securities for payment, registration of transfer, or exchange. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Reports.
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as any debt securities of a particular series are outstanding under the indenture, the Company will file with the trustee,
within 30 days after the Company has filed the same with the SEC, unless such reports are available on the SEC&#8217;s EDGAR filing system (or any successor thereto), copies of the annual reports and of the information, documents and other reports
(or copies of such portions of any of the foregoing as the SEC may from time to time by rules and regulations prescribe) which the Company may be required to file with the SEC pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act;
or, if the Company is not required to file information, documents or reports pursuant to either of said Sections, then it shall file with the trustee and the SEC, in accordance with rules and regulations prescribed from time to time by the SEC, such
of the supplementary and periodic information, documents and reports which may be required pursuant to Section&nbsp;13 of the Exchange Act in respect of a security listed and registered on a national securities exchange as may be prescribed from
time to time in such rules and regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Additional Covenants. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any additional covenants of the Company with respect to any series of debt securities will be set forth in the applicable prospectus
supplement, documents incorporated by reference or free writing prospectus relating thereto. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conversion Rights</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms and conditions, if any, upon which the debt securities are convertible into common stock or preferred stock will be set forth in the
applicable prospectus supplement, documents incorporated by reference or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
free writing prospectus relating thereto. Such terms will include the conversion price (or manner of calculation thereof), the conversion period, provisions as to whether conversion will be at
the option of the holders or the Company, the events requiring an adjustment of the conversion price and provisions affecting conversion in the event of redemption of such debt securities and any restrictions on conversion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption; Repurchase at the Option of the Holder; Sinking Fund</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms and conditions, if any, upon which (a)&nbsp;the debt securities are redeemable at the option of the Company, (b)&nbsp;the holder of
debt securities may cause the Company to repurchase such debt securities or (c)&nbsp;the debt securities are subject to any sinking fund will be set forth in the applicable prospectus supplement, documents incorporated by reference or free writing
prospectus relating thereto. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Repurchases on the Open Market</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company or any affiliate of the Company may at any time or from time to time repurchase any debt security in the open market or otherwise.
Such debt securities may, at the option of the Company or the relevant affiliate of the Company, be held, resold or surrendered to the trustee for cancellation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Discharge, Defeasance and Covenant Defeasance</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides, with respect to each series of debt securities issued thereunder, that the Company may satisfy and discharge its
obligations under such debt securities of a series and such indenture with respect to debt securities of such series if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all debt securities of such series previously authenticated and delivered, with certain exceptions, have been
delivered to the trustee for cancellation; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the debt securities of such series have become due and payable, or mature within one year, or all of them are
to be called for redemption within one year under arrangements satisfactory to the trustee for giving the notice of redemption and the Company irrevocably deposits in trust with the trustee, as trust funds solely for the benefit of the holders of
such debt securities, for that purpose, money or governmental obligations or a combination thereof sufficient (in the opinion of a nationally recognized independent registered public accounting firm expressed in a written certification thereof
delivered to the trustee) to pay and discharge the entire indebtedness on the debt securities of such series to maturity or redemption, as the case may be, and pays all other sums payable by it under such indenture; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company delivers to the trustee an officers&#8217; certificate and an opinion of counsel, in each case
stating that all conditions precedent provided for in such indenture relating to the satisfaction and discharge of such indenture with respect to the debt securities of such series have been complied with. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding such satisfaction and discharge, the obligations of the Company to compensate and indemnify the trustee, to pay additional
amounts, if any, in respect of debt securities in certain circumstances and to convert or exchange debt securities pursuant to the terms thereof and the obligations of the Company and the trustee to hold funds in trust and to apply such funds
pursuant to the terms of the indenture, with respect to issuing temporary debt securities, with respect to the registration, transfer and exchange of debt securities, with respect to the replacement of mutilated, destroyed, lost or stolen debt
securities and with respect to the maintenance of an office or agency for payment, shall in each case survive such satisfaction and discharge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless inapplicable to debt securities of a series pursuant to the terms thereof, the indenture provides that (i)&nbsp;the Company will be
deemed to have paid and will be discharged from any and all obligations in respect of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
debt securities issued thereunder of any series, and the provisions of such indenture will, except as noted below, no longer be in effect with respect to the debt securities of such series
(&#8220;defeasance&#8221;) and (ii)&nbsp;(1) the Company may omit to comply with the covenant under &#8220;&#8212;Consolidation, Merger and Sale of Assets&#8221; and any other additional covenants established pursuant to the terms of such series,
and such omission shall be deemed not to be an event of default under clause (d)&nbsp;or (f) of the first paragraph of &#8220;&#8212;Events of Default&#8221; and (2)&nbsp;the occurrence of any event described in clause (f)&nbsp;of the first
paragraph of &#8220;&#8212;Events of Default&#8221; shall not be deemed to be an event of default, in each case with respect to the outstanding debt securities of such series ((1) and (2)&nbsp;of this clause (ii), &#8220;covenant defeasance&#8221;);
provided that the following conditions shall have been satisfied with respect to such series: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company has irrevocably deposited in trust with the trustee as trust funds solely for the benefit of the
holders of the debt securities of such series, for payment of the principal of and interest of the debt securities of such series, money or government obligations or a combination thereof sufficient (in the opinion of a nationally recognized
independent registered public accounting firm expressed in a written certification thereof delivered to the trustee) without consideration of any reinvestment to pay and discharge the principal of and accrued interest on the outstanding debt
securities of such series to maturity or earlier redemption, as the case may be; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such defeasance or covenant defeasance will not result in a breach or violation of, or constitute a default
under, such indenture or any other material agreement or instrument to which the Company is a party or by which it is bound; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no event of default or event which with notice or lapse of time would become an event of default with respect
to such debt securities of such series shall have occurred and be continuing on the date of such deposit; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company shall have delivered to such trustee an opinion of counsel as described in the indenture to the
effect that the holders of the debt securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of the Company&#8217;s exercise of its option under this provision of such indenture and will be
subject to federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit and defeasance or covenant defeasance had not occurred; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company has delivered to the trustee an officers&#8217; certificate and an opinion of counsel, in each case
stating that all conditions precedent provided for in such indenture relating to the defeasance contemplated have been complied with; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the debt securities are to be redeemed prior to their maturity, notice of such redemption shall have been
duly given or in another manner satisfactory to the trustee; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any such defeasance or covenant defeasance shall comply with any additional or substitute terms provided for by
the terms of such debt securities of such series. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding a defeasance or covenant defeasance, the
Company&#8217;s obligations with respect to the following in respect of debt securities of such series will survive with respect to such securities until otherwise terminated or discharged under the terms of the indenture or no debt securities of
such series are outstanding: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the rights of holders of outstanding debt securities of such series to receive payments in respect of the
principal of, interest on or premium or additional amounts, if any, payable in respect of, such debt securities when such payments are due from the trust referred in clause (a)&nbsp;in the preceding paragraph, and any rights of such holder to
convert or exchange such debt securities into common stock or other securities, cash or other property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issuance of temporary debt securities, the registration, transfer and exchange of debt securities, the
replacement of mutilated, destroyed, lost or stolen debt securities and the maintenance of an office or agency for payment and holding payments in trust, and the Company&#8217;s obligations with respect to the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
payment of additional amounts, if any, on such securities, and with respect to any rights to convert or exchange such securities into common stock or other securities, cash or other property;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the rights, powers, trusts, duties and immunities of the trustee, and the Company&#8217;s obligations in
connection therewith; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the defeasance or covenant defeasance provisions of the indenture. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Concerning the Trustee</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
trustee, other than during the occurrence and continuance of an event of default under the indenture, undertakes to perform only those duties as are specifically set forth in the indenture. Upon an event of default under the indenture, the trustee
must use the same degree of care as a prudent person would exercise or use under the circumstances in the conduct of his or her own affairs. Subject to this provision and certain other limitations, the trustee is under no obligation to exercise any
of the powers given it by the indenture at the request of any holder of debt securities unless it is offered indemnity satisfactory to it against the costs, expenses and liabilities that it might incur. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Applicable Law</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides
that the debt securities and the indenture will be governed by and construed in accordance with the laws of the State of New York, except to the extent that the Trust Indenture Act is applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_8"></A>DESCRIPTION OF OUR WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue warrants to purchase our debt or equity securities or securities of third parties or other rights, including rights to receive
payment in cash or securities based on the value, rate or price of one or more specified commodities, currencies, securities or indices, or any combination of the foregoing. Warrants may be issued independently or together with any other securities
and may be attached to, or separate from, such securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The terms of any warrants to be issued and a description of the
material provisions of the applicable warrant agreement will be set forth in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_9"></A>DESCRIPTION OF OUR UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As specified in the applicable prospectus supplement, we may issue units consisting of one or more shares of common stock, shares of preferred
stock, debt securities or warrants or any combination of such securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_10"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer and sell the securities being offered hereby in one or more of the following ways from time to time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to or through underwriters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on any national securities exchange or quotation service on which the securities may be listed or quoted at the
time of sale; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions other than on these exchanges or systems or in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in &#8220;at the market offerings,&#8221; within the meaning of Rule 415(a)(4) of the Securities Act, to or
through market makers or into an existing market for the securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a
portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an accelerated securities repurchase program; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any of these methods of sale; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will identify the specific plan of distribution, including any underwriters, dealers, agents or other purchasers, persons or entities, and
any applicable compensation, in a prospectus supplement, in an amendment to the registration statement of which this prospectus is a part, or in other filings we make with the SEC under the Exchange Act, which are incorporated by reference. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the applicable prospectus supplement indicates otherwise, the validity of the securities being offered by this prospectus will be
passed upon by Orrick, Herrington&nbsp;&amp; Sutcliffe LLP, San Francisco, California. Additional legal matters may be passed upon for us or any underwriters, dealers or agents, by counsel that we will name in the applicable prospectus supplement.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, has audited our financial statements included in our Annual Report
on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K&nbsp;for</FONT> the year ended December&nbsp;31, 2024, as set forth in their report, which is incorporated by reference in this prospectus and elsewhere in the registration statement. Our financial
statements are incorporated by reference in reliance on Ernst&nbsp;&amp; Young LLP&#8217;s report, given on their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_13"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the
public at the SEC&#8217;s website at www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> relating to the securities covered by this prospectus. This prospectus is a part of the registration statement and does not contain all the information in the registration statement. Other documents establishing
the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. Whenever a reference is made in this prospectus to a contract or other document
of ours, the reference is only a summary and you should refer to the exhibits that are a part of the registration statement for a copy of the contract or other document. You may review a copy of the registration statement through the SEC&#8217;s
website, as provided above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc31173_14"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#8220;incorporate by reference&#8221; the information from other documents we file with the SEC, which means that we can
disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus. The information incorporated by reference is considered to be part of this prospectus, and later information
that we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act on
or after the date of this prospectus (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules) until the termination of the registration statement of which this prospectus is a
part: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December 31, 2024,
filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000095017025046217/bcab-20241231.htm">March<U></U>&nbsp;28, 2025</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The information specifically incorporated by reference into our Annual Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K&nbsp;for</FONT> the year ended December&nbsp;
31, 2024 from our definitive proxy statement on Schedule 14A, as filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025058011/bcab-20250424.htm">April<U></U>&nbsp;24,
2025</A>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended March&nbsp;31,
2025, June&nbsp;30, 2025 and September&nbsp;30, 2025, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000095017025064594/bcab-20250331.htm">May<U></U>&nbsp;
6, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000095017025105220/bcab-20250630.htm">August<U></U>&nbsp;
7, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000119312525280435/bcab-20250930.htm">November<U></U>&nbsp;13, 2025</A>, respectively; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025016321/bcab-20250206.htm">February
<U></U>&nbsp;7, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025039400/bcab-20250311.htm">March<U></U>&nbsp;
14, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025046065/bcab-20250327.htm">March<U></U>&nbsp;
27, 2025</A> (Item 2.05 only), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025073688/bcab-20250512.htm">May<U></U>&nbsp;
16, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025088499/bcab-20250617.htm">June<U></U>&nbsp;
20, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000119312525211305/bcab-20250916.htm">September<U></U>&nbsp;
22, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000119312525290474/bcab-20251120.htm">November<U></U>&nbsp;
21, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000119312525337078/bcab-20251230.htm">December<U></U>&nbsp;
30, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000119312525337646/d20340d8k.htm">December<U></U>&nbsp;
31, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000119312526010458/bcab-20260109.htm">January&nbsp;12, 2026</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our common stock contained in the Registration Statement on Form <FONT
STYLE="white-space:nowrap">8-A,</FONT> dated <A HREF="http://www.sec.gov/Archives/edgar/data/1826892/000119312520313813/d75718d8a12b.htm">December<U></U>&nbsp;9, 2020</A> as updated by the Description of the Registrant&#8217;s Securities Registered
Pursuant to Section&nbsp;12 of the Exchange Act of 1934, as amended, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1826892/000095017025046217/bcab-ex4_3.htm">Exhibit 4.3</A> to our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025046217/bcab-20241231.htm">December<U></U>&nbsp;31, 2024</A>, and including
any amendment or report subsequently filed for the purpose of updating such description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement contained in
this prospectus, or in a document all or a portion of which is incorporated by reference, shall be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus, any applicable prospectus
supplement and any related free writing prospectus or any document incorporated by reference modifies or supersedes such statement. Any such statement so modified or superseded shall not, except as so modified or superseded, constitute a part of
this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon request, we will provide, without charge, to each person, including any beneficial owner, to whom a copy of this
prospectus is delivered a copy of the documents incorporated by reference into this prospectus. You may request a copy of these filings, and any exhibits we have specifically incorporated by reference as an exhibit in this prospectus, at no cost by
writing or telephoning us at the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BioAtla, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11085 Torreyana Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">San Diego,
California 92121 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(858) <FONT STYLE="white-space:nowrap">558-0708</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn: Investor Relations </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may
also access these documents, free of charge on the SEC&#8217;s website at www.sec.gov or on the &#8220;Investor Relations&#8221; page of our website at www.ir.bioatla.com. Information contained on our website is not incorporated by reference into
this prospectus, and you should not consider any information on, or that can be accessed from, our website as part of this prospectus or any accompanying prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV STYLE="position:relative; overflow:visible; width:651pt; height:30pt; transform-origin:bottom left; transform: rotate(-90deg) translate(-100%, 100%) translateX(30pt);">
<P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:10.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#ff4338"><B>The information in this preliminary prospectus supplement is not complete and may be changed. We may not sell these
securities until the U.S. Securities and Exchange Commission declares our registration statement effective. This preliminary prospectus supplement is not an offer to sell these securities and we are not soliciting offers to buy&nbsp;these securities
in any state or jurisdiction where the offer or sale is not permitted. </B></FONT></P></DIV><DIV STYLE="position:relative; overflow:visible; margin-left:48pt; margin-right:48pt; transform: translateY(-30pt);">
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>SUBJECT TO COMPLETION, DATED JANUARY&nbsp;16, 2026 </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(To Prospectus dated &#8195; ,
2026) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g31173g03a03.jpg" ALT="LOGO" STYLE="width:1.47222in;height:0.742361in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Up to $18.75&nbsp;million of Common Stock </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are offering up to $18.75&nbsp;million of shares of our common stock, par value $0.0001 per share, pursuant to this prospectus supplement and the
accompanying prospectus, directly to YA II PN, Ltd., a Cayman Islands exempt limited company (&#8220;Yorkville&#8221;), Anson Investments Master Fund LP, a Cayman Islands exempted limited partnership (&#8220;Anson Investments Master Fund&#8221;),
and Anson East Master Fund LP, a Cayman Islands exempted limited partnership (&#8220;Anson East Master Fund&#8221; and, collectively with Yorkville and Anson Investments Master Fund, the &#8220;Investors&#8221;), in connection with the <FONT
STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements that we entered into with the Investors on November&nbsp;20, 2025 (the <FONT STYLE="white-space:nowrap">&#8220;Pre-Paid</FONT> Advance Agreements&#8221;) and (ii)&nbsp;the Standby Equity
Purchase Agreement that we entered into with Yorkville on November&nbsp;20, 2025 (the &#8220;Standby Equity Purchase Agreement&#8221; and the date and time of actual execution of the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance
Agreements and the Standby Equity Purchase Agreement shall be referred to herein as the &#8220;Effective Date&#8221;). In accordance with the terms of the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements, on November&nbsp;21,
2025, the Investors advanced to us <FONT STYLE="white-space:nowrap">pre-paid</FONT> advances in the aggregate principal amount of $7.5&nbsp;million (each, a <FONT STYLE="white-space:nowrap">&#8220;Pre-Paid</FONT> Advance&#8221; and collectively, the
<FONT STYLE="white-space:nowrap">&#8220;Pre-Paid</FONT> Advances&#8221;). The <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advances were purchased by the Investors at 95% of the face amount. As of January&nbsp;15, 2026, the aggregate principal
amount of $3.75&nbsp;million remained outstanding under the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements. At any time that there is an outstanding balance under a <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance, the
applicable Investor may provide written notice (each, a &#8220;Purchase Notice&#8221;) requiring that we issue and sell shares of our common stock (the &#8220;PPA Shares&#8221;) to the applicable Investor, which shall be offset against the amount
outstanding under the applicable <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance, at a price per share equal to the lower of (a) $1.39 (the &#8220;Fixed Price&#8221;) and (b) 95% of the lowest daily volume weighted average price (the
&#8220;VWAP&#8221;) of our common stock on The Nasdaq Capital Market during the seven (7)&nbsp;consecutive trading days immediately preceding the date on which the applicable Investor provides the Purchase Notice to us (the &#8220;Market
Price&#8221;), but in no event shall the Market Price be less than $0.23 (the &#8220;Floor Price&#8221;) and provided that for any date the applicable Investor delivers to the Company a Purchase Notice before November&nbsp;28, 2025, the Market Price
shall instead equal to 95% of the lowest daily VWAP during the shorter period commencing on November&nbsp;18, 2025 and ending on the trading day immediately prior to the date the applicable Investor delivers to the Company a Purchase Notice, and
provided further that the applicable Investor may elect to use the Fixed Price in any Purchase Notice even if such price is greater than or less than the Market Price. The issuance of PPA Shares is subject to certain limitations and conditions,
including pursuant to the rules of The Nasdaq Capital Market and that the shares of common stock beneficially owned by the applicable Investor and its affiliates at any one time will not exceed 4.99% of the then-outstanding shares of our common
stock. Interest shall accrue on the outstanding balance of each <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance at an annual rate of 4%, subject to an increase to 18% upon events of default described in the
<FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in accordance with the terms of the Standby Equity Purchase Agreement,
we will have the right, at our sole discretion, to issue and sell shares of common stock (the &#8220;SEPA Shares&#8221;) having an aggregate gross sales price of up to $15&nbsp;million (the &#8220;Commitment Amount&#8221;) to Yorkville from time to
time during the 36 months following the effective date of the Standby Equity Purchase Agreement. The SEPA Shares will be sold at the Company&#8217;s option at a price equal to 97% of the prevailing market price, subject to certain limitations,
including that Yorkville may not purchase any SEPA Shares that would result in Yorkville and its affiliates beneficially owning more than 4.99% of the then-outstanding shares of our common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The Nasdaq Capital Market under the symbol &#8220;BCAB.&#8221; The last reported sale price of our common stock on The Nasdaq
Capital Market on January&nbsp;15, 2026 was $0.3196 per share. </P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P></div>
</DIV> <p STYLE="clear:both; font-size:1pt; height:0">&nbsp;</p>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;21, 2025, the Company filed a prospectus supplement (the &#8220;Prior Prospectus
Supplement&#8221;), covering the offering, issuance and sale of up to $22.5&nbsp;million of shares of our common stock directly to the Investors in connection with the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements and Standby
Equity Purchase Agreement. As of immediately prior to the filing of this prospectus supplement, $18.75&nbsp;million of shares of common stock remained available for sale under the Prior Prospectus Supplement, which are the PPA Shares and the SEPA
Shares offered pursuant to this prospectus supplement and the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements and the Standby Equity Purchase Agreement, as applicable. In addition, this prospectus supplement also covers the
resale of those shares from time to time by the Investors to the public. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we have been advised by each Investor, and each Investor represents in
the applicable <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreement and the Standby Equity Purchase Agreement, that it is purchasing the shares for its own account, for investment purposes in which it takes investment risk (including,
without limitation, the risk of loss), and without any view or intention to distribute such shares in violation of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or any other applicable securities laws, the Securities and
Exchange Commission (the &#8220;SEC&#8221;) may take the position that each Investor may be deemed an &#8220;underwriter&#8221; within the meaning of Section&nbsp;2(a)(11) of the Securities Act and any profits on the sales of shares of our common
stock by the Investors and any discounts, commissions or concessions received by the Investors may be deemed to be underwriting discounts and commissions under the Securities Act. For additional information on the methods of sale that may be used by
the Investors, see &#8220;Plan of Distribution&#8221; beginning on page <FONT STYLE="white-space:nowrap">S-15</FONT> of this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tungsten Partners LLC d/b/a Tungsten&nbsp;Advisors (through its Broker-Dealer, Finalis Securities LLC) (the &#8220;Placement Agent&#8221;) acted as the sole
placement agent for the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements and the Standby Equity Purchase Agreement. We have paid the Placement Agent a placement fee equal to 6% of the face amount of the <FONT
STYLE="white-space:nowrap">Pre-Paid</FONT> Advances and agreed to pay 3% of the aggregate purchase price of any SEPA Shares when and if purchased by Yorkville pursuant to the Standby Equity Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of January&nbsp;16, 2026, the aggregate market value of our outstanding common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> was
approximately $74.4&nbsp;million, which we calculated based on 63,464,322 shares of outstanding common stock as of December&nbsp;31, 2025, of which 60,967,643 shares were held <FONT STYLE="white-space:nowrap">by&nbsp;non-affiliates,&nbsp;and</FONT>
a price per share of $1.22, which was the closing price of our common stock on November&nbsp;18, 2025. We have not offered any securities pursuant to General Instruction I.B.6 <FONT STYLE="white-space:nowrap">of&nbsp;Form&nbsp;S-3&nbsp;during</FONT>
the <FONT STYLE="white-space:nowrap">prior&nbsp;12-calendar-month&nbsp;period</FONT> that ends on and includes the date of this prospectus supplement, other than $22.8&nbsp;million pursuant to the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT>
Advance Agreements and the Standby Equity Purchase Agreement.&nbsp;Pursuant to General Instruction I.B.6 of <FONT STYLE="white-space:nowrap">Form&nbsp;S-3,&nbsp;in</FONT> no event will we sell, pursuant to the registration statement of which this
prospectus supplement forms a part, securities with a value <FONT STYLE="white-space:nowrap">exceeding&nbsp;one-third&nbsp;of</FONT> the aggregate market value of our outstanding common stock held
<FONT STYLE="white-space:nowrap">by&nbsp;non-affiliates&nbsp;in</FONT> <FONT STYLE="white-space:nowrap">any&nbsp;12-month&nbsp;period,</FONT> so long as the aggregate market value of our outstanding common stock held
<FONT STYLE="white-space:nowrap">by&nbsp;non-affiliates&nbsp;remains</FONT> below $75.0&nbsp;million. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Investing in our securities involves a high degree of risk. You should carefully consider the risks described under the heading &#8220;<A HREF="#supptoc31173_5">Risk
 Factors</A>&#8221; beginning on page <FONT STYLE="white-space:nowrap">S-8</FONT> of this prospectus supplement and the documents incorporated by reference into this prospectus supplement. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a &#8220;smaller reporting company&#8221; as defined under the federal securities laws and, as such, have elected to comply with certain reduced public
company reporting requirements for this prospectus supplement and the documents incorporated by reference herein and may elect to comply with reduced public company reporting requirements in future filings. See &#8220;Prospectus Supplement
Summary&#8212;Implications of Being a Smaller Reporting Company.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement dated&#8195;&#8195;&#8195;&#8195; , 2026 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_2">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_3">PROSPECTUS SUPPLEMENT SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_4">THE OFFERING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_5">RISK FACTORS </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_6">USE OF PROCEEDS </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_7">DILUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_8">DESCRIPTION OF SECURITIES </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_9">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_10">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_11">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc31173_12">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-18</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This prospectus supplement and the accompanying prospectus relate to a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> that
we filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on January&nbsp;16, 2026 using a shelf registration process. Under this shelf registration process, we may from time to time sell shares of our common stock having an
aggregate offering price of up to $200,000,000 (subject to compliance with General Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3).</FONT> Under this prospectus supplement and accompanying prospectus, we may from time to time sell
shares of our common stock having an aggregate offering price of up to $3.75&nbsp;million, at prices and on terms set forth in the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements, and up to $15&nbsp;million, at prices and on
terms set forth in the Standby Equity Purchase Agreement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This prospectus supplement describes the specific terms of this offering of common stock
and updates the information contained in the accompanying prospectus and the documents incorporated by reference herein and therein. To the extent the information contained in this prospectus supplement differs or varies from the information
contained in the accompanying prospectus or documents previously filed with the SEC that are incorporated by reference herein, the information in this prospectus supplement will supersede such information. For a more detailed understanding of an
investment in our common stock, you should read both this prospectus supplement and the accompanying prospectus, together with the information incorporated by reference herein and therein and additional information described under the heading
&#8220;Incorporation of Certain Documents by Reference&#8221; in this prospectus supplement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Company nor the Placement Agent has
authorized anyone to provide you with information that is different from or in addition to the information contained in this prospectus supplement and the accompanying prospectus and in any related free writing prospectus filed by us with the SEC.
Accordingly, neither the Company nor the Placement Agent takes any responsibility for, and cannot provide any assurance as to the reliability of, any information that others may give. Neither the Company nor the Placement Agent is making offers to
sell or seeking offers to buy shares of our common stock in any jurisdiction where the offer or sale is not permitted. You should assume that the information contained in this prospectus supplement, the accompanying prospectus, the documents
incorporated by reference herein and therein and any related free writing prospectus is accurate only as of the respective dates of such documents, regardless of the time of delivery of this prospectus supplement or any sale of the common stock
offered hereby. Our business, financial condition, results of operations and prospects may have changed materially since those dates. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unless the
context otherwise indicates, references in this prospectus supplement and the accompanying prospectus to &#8220;BioAtla&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; and &#8220;our&#8221; refer to BioAtla, Inc., a Delaware
corporation. BioAtla is a trademark of BioAtla, Inc. Our logos and trademarks are the property of BioAtla. All other brand names or trademarks appearing in this prospectus supplement and the accompanying prospectus are the property of their
respective holders. Use or display by us of other parties&#8217; trademarks or trade dress in this prospectus supplement and the accompanying prospectus is not intended to, and does not, imply a relationship with, or endorsements or sponsorship of,
us by the trademark or trade dress owners. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_2"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement, the accompanying prospectus and the other documents that are incorporated herein or therein by reference contain forward-looking
statements. We may, in some cases, use words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221;
&#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or the negative of those terms, and similar expressions that convey uncertainty of future events or outcomes to
identify these forward-looking statements. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect
our financial condition, results of operations, business strategy short-term and long-term business operations and objectives and financial needs. These forward-looking statements are subject to known and unknown risks, uncertainties and
assumptions, including risks described in the &#8220;Risk Factors&#8221; section of this prospectus supplement and the documents incorporated by reference into this prospectus supplement. It is not possible for our management to predict all risks,
nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of
these risks, uncertainties and assumptions, the future events and trends discussed in this prospectus supplement, the accompanying prospectus and the other documents that are incorporated herein or therein by reference may not occur, and actual
results may differ materially and adversely from those anticipated or implied in the forward- looking statements. Such forward-looking statements include, but are not limited to, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop and advance our current product candidates and programs into, and successfully complete,
clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our clinical trials to demonstrate safety and efficacy of our product candidates and other
positive results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size of the market opportunity for our product candidates, including our estimates of the number of patients
who suffer from the diseases we are targeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential benefits of our strategic relationships and our plans, timing of, and ability to establish
collaborations or other strategic partnerships for selected assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ability to achieve milestones and the plans, timing and expectations regarding future data updates, clinical
trials, regulatory meetings and regulatory submissions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our manufacturing, commercialization and marketing capabilities and strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategies to develop and commercialize our CAB antibodies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans to further develop our technology platform and expand our pipeline of product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential benefits and advantages of our current and future product candidates that we may develop from our
patented technology platform; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential regulatory approval path for our product candidates and the timing or likelihood of regulatory
filings and approvals for our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments in the United States and Europe and other foreign countries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations and plans to obtain funding for our operations, including from our existing and potential future
collaboration and licensing agreements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to continue as a going concern; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding our ability to obtain and maintain intellectual property protection for our technology
platform and product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our continued reliance on third parties to conduct additional clinical trials of our product candidates and for
the manufacture of our product candidates for preclinical studies and clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to achieve the expected benefits of our workforce reduction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of health epidemics and outbreaks on our business, financial condition, results of operations, and
prospects. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they
were made. We disclaim any obligation, except as specifically required by law, and the rules of the SEC, to publicly update or revise any such statements to reflect any change in our expectations or in events, conditions or circumstances on which
any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in such forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein with the understanding
that our actual future results may be materially different from those expressed in forward-looking statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_3"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information included or incorporated by reference in this prospectus supplement and the accompanying prospectus and does
not contain all of the information that may be important to you. You should carefully review this entire prospectus supplement and the accompanying prospectus, including the risk factors and financial statements and related notes thereto included or
incorporated by reference herein and therein, before making a decision to purchase our common stock. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biopharmaceutical company developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of
solid tumor cancer. Our CABs capitalize on our proprietary discoveries with respect to tumor biology, enabling us to target known and widely validated tumor antigens that have previously been difficult or impossible to target. Our novel CAB
therapeutic candidates exploit characteristic pH differences between the tumor microenvironment and healthy tissue. Unlike healthy tissue, the tumor microenvironment is acidic, and we have designed our antibodies to selectively bind to their targets
on tumor cells under acidic pH conditions but not on targets in normal tissues. Our approach is to identify the necessary targeting and potency required for cancer cell destruction, while aiming to eliminate or greatly reduce <FONT
STYLE="white-space:nowrap">on-target,</FONT> <FONT STYLE="white-space:nowrap">off-tumor</FONT> toxicity&#8212;one of the fundamental challenges of existing cancer therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a United States-based company with facilities in San Diego, California. Since the commencement of our operations, we have focused substantially all of
our resources on conducting research and development activities, including drug discovery, preclinical studies and clinical trials of our product candidates, including the ongoing Phase 2 clinical trials of mecbotamab vedotin (BA3011), ozuriftamab
vedotin (BA3021), and evalstotug (BA3071), and our Phase 1 clinical trial of BA3182 <FONT STYLE="white-space:nowrap">(CAB-EpCAM</FONT> x <FONT STYLE="white-space:nowrap">CAB-CD3),</FONT> establishing and maintaining our intellectual property
portfolio, manufacturing clinical and research material through third parties, hiring personnel, establishing product development and commercialization collaborations with third parties, raising capital and providing general and administrative
support for these operations. Since 2014, such research and development activities have exclusively related to the research, development, manufacture and Phase 1 and Phase&nbsp;2 clinical testing of our CAB antibody-based product candidates and the
strengthening of our proprietary CAB technology platform and pipeline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that there is significant potential to improve therapeutics for our
patients with our proprietary CAB antibody technology across well-validated oncology targets in solid tumors. The following table summarizes our current product candidate pipeline. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g31173g01n31.jpg" ALT="LOGO" STYLE="width:5.47062in;height:2.84028in;">
 </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business was founded in March 2007 and originally operated as a Delaware limited liability company, BioAtla, LLC. In July 2020, we converted from a limited
liability company into a Delaware corporation pursuant to a statutory conversion and changed our name from BioAtla, LLC to BioAtla, Inc. Our principal executive offices are located at 11085 Torreyana Road, San Diego, California 92121, and our
telephone number is <FONT STYLE="white-space:nowrap">(858)&nbsp;558-0708.</FONT> Our corporate website address is www.bioatla.com. Information contained on, or that may be accessed through, our website is not incorporated by reference into this
prospectus supplement or the underlying prospectus and should not be considered a part of either document. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being a Smaller Reporting
Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a &#8220;smaller reporting company,&#8221; as defined by the Exchange Act, and the rules and regulations thereunder, meaning that the
market value of our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is less than $250.0&nbsp;million measured on the last business day of our second fiscal quarter or our annual revenue is less than $100.0&nbsp;million
during the most recently completed fiscal year and the market value of our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is less than $700.0&nbsp;million measured on the last business day of our second fiscal quarter.
Accordingly, we may provide less public disclosure than larger public companies, including the inclusion of only two years of audited financial statements and only two years of management&#8217;s discussion and analysis of financial condition and
results of operations disclosure. As a result, the information that we provide to our stockholders may be different than you might receive from other public reporting companies in which you hold equity interests. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_4"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Common stock offered by us</B> </P></TD>
<TD>PPA Shares: Shares of our common stock having an aggregate offering price of up to $3.75&nbsp;million at a price per share equal to the lower of (a)&nbsp;the Fixed Price of $1.39 and (b)&nbsp;the Market Price, but in no event shall the Market
Price be less than the Floor Price of $0.23 and provided further that the applicable Investor may elect to use the Fixed Price in any Purchase Notice even if such price is greater than or less than the Market Price. The amount and timing of sales of
PPA Shares is at the sole discretion of the Investors. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">SEPA Shares: Up to $15&nbsp;million of our common stock which we may sell to Yorkville from time to time, at our sole discretion, at a price equal to 97% of the prevailing market price, subject to certain limitations.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Common stock to be outstanding after this offering </B></P></TD>
<TD>Up to 117,459,170 shares, assuming the sale of (i) 11,733,415 PPA Shares at an offering price of $0.3196 per share, which was the last reported sale price of our common stock on The Nasdaq Capital Market on January&nbsp;15, 2026 and (ii)
46,933,667 SEPA Shares at an offering price of $0.3196 per share, which was the last reported sale price of our common stock on The Nasdaq Capital Market on January&nbsp;15, 2026. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Use of proceeds</B> </P></TD>
<TD>We intend to use the net proceeds we receive from this offering, together with existing cash and cash equivalents, primarily to fund our research and development efforts and for working capital and other general corporate purposes. See
&#8220;Use of Proceeds&#8221; on <FONT STYLE="white-space:nowrap">page&nbsp;S-11</FONT> of this prospectus supplement for additional information. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Risk factors</B> </P></TD>
<TD>An investment in our securities involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page <FONT STYLE="white-space:nowrap">S-8</FONT> of this prospectus supplement and in the documents incorporated by reference in this
prospectus supplement for a discussion of factors to consider before deciding to invest in our securities. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Nasdaq Capital Market symbol</B> </P></TD>
<TD>Our common stock is listed on The Nasdaq Capital Market under the symbol &#8220;BCAB.&#8221; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise indicated herein, the
number of shares of our common stock to be outstanding immediately after this offering is based on 58,792,088 shares of our common stock outstanding as of September 30, 2025 and 0 shares of our Class&nbsp;B common stock outstanding as of September
30, 2025 and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">5,871,489 shares of our common stock issuable upon the exercise of stock options outstanding as of September 30,
2025 at a weighted average exercise price of $7.69 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,679,158 shares of common stock issuable upon the exercise of warrants outstanding as of September&nbsp;30,
2025, at an exercise price of $1.19 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2,523,000 shares of our common stock issuable pursuant to unvested restricted stock units outstanding as of
September 30, 2025; </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,353,483 shares of our common stock issued upon conversion of $3.75&nbsp;million aggregate principal amount
under the PPAs since November&nbsp;20, 2025 and the 243,428 commitment fee shares issued to Yorkville in connection with the SEPA; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,613,051 shares of our common stock reserved and available for future issuance as of September 30, 2025, under
our equity incentive plans, consisting of (1) 1,302,358 shares of common stock reserved and available for issuance under our 2020 Equity Incentive Plan as of September 30, 2025 and (2)&nbsp;2,310,693 shares of common stock reserved for issuance
under our 2020 Employee Stock Purchase Plan as of September 30, 2025. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise indicated, all information in this prospectus
supplement reflects and assumes no purchases of PPA Shares and SEPA Shares to be sold to Investors in this offering, no issuance, exercise or settlement of stock-based awards under our 2020 Equity Incentive Plan or 2020 Employee Stock Purchase Plan
and no exercise of outstanding warrants. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An investment in our common stock involves significant risks. Before making an investment in our common stock, you should carefully read all of the
information contained in this prospectus supplement, the accompanying prospectus and in the documents incorporated by reference herein and therein. For a discussion of risks that you should carefully consider before deciding to purchase any of our
common stock, please review the risk factors disclosed below and those incorporated by reference herein contained in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December 31, 2024 and in our
Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly periods ended March&nbsp;31, 2025, June&nbsp;30, 2025 and September 30, 2025, respectively, together with the other information in this prospectus supplement,
the accompanying prospectus, and the information and documents incorporated by reference herein and therein. Any of these risks, as well as additional risks not currently known to us or that we currently deem immaterial, may adversely affect our
business, financial condition, results of operations, and prospects, resulting in a decline in the trading price of our common stock and loss of all or part of your investment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to this Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our management
will have broad discretion over the actual amount and timing of the expenditures of the proceeds we receive in this offering and might not apply these proceeds in ways that enhance our financial condition or operating results or increase the value
of your investment. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds we receive from this offering, together with existing cash and cash equivalents, primarily
to fund our research and development efforts and for working capital and other general corporate purposes. This expected use of our net proceeds from this offering represents our intentions based upon our current plans and business conditions. The
amount and timing of our actual expenditures may vary significantly depending on numerous factors, including the expenses related to our clinical and preclinical trials, the expenses related to any potential commercialization, as well as any
strategic transactions that we may enter into with third parties, and any unforeseen cash needs. Because of the number and variability of factors that will determine our use of the proceeds from this offering, their ultimate use may vary
substantially from their currently intended use. As a result, our management will retain broad discretion over the allocation of the net proceeds we receive from this offering and could spend the proceeds in ways that do not necessarily improve our
financial condition or operating results or enhance the value of our common stock and your investment therein. Additionally, until the net proceeds we receive are used, they may be placed in investments that do not produce income or that lose value.
See &#8220;Use of Proceeds&#8221; for additional information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If you purchase our common stock in this offering, you may incur immediate and
substantial dilution in the book value of your shares. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offering price per share of our common stock in this offering may exceed the net
tangible book value per share of our common stock outstanding prior to this offering. Assuming that an aggregate of 58,667,082 PPA Shares and SEPA Shares are sold pursuant to this prospectus supplement at a price of $0.3196 per share, which was the
last reported sale price of our common stock on The Nasdaq Capital Market on January&nbsp;15, 2026, you would experience immediate dilution of $0.4442 per share, representing the difference between our as adjusted net tangible book value per share
after giving effect to this offering and the assumed offering price. Further dilution of your investment will result from, among other things, the future exercise of stock options and vesting of restricted stock units. See the section titled
&#8220;Dilution&#8221; below for a more detailed illustration of the dilution you could incur if you purchase shares in this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Substantial
blocks of our common stock may be sold into the market as a result of <FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements and the Standby Equity Purchase Agreement. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The price of our common stock could decline and be volatile if there are substantial sales of shares of our common stock, if there is a large number of shares
of our common stock available for sale, or if there is the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
perception that these sales could occur. In accordance with the terms of <FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements, on November 21, 2025, the Investors
advanced to us the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advances in the aggregate principal amount of $7.5&nbsp;million. Each <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance was purchased by the Investors at 95% of the face
amount. At any time that there is an outstanding balance under a <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance, the applicable Investor may provide a Purchase Notice requiring that we issue and sell shares of our common stock to the
applicable Investor, which shall be offset against the amount outstanding under the applicable <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance. In addition, in accordance with the terms of the Standby Equity Purchase Agreement, we will have
the right, at our sole discretion, to issue and sell the SEPA Shares having an aggregate gross sales price of up to $15&nbsp;million to Yorkville from time to time during the 36 months following the Effective Date. Any issuances of the PPA Shares to
offset any outstanding <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advances or issuances of the SEPA Shares will dilute the percentage ownership of stockholders and may dilute the per share projected earnings (if any) or book value of our
common stock. Sales of a substantial number of shares of our common stock in the public market or other issuances of shares of our common stock, or the perception that these sales or issuances could occur, could cause the market price of our common
stock to decline and may make it more difficult for you to sell your shares at a time and price that you deem appropriate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We do not have the right
to control the timing and amount of the issuance of our shares of common stock to the Investors under <FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements and, accordingly, it is not possible to predict the actual number
of shares we will issue pursuant to <FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements at any one time or in total. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have the right to control the timing and amount of any issuance of the PPA Shares to the Investors under
<FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements. Sales of our common stock, if any, to the Investors under <FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements will depend upon market
conditions and other factors, and the discretion of the Investors. We may ultimately sell to the Investors all, some or none of the PPA Shares that may be available for us to sell to the Investors pursuant to
<FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because the purchase price per share to be paid by the Investors for
the PPA Shares, if any, will fluctuate based on the market prices of our common stock, it is not possible for us to predict, as of the date of this prospectus supplement and prior to any such sales, the number of PPA Shares that we will issue to the
Investors under <FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements, the purchase price per share that the Investors will pay for the PPA Shares, or the aggregate gross proceeds that we will receive from the Investors
under <FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>It is not possible to predict the actual number of
shares we will sell under the Standby Equity Purchase Agreement, and fluctuating sales prices and timing of sales of the SEPA Shares may result in variable proceeds and price volatility for investors. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to certain limitations in the Standby Equity Purchase Agreement and compliance with applicable law, we will have discretion, subject to market demand,
to vary the timing, prices and numbers of the SEPA Shares sold to Yorkville. The number of SEPA Shares that are sold to Yorkville after delivering an advance notice will fluctuate based on a number of factors, including the market price of our
common stock during the sales period. Because the price per share of each SEPA Share sold will fluctuate during the sales period, it is not currently possible to predict the number of SEPA Shares that will be sold or the gross proceeds to be raised
in connection with those sales, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if and when we do elect to sell the SEPA Shares to Yorkville pursuant to the Standby Equity Purchase
Agreement, Yorkville may resell all, some or none of such shares at any time or from time to time in its discretion and at different prices. As a result, investors who purchase SEPA Shares from Yorkville in this offering at different times will
likely pay different prices for those shares, and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results. In addition, investors may experience a decline in the value
of the SEPA Shares they purchase from Yorkville in this offering as a result of future sales made by us to Yorkville at prices lower than the prices such investors paid for their shares in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Upon an Amortization Event, we may be required to make payments under the <FONT
STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements that could cause financial hardship to the company. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the <FONT
STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements, an &#8220;Amortization Event&#8221; occurs if (1)&nbsp;the daily VWAP of our common stock is lower than the Floor Price for any five (5)&nbsp;of seven (7)&nbsp;consecutive trading days,
(2)&nbsp;we have issued substantially all of the shares available under the Exchange Cap or (3)&nbsp;any of the PPA Shares to be issued under the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements are not eligible to be sold
pursuant a registration statement for ten&nbsp;(10)&nbsp;consecutive trading days. Within seven (7)&nbsp;trading days of an Amortization Event, we must make cash repayments to each Investor of the amount outstanding under the&nbsp;applicable <FONT
STYLE="white-space:nowrap">Pre-Paid&nbsp;Advances</FONT> in equal monthly installments, plus any accrued and unpaid interest (if any), and a 10% redemption premium until such time as the obligation to make such prepayments ceases pursuant to the
applicable <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements. If we do not have sufficient cash on hand to make such repayments when due, we could be required to modify our operating plan to redirect our cash resources to such
repayments, which could have a material adverse effect on our financial condition and liquidity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We received aggregate gross proceeds from the offering in connection with the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements of
approximately $7.13&nbsp;million, and we will not receive any additional proceeds in connection with the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may receive up to $15&nbsp;million in aggregate gross proceeds from any sales we make to Yorkville pursuant to the Standby Equity Purchase Agreement from
and after the date of this prospectus supplement. We may sell fewer than all of the shares of common stock offered by this prospectus supplement, in which case our offering proceeds will be less. Because we are not obligated to sell any of our
shares of common stock under the Standby Equity Purchase Agreement, the actual total offering amount and proceeds to us, if any, are not determinable at this time. See &#8220;Plan of Distribution&#8221; elsewhere in this prospectus supplement for
more information. We will not receive any proceeds from the issuance of the Commitment Shares to Yorkville pursuant to the Standby Equity Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that we do elect to sell shares of our common stock to Yorkville pursuant to the Standby Equity Purchase Agreement, the amount of proceeds from
this offering will depend upon the number of shares of common stock sold and the price at which they are sold. There can be no assurance that we will be able to sell any shares of common stock under or fully utilize the Standby Equity Purchase
Agreement as a source of financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently plan to use the net proceeds we receive from the Standby Equity Purchase Agreement, if any, together
with the net proceeds from the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements and existing cash and cash equivalents, primarily to fund our research and development efforts and for working capital and other general corporate
purposes. We do not currently have specific plans or commitments with respect to the net proceeds from this offering, if any, and, accordingly, are not able to quantify the allocation of such proceeds among the various potential uses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amounts and timing of our actual expenditures will depend on numerous factors, including the progress of our clinical trials and other development efforts
and other factors described under &#8220;Risk Factors&#8221; in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein, as well as the amount of cash used in our operations. We may find
it necessary or advisable to use the net proceeds for other purposes, and we will have broad discretion in the application of the net proceeds. Pending the uses described above, we plan to invest the net proceeds from this offering in short-term,
interest-bearing accounts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_7"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you invest in our common stock in this offering, your ownership interest will be diluted immediately to the extent of the difference between the offering
price per share of our common stock and the net tangible book value per share of our common stock immediately after this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net tangible book
value per share is equal to our total tangible assets, less our total liabilities, divided by the total number of shares outstanding as of December&nbsp;31, 2025. Our historical net tangible book value as of September&nbsp;30, 2025. Our historical
net tangible book value as of September&nbsp;30, 2025 was $(37.0) million, or $(0.63) per share of our common stock, based upon 58,792,088 shares of common stock outstanding on September&nbsp;30, 2025. After giving effect to (i) 6,353,483 shares of
our common stock issued upon conversion of $3.75&nbsp;million aggregate principal amount under the PPAs since November&nbsp;20, 2025 and the 243,428 commitment fee shares issued to Yorkville in connection with the SEPA; and (ii)&nbsp;the sale of
$3.75&nbsp;million of PPA Shares and $15&nbsp;million of SEPA Shares at an assumed offering price of $0.3196 per share, which was last reported sale price of our common stock on The Nasdaq Capital Market on January 15, 2026, less Placement Agent
fees and estimated offering expenses, our <FONT STYLE="white-space:nowrap">as-adjusted</FONT> net tangible book value would have been approximately $(15.5) million, or approximately $(0.1246) per share of common stock. This represents an immediate
increase in net tangible book value of $0.5045 per share to our existing shareholders and an immediate dilution in net tangible book value of $0.4442 per share to investors purchasing shares of our common stock in this offering. The following table
illustrates this calculation on a per share basis: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.3196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net tangible book value per share as of September&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.6291</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in net tangible book value per share attributable to the offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.5045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">As-adjusted</FONT> net tangible book value per share after this
offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.1246</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to investors in the offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.4442</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise indicated herein, the number of shares of our common stock to be outstanding immediately after this
offering is based on 58,792,088 shares of our common stock outstanding as of September 30, 2025 and 0 shares of our Class&nbsp;B common stock outstanding as of September 30, 2025 and excludes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">5,871,489 shares of our common stock issuable upon the exercise of stock options outstanding as of September 30,
2025 at a weighted average exercise price of $7.69 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,679,158 shares of common stock issuable upon the exercise of warrants outstanding as of September&nbsp;30,
2025, at an exercise price of $1.19 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2,523,000 shares of our common stock issuable pursuant to unvested restricted stock units outstanding as of
September 30, 2025; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,353,483 shares of our common stock issued upon conversion of $3.75&nbsp;million aggregate principal amount
under the PPAs since November&nbsp;20, 2025 and the 243,428 commitment fee shares issued to Yorkville in connection with the SEPA; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,613,051 shares of our common stock reserved and available for future issuance as of September 30, 2025, under
our equity incentive plans, consisting of (1) 1,302,358 shares of common stock reserved and available for issuance under our 2020 Equity Incentive Plan as of September 30, 2025 and (2)&nbsp;2,310,693 shares of common stock reserved for issuance
under our 2020 Employee Stock Purchase Plan as of September 30, 2025. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors purchasing shares of our common stock in this offering will experience further dilution upon,
among other things, the future exercise of stock options, vesting of restricted stock units and exercise of warrants. Furthermore, we may choose to raise additional capital through the sale of additional securities due to market conditions or
strategic considerations even if we believe we have sufficient funds on hand for our current or future operating plans. To the extent that we raise additional capital in this manner, the issuance of such securities would likely result in further
dilution to investors purchasing shares of our common stock in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_8"></A>DESCRIPTION OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The material terms and provisions of our common stock are described under the heading &#8220;Common stock and class B common stock&#8221; in the Description
of Our Capital Stock section of the accompanying prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_9"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November 20, 2025, we entered into <FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements with the Investors and the Standby
Equity Purchase Agreement with Yorkville. On November 21, 2025, the Investors advanced to us the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advances in the aggregate principal amount of $7.5&nbsp;million. Each
<FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance was purchased by the Investors at 95% of the face amount. At any time that there is an outstanding balance under a <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance, the applicable
Investor may provide a Purchase Notice requiring that we issue and sell shares of our common stock to the applicable Investor, which shall be offset against the amount outstanding under the applicable <FONT STYLE="white-space:nowrap">Pre-Paid</FONT>
Advance, at a price per share equal to the lower of (a)&nbsp;the Fixed Price and (b)&nbsp;the Market Price, but in no event shall the Market Price be less than the Floor Price. The issuance of PPA Shares is subject to certain limitations and
conditions, including pursuant to the rules of The Nasdaq Capital Market and that the shares of common stock beneficially owned by the applicable Investor and its affiliates at any one time will not exceed 4.99% of the then-outstanding shares of the
common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Standby Equity Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, Yorkville committed to
purchase shares of our common stock having an aggregate gross sales price of up to $15&nbsp;million over a <FONT STYLE="white-space:nowrap">36-month</FONT> commitment period upon our delivery of an advance notice to Yorkville. The shares would be
sold at the Company&#8217;s option at 97% of the prevailing market price, subject to certain limitations, including that Yorkville may not purchase any shares of the common stock that would result in it owning more than 4.99% of the then-outstanding
voting power or number of common stock. Each advance notice may be for an amount up to 100% of the average of the daily trading volume of our common stock on The Nasdaq Capital Market during the five consecutive trading days immediately preceding an
advance notice. In connection with any advance notice, if any portion of an advance would cause the beneficial ownership of our then outstanding common stock by Yorkville to exceed 4.99%, then such portion shall automatically be deemed to be
withdrawn by us with no further action required by us. The Standby Equity Purchase Agreement may be terminated by us upon five (5)&nbsp;trading days of prior notice to Yorkville, provided that there are no advances outstanding and we have paid to
the Investors all amounts then due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to our issuance of common stock to the Investors pursuant to
<FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements and the Standby Equity Purchase Agreement, this prospectus supplement also covers the resale of those shares from time to time by the Investors to the public. Though
we have been advised by each Investor, and each Investor represents in the&nbsp;applicable <FONT STYLE="white-space:nowrap">Pre-Paid&nbsp;Advance</FONT> Agreement and the Standby Equity Purchase Agreement, that it is purchasing the shares for its
own account, for investment purposes in which it takes investment risk (including, without limitation, the risk of loss), and without any view or intention to distribute such shares in violation of the Securities Act or any other applicable
securities laws, the SEC may take the position that each Investor may be deemed an &#8220;underwriter&#8221; within the meaning of Section&nbsp;2(a)(11) of the Securities Act. We have agreed in
<FONT STYLE="white-space:nowrap">the&nbsp;Pre-Paid&nbsp;Advance</FONT> Agreements and the Standby Equity Purchase Agreement to provide customary indemnification to each Investor. It is possible that our shares may be sold by each Investor in one or
more of the following manners: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker solicits purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a block trade in which the broker or dealer so engaged will attempt to sell the shares as agent, but may position
and resell a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to a broker-dealer as principal and resale by the broker-dealer for its account; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Investors will be subject to liability under the federal securities laws and must comply with the requirements of the Exchange Act, including, without
limitation, <FONT STYLE="white-space:nowrap">Rule&nbsp;10b-5</FONT> and Regulation M under the Exchange Act. With certain exceptions, Regulation&nbsp;M precludes the Investors, any affiliated purchasers, and any broker-dealer or other person who
participates in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase, any security that is the subject of the distribution until the entire distribution is
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
complete. Regulation&nbsp;M also prohibits any bids or purchases made in order to stabilize the price of a security in connection with the distribution of that security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These restrictions may affect the marketability of the shares of our common stock by the Investors and any unaffiliated broker-dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have paid the expenses incident to the registration under the Securities Act of the offer and sale of the shares of our common stock covered by this
prospectus supplement and the accompanying prospectus. We also paid a $25,000 structuring fee to Yorkville in connection with entry into the Standby Equity Purchase Agreement with Yorkville. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have paid the Placement Agent a placement fee equal to 6% of the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance and have agreed to pay 3% of the
aggregate purchase price of any SEPA Shares when and if purchased by Yorkville pursuant to the Standby Equity Purchase Agreement. We also have agreed to indemnify the Placement Agent against certain liabilities, including civil liabilities under the
Securities Act and the Exchange Act and to contribute to payments that the Placement Agent may be required to make in respect of those liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_10"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of the securities offered by this prospectus supplement will be passed upon for the Company by Orrick, Herrington&nbsp;&amp; Sutcliffe LLP. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_11"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, has audited our financial statements included in our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December 31, 2024, as set forth in their report, which is incorporated by reference in this prospectus supplement and elsewhere in the registration statement. Our financial statements are
incorporated by reference in reliance on Ernst&nbsp;&amp; Young LLP&#8217;s report, given on their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc31173_12"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#8220;incorporate by reference&#8221; the information we file with it, which means that we can disclose important information to you by
referring to those publicly available documents. The information that we incorporate by reference is considered to be part of this prospectus supplement. We incorporate by reference the documents listed below (File
<FONT STYLE="white-space:nowrap">No.&nbsp;001-39787)</FONT> and any future filings we make with the SEC under Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act (in each case, other than those documents or the portions of those documents
not deemed to be filed, except as expressly noted below) between the date of this prospectus supplement and the date this offering is terminated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2024,
filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000095017025046217/bcab-20241231.htm">March&nbsp;28, 2025</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The information specifically incorporated by reference into our Annual Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K&nbsp;for</FONT> the year ended December&nbsp;
31, 2024 from our definitive proxy statement on Schedule 14A, as filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025058011/bcab-20250424.htm">April&nbsp;24, 2025</A>;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended March&nbsp;31,
2025, June&nbsp;30, 2025 and September&nbsp;
30, 2025, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000095017025064594/bcab-20250331.htm">May 6, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000095017025105220/bcab-20250630.htm">August
 7, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000119312525280435/bcab-20250930.htm">November&nbsp;13, 2025</A>, respectively; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025016321/bcab-20250206.htm">February&nbsp;7,
 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025039400/bcab-20250311.htm">March&nbsp;
14, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025046065/bcab-20250327.htm">March&nbsp;
27, 2025</A> (Item 2.05 only), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025073688/bcab-20250512.htm">May&nbsp;
16, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025088499/bcab-20250617.htm">June&nbsp;
20, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000119312525211305/bcab-20250916.htm">September&nbsp;
22, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000119312525290474/bcab-20251120.htm">November<U></U>&nbsp;
21, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000119312525337078/bcab-20251230.htm">December<U></U>&nbsp;
30, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1826892/000119312525337646/d20340d8k.htm">December<U></U>&nbsp;
31, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000119312526010458/bcab-20260109.htm">January&nbsp;12, 2026</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Description of our common stock contained in the Registration Statement on Form
<FONT STYLE="white-space:nowrap">8-A,</FONT> dated <A HREF="http://www.sec.gov/Archives/edgar/data/1826892/000119312520313813/d75718d8a12b.htm">December&nbsp;9, 2020</A> as updated by the Description of the Registrant&#8217;s Securities Registered
Pursuant to Section&nbsp;12 of the Exchange Act of 1934, as amended, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1826892/000095017025046217/bcab-ex4_3.htm">Exhibit 4.3</A> to our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017025046217/bcab-20241231.htm">December&nbsp;31, 2024</A>, and including any
amendment or report subsequently filed for the purpose of updating such description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may access our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> Current Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K,</FONT> proxy statement, and other information, if any, we file with or
furnish to the SEC free of charge at the SEC&#8217;s website (www.sec.gov) or our website (www.bioatla.com) as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information contained in,
or that can be accessed through, our website is not part of this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may also request a copy of our SEC filings at no cost, by
telephoning or writing us at the following telephone number or address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BioAtla, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11085 Torreyana Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">San Diego,
California </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(858) <FONT STYLE="white-space:nowrap">558-0708</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g31173g03a03.jpg" ALT="LOGO" STYLE="width:1.47222in;height:0.742361in;">
 </P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Up to $18.75&nbsp;million of Common Stock </B></P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#8195;&#8195;&#8195;&#8195;, 2026 </B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN THE PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&#8201;14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Other Expenses of Issuance and Distribution</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a statement of the estimated expenses (other than underwriting discounts and commissions) to be incurred by our company in
connection with the issuance and distribution of the securities registered under this registration statement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">559.30<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses (including Blue Sky fees)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent, trustee and warrant agent fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These fees and expenses depend on the securities offered and the number of issuances and accordingly cannot be
estimated at this time and will be provided as applicable by amendment or in a filing with the SEC pursuant to the Exchange Act and incorporated herein by reference. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The $200,000,000 of securities registered pursuant to this registration statement includes $195.95&nbsp;million
of Unsold Securities registered pursuant to the Prior Registration Statement. Pursuant to Rule 415(a)(6) under the Securities Act, the filing fees previously paid in connection with the Unsold Securities will continue to be applied to the Unsold
Securities. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&#8201;15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Indemnification of Directors and Officers</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145 of the Delaware General Corporation Law authorizes a court to award, or a corporation&#8217;s board of directors to grant,
indemnity to directors and officers in terms sufficiently broad to permit such indemnification under certain circumstances for liabilities (including reimbursement for expenses incurred) arising under the Securities Act. Article V of our amended and
restated bylaws provides for indemnification of our directors, officers, employees and other agents to the maximum extent permitted by the Delaware General Corporation Law. In addition, we have entered into indemnification agreements with our
officers and directors, whereby we have agreed to indemnify our directors and officers to the fullest extent permitted by law. These indemnification agreements also generally require us to advance any expenses incurred by the directors or officers
as a result of any proceeding against them as to which they could be indemnified. In addition, we have purchased a policy of directors&#8217; and officers&#8217; liability insurance that insures our directors and officers against the cost of
defense, settlement or payment of a judgment in some circumstances. The underwriters will be obligated, under certain circumstances, pursuant to any underwriting agreements we enter into in connection with the sale of any securities being registered
hereby, to indemnify us and our officers and directors against certain liabilities under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&#8201;16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Exhibits</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center"><B>Exhibit<BR>No.</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit title</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incorporated by reference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Form</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>File No.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>No.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filing date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filed&nbsp;or<BR>furnished<BR>herewith</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;1.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Underwriting Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001826892/000119312520321571/d89083dex31.htm">Amended and Restated Certificate of Incorporation</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">8-K</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">001-39787</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1826892/000095017024047595/bcab-ex3_1.htm">Amended and Restated Bylaws</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">8-K</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">001-39787</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/24/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1826892/000119312520312311/d258427dex41.htm">Form of Specimen Common Stock Certificate</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">S-1/A</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">333-250093</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/8/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1826892/000119312520312311/d258427dex42.htm">Investors&#8217; Rights Agreement, dated July&nbsp;13, 2020 </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">333-250093</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/8/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;4.3*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of any certificate of designation with respect to any preferred stock issued hereunder and the related form of preferred stock certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;4.4*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of any warrant agreement with respect to each particular series of warrants issued hereunder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;4.5*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of any unit agreement with respect to any unit issued hereunder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;4.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d31173dex46.htm">Form of Indenture</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;4.7*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Note</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d31173dex51.htm">Opinion of Orrick, Herrington&nbsp;&amp; Sutcliffe LLP relating to the base prospectus </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;5.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d31173dex52.htm">Opinion of Orrick, Herrington&nbsp;&amp; Sutcliffe LLP relating to the prospectus supplement </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d31173dex51.htm">Consent of Orrick, Herrington&nbsp;&amp; Sutcliffe LLP (included in Exhibit 5.1) </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d31173dex52.htm">Consent of Orrick, Herrington&nbsp;&amp; Sutcliffe LLP (included in Exhibit&nbsp;5.2)</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d31173dex233.htm">Consent of Independent Registered Public Accounting Firm </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (included on the signature page to this registration statement) </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>25.1**</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form <FONT STYLE="white-space:nowrap">T-1</FONT> Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Debt Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>107</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d31173dexfilingfees.htm">Filing Fee Table </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be filed, if necessary, subsequent to the effectiveness of this registration statement by an amendment to
this registration statement or incorporation by reference pursuant to a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> in connection with an offering of securities. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be filed as an exhibit to a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> or pursuant
to Section&nbsp;305(b)(2) of the Trust Indenture Act of 1939 and incorporated herein by reference. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&#8201;17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><I>Undertakings</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant hereby undertakes: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule&nbsp;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20&nbsp;percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221;
table in the effective registration statement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To include any material information with respect to the plan of distribution not
previously disclosed in the registration statement or any material change to such information in the registration statement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in
a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934 that are incorporated by
reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post- effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date
the filed prospectus was deemed part of and included in the registration statement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each prospectus required to be filed
pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x)&nbsp;for the purpose of providing the information required by
Section&nbsp;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of
sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the
registration statement relating to the securities in the registration statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. <I>Provided</I>,
<I>however</I>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such effective date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) That, for the purpose of determining liability of the Registrant under the Securities
Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the
underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be
considered to offer or sell such securities to such purchaser: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Any preliminary prospectus or prospectus of the undersigned Registrant
relating to the offering required to be filed pursuant to Rule 424; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Any free writing prospectus relating to the offering prepared by
or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The portion of any other free
writing prospectus relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) That, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s annual report
pursuant to Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section&nbsp;15(d) of the Securities Exchange Act of 1934) that is
incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) To file an application for the purpose of determining the eligibility of the trustee to act under
subsection&nbsp;(a) of Section&nbsp;310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section&nbsp;305(b)(2) of the Trust Indenture Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and
is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of
such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form <FONT STYLE="white-space:nowrap">S-3</FONT> and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San&nbsp;Diego, State of
California, on January&nbsp;16, 2026. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BIOATLA, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jay M. Short, Ph.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Jay M. Short, Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer and Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Jay M. Short, Ph.D. and Richard A. Waldron, and
each or any of them, as their true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of substitution and resubstitution, for their and in their name, place and
stead, in any and all capacities, to sign any and all amendments to this registration statement, and to sign any registration statement for the same offering covered by this registration statement filed pursuant to Rule 462(b) under the Securities
Act of 1933, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection
therewith, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, or any
of them, or their substitutes, may lawfully do or cause to be done by virtue thereof. This Power of Attorney may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and
hereto were upon the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933 this registration statement has been signed by the
following persons in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jay M. Short, Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Jay M. Short, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer and Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(<I>Principal Executive Officer</I>)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;16, 2026</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard A. Waldron</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Richard A. Waldron</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(<I>Principal Financial and Accounting Officer)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;16, 2026</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scott Smith</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Scott Smith</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;16, 2026</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mary Ann Gray</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Mary Ann Gray</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;16, 2026</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Susan Moran</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Susan Moran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;16, 2026</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edward Williams</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Edward Williams</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;16, 2026</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lawrence Steinman</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Lawrence Steinman</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;16, 2026</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sylvia McBrinn</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Sylvia McBrinn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;16, 2026</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>2
<FILENAME>d31173dex46.htm
<DESCRIPTION>EX-4.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.6 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BioAtla, Inc. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U></U>________________________, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>as Trustee </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDENTURE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of _____________________<U></U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Reconciliation and tie between </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Trust Indenture Act of 1939, as amended, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and the Indenture </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Trust Indenture Act Section</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Indenture<BR>Section</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#167;310(a)(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.8</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.8</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#167;312(a)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(c)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#167;313(a)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(c)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(d)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#167;314(a)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(c)(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(c)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(e)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#167;316(a) (last sentence)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(1)(A)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.2,&nbsp;5.12</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(1)(B)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.8</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#167;317(a)(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">10.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#167;318(a)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.8</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Note: This reconciliation and tie shall not, for any purpose, be deemed to be part of
the Indenture.</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions; Rules of Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance Certificates and Opinions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Form of Documents Delivered to Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acts of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices, etc., to Trustee and Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice to Holders of Securities; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Language of Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Incorporation by Reference of Trust Indenture Act; Trust Indenture Act Controls</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Headings and Table of Contents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successors and Assigns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Separability Clause</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Benefits of Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law; Waiver of Trial by Jury</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legal Holidays</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Judgment Currency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Individual Liability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 2 SECURITIES FORMS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Forms Generally</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Form of Trustee&#8217;s Certificate of Authentication</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Securities in Global Form</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 3 THE SECURITIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amount Unlimited; Issuable in Series</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Currency; Denominations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Execution, Authentication, Delivery and Dating</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Temporary Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Registration, Transfer and Exchange</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Mutilated, Destroyed, Lost and Stolen Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment of Interest and Certain Additional Amounts; Rights to Interest and Certain Additional Amounts Preserved</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Persons Deemed Owners</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cancellation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Computation of Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CUSIP and ISIN Numbers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 4 SATISFACTION AND DISCHARGE OF INDENTURE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Satisfaction and Discharge</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Defeasance and Covenant Defeasance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Application of Trust Money</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Qualifying Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 5 REMEDIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Events of Default</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acceleration of Maturity; Rescission and Annulment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Collection of Indebtedness and Suits for Enforcement by Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Trustee May File Proofs of Claim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Trustee May Enforce Claims without Possession of Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Application of Money Collected</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitations on Suits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Unconditional Right of Holders to Receive Principal and Any Premium, Interest and Additional Amounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Restoration of Rights and Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rights and Remedies Cumulative</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Delay or Omission Not Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Control by Holders of Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver of Past or Existing Defaults</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver of Stay or Extension Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Undertaking for Costs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 6 THE TRUSTEE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Duties and Responsibilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Rights of Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice of Defaults</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Not Responsible for Recitals or Issuance of Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>May Hold Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Money Held in Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compensation and Reimbursement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Trustee Required; Eligibility; Conflicting Interests</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Resignation and Removal; Appointment of Successor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acceptance of Appointment by Successor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger, Conversion, Consolidation or Succession to Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Appointment of Authenticating Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 7 HOLDERS LISTS AND REPORTS BY TRUSTEE AND COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company to Furnish Trustee Names and Addresses of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preservation of Information; Communications to Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reports by Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reports by Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 8 CONSOLIDATION, MERGER AND SALES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company May Consolidate, etc., Only on Certain Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successor Person Substituted for Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 9 SUPPLEMENTAL INDENTURES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Supplemental Indentures without Consent of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Supplemental Indentures with Consent of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Execution of Supplemental Indentures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Revocation of Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Supplemental Indentures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reference in Securities to Supplemental Indentures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conformity with Trust Indenture Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice of Supplemental Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 10 COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment of Principal, Any Premium, Interest and Additional Amounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Maintenance of Office or Agency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Money for Securities Payments to Be Held in Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Additional Amounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver of Certain Covenants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 11 REDEMPTION OF SECURITIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Applicability of Article</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Election to Redeem; Notice to Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Selection by Trustee of Securities to Be Redeemed</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice of Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Deposit of Redemption Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Securities Payable on Redemption Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Securities Redeemed in Part</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Repurchases on the Open Market</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 12 SINKING FUNDS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Applicability of Article</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Satisfaction of Sinking Fund Payments with Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Redemption of Securities for Sinking Fund</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 13 REPAYMENT AT THE OPTION OF HOLDERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;13.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Applicability of Article</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 14 SECURITIES IN FOREIGN CURRENCIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;14.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Applicability of Article</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 15 MEETINGS OF HOLDERS OF SECURITIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Purposes for Which Meetings May Be Called</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Call, Notice and Place of Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Persons Entitled to Vote at Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Quorum; Action</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Determination of Voting Rights; Conduct and Adjournment of Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iv- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counting Votes and Recording Action of Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-v- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">INDENTURE (the &#8220;<U>Indenture</U>&#8221;), dated as of ____________________, between
BioAtla, Inc., a corporation existing under the laws of the State of Delaware (the &#8220;<U>Company</U>&#8221;), and ____________________, as trustee (the &#8220;<U>Trustee</U>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RECITALS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has duly
authorized the execution and delivery of this Indenture to provide for the issuance from time to time of its debentures, notes or other evidences of indebtedness (hereinafter called the &#8220;<U>Securities</U>&#8221;), unlimited as to principal
amount, to bear such rates of interest, to mature at such time or times, to be issued in one or more series and to have such other provisions as shall be fixed as hereinafter provided. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All things necessary to make this Indenture a valid and legally binding agreement of the Company, in accordance with its terms, have been
done. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, THIS INDENTURE WITNESSETH: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For and in consideration of the premises and the purchase of the Securities by the Holders (as herein defined) thereof, it is mutually
covenanted and agreed, for the equal and proportionate benefit of all Holders of the Securities or of any series thereof as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
AND OTHER PROVISIONS OF GENERAL APPLICATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Definitions; Rules of Construction</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise expressly provided in or pursuant to this Indenture or unless the context otherwise requires, for all purposes of this
Indenture: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the terms defined in this Article 1 have the meanings assigned to them in this Article 1, and include the plural as well
as the singular; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all other terms used herein that are defined in the Trust Indenture Act, either directly or by reference therein,
have the meanings assigned to them therein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) all accounting terms not otherwise defined herein have the meanings assigned to them in
accordance with generally accepted accounting principles and, except as otherwise herein expressly provided, the terms &#8220;generally accepted accounting principles&#8221; or &#8220;GAAP&#8221; with respect to any computation required or permitted
hereunder shall mean such accounting principles as are generally accepted as of the date hereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the words &#8220;herein,&#8221;
&#8220;hereof,&#8221; &#8220;hereto&#8221; and &#8220;hereunder&#8221; and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the word &#8220;or&#8221; is always used inclusively (for example, the phrase &#8220;A or B&#8221; means &#8220;A or B or both,&#8221; not
&#8220;either A or B but not both&#8221;); </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) provisions apply to successive events and transactions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) any reference to gender includes the masculine, feminine and the neuter, as the case may be; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) references to agreements and other instruments include subsequent amendments thereto and restatements thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) &#8220;including&#8221; means &#8220;including without limitation&#8221;; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) all exhibits are incorporated by reference herein and expressly made a part of this Indenture; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) all references to articles, sections and exhibits (and subparts thereof) are to this Indenture; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) any transaction or event shall be considered &#8220;permitted by&#8221; or made &#8220;in accordance with&#8221; or &#8220;in compliance
with&#8221; this Indenture or any particular provision thereof if such transaction or event is not expressly prohibited by this Indenture or such provision, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain terms used principally in certain Articles hereof are defined in those Articles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Act</U>,&#8221; when used with respect to any Holders, has the meaning specified in Section&nbsp;1.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Additional Amounts</U>&#8221; means any additional amounts which are required by this Indenture or by any Security, under
circumstances specified herein or therein, to be paid by the Company in respect of certain taxes, assessments or other governmental charges imposed on Holders specified therein and which are owing to such Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Affiliate</U>&#8221; of any specified Person means any other Person directly or indirectly controlling or controlled by or under
direct or indirect common control with such specified Person. For the purposes of this definition, &#8220;control,&#8221; when used with respect to any specified Person, means the power to direct the management and policies of such Person, directly
or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms &#8220;controlling&#8221; and &#8220;controlled&#8221; have the meanings correlative to the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Applicable Procedures</U>&#8221; means, with respect to any transfer or exchange of or for beneficial interests in any Global
Security, the rules and procedures of the Depositary that apply to such transfer or exchange at the relevant time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Authenticating Agent</U>&#8221; means any Person authorized by the Trustee pursuant to Section&nbsp;6.12 to act on behalf of the
Trustee to authenticate Securities of one or more series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Authorized Newspaper</U>&#8221; means a newspaper, in an official
language of the place of publication or in the English language, customarily published on each day that is a Business Day in the place of publication, whether or not published on days that are Legal Holidays in the place of publication, and of
general circulation in each place in connection with which the term is used </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or in the financial community of each such place. Where successive publications are required to be made in Authorized Newspapers, the successive publications may be made in the same or in
different newspapers in the same city meeting the foregoing requirements and in each case on any day that is a Business Day in the place of publication. If it shall be impractical in the opinion of the Trustee to make any publication of any notice
required hereby in an Authorized Newspaper, any publication or other notice in lieu thereof which is made or given with the approval of the Trustee shall constitute a sufficient publication of such notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Board of Directors</U>&#8221; means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) with respect to the Company, the board of directors of the Company or any committee of the board of directors of the Company duly
authorized to act generally or in any particular respect for the Company under this Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) with respect to any other corporation,
the board of directors of the corporation or any authorized committee thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) with respect to a limited liability company, the
managing member or managing members of such limited liability company or any authorized committee thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) with respect to a
partnership, the board of directors of the general partner of the partnership or any authorized committee thereof; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) with respect
to any other Person, the board or committee of such Person serving a similar function. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Board Resolution</U>&#8221; means a copy
of one or more resolutions (which may be standing resolutions), certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors of the Company and to be in full force and effect on the date of
such certification, and delivered to the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Business Day</U>&#8221; means, unless otherwise specified with respect to any
Securities pursuant to Section&nbsp;3.1, each day that is not a Saturday, Sunday or other day on which banking institutions in New York, New York or another Place of Payment are authorized or required by law, regulation or executive order to close.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Capital Stock</U>&#8221; means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) in the case of a corporation, corporate stock; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however
designated) of corporate stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) in the case of a partnership or limited liability company, partnership or membership interests
(whether general or limited); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) any other interest or participation that confers on a Person the right to receive a share of the
profits and losses of, or distributions of assets of, the issuing Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Commission</U>&#8221; means the Securities and Exchange Commission, as from time
to time constituted, created under the Exchange Act or any successor agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Common Stock</U>&#8221; includes any Capital Stock
of any class of the Company which has no preference in respect of dividends or of amounts payable in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Company</U>&#8221; means the Person named as the &#8220;Company&#8221; in the first paragraph of this Indenture until a successor
Person shall have become such pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Company&#8221; shall mean such successor Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Company Request</U>&#8221; and &#8220;<U>Company Order</U>&#8221; mean, respectively, a written request or order, as the case may
be, signed in the name of the Company by the Chairman of the Board of Directors of the Company, a Vice Chairman, the President, a Vice President, the Treasurer, the Assistant Treasurer, the Secretary or the Assistant Secretary or other person
authorized by resolution of the Board of Directors of the Company, and delivered to the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Corporate Trust
Office</U>&#8221; means the designated office of the Trustee at which the corporate trust business of the Trustee shall at any particular time be administered, which office at the date of original execution of this Indenture is located at
____________________. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Corporation</U>&#8221; includes corporations and limited liability companies and, except for purposes of
Article 8, associations, companies (other than limited liability companies) and business trusts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Currency</U>&#8221; means,
with respect to any payment, deposit or other transfer in respect of the principal of or any premium or interest on or any Additional Amounts with respect to any Security, Dollars or Foreign Currency, as the case may be, in which such payment,
deposit or other transfer is required to be made by or pursuant to the terms hereof or such Security and, with respect to any other payment, deposit or transfer pursuant to or contemplated by the terms hereof or such Security, means Dollars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>CUSIP number</U>&#8221; means the alphanumeric designation assigned to a Security by Standard&nbsp;&amp; Poor&#8217;s Corporation,
CUSIP Service Bureau. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Defaulted Interest</U>&#8221; has the meaning specified in Section&nbsp;3.7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Definitive Security</U>&#8221; means a certificated Security registered in the name of the Holder thereof (other than a Depositary
or its nominee) issued under this Indenture pursuant to Section&nbsp;3.1 and Section&nbsp;3.5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Dollars</U>&#8221; or
&#8220;<U>$</U>&#8221; means a dollar or other equivalent unit of legal tender for payment of public or private debts in the United States of America. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Event of Default</U>&#8221; has the meaning specified in Section&nbsp;5.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Exchange Act</U>&#8221; means the Securities Exchange Act of 1934, as amended, or any successor thereto, in each case as amended
from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Foreign Currency</U>&#8221; means any currency, currency unit or composite
currency, including, without limitation, the euro, issued by the government of one or more countries other than the United States of America or by any recognized confederation or association of such governments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>GAAP</U>&#8221; means generally accepted accounting principles in the United States, which are in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Global Security</U>&#8221; means a Security issued under this Indenture in global form pursuant to Section&nbsp;3.1, bearing the
legend set forth in Section&nbsp;2.3 and deposited with, or on behalf of, and registered in the name of, the Depositary or its nominee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Government Obligations</U>&#8221; means securities which are (i)&nbsp;direct obligations of the United States of America or the
other government or governments in the confederation which issued the Foreign Currency in which the principal of or any premium or interest on any Security or any Additional Amounts in respect thereof shall be payable, in each case where the payment
or payments thereunder are supported by the full faith and credit of the United States or such government or governments or (ii)&nbsp;obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States
of America or such other government or governments, in each case where the timely payment or payments thereunder are unconditionally guaranteed as a full faith and credit obligation by the United States of America or such other government or
governments, and which, in the case of (i)&nbsp;or (ii), are not callable or redeemable at the option of the issuer or issuers thereof, and shall also include a Depositary receipt issued by a bank or trust company as custodian with respect to any
such Government Obligation or a specific payment of interest on or principal of or other amount with respect to any such Government Obligation held by such custodian for the account of the holder of a Depositary receipt, provided that (except as
required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such Depositary receipt from any amount received by the custodian in respect of the Government Obligation or the specific payment of
interest on or principal of or other amount with respect to the Government Obligation evidenced by such Depositary receipt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Holder</U>&#8221; means, in the case of any Registered Security, the Person in whose name such Security is registered in the
Security Register. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Indenture</U>&#8221; means this instrument as it may from time to time be supplemented or amended by one or
more indentures supplemental hereto entered into pursuant to the applicable provisions hereof and, with respect to any Security of any series, by the terms and provisions of such Security established pursuant to Section&nbsp;3.1 (as such terms and
provisions may be amended pursuant to the applicable provisions hereof); provided, however, that, if at any time more than one Person is acting as Trustee under this instrument, &#8220;Indenture&#8221; shall mean, with respect to any one or more
series of Securities for which such Person is Trustee, this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental hereto entered into pursuant to the applicable provisions
hereof and shall include the terms of those particular series of Securities for which such Person is Trustee established pursuant to Section&nbsp;3.1, exclusive, however, of any provisions or terms which relate solely to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other series of Securities for which such Person is not Trustee, regardless of when such terms or provisions were adopted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Independent Registered Public Accounting Firm</U>&#8221; means a firm of accountants that, with respect to the Company and any other
obligor under the Securities, is an independent registered public accounting firm within the meaning of the Securities Act of 1933, as amended, and the rules and regulations promulgated by the Commission thereunder, who may be the independent
registered public accounting firm regularly retained by the Company or who may be another independent registered public accounting firm. Such firm shall be entitled to rely upon any Opinion of Counsel as to the interpretation of any legal matters
relating to this Indenture or certificates required to be provided hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Indexed Security</U>&#8221; means a Security the
terms of which provide that the principal amount thereof payable at Stated Maturity may be more or less than the principal face amount thereof at original issuance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Indirect Participant</U>&#8221; means an entity that, with respect to any Depositary, clears through or maintains a direct or
indirect, custodial relationship with a Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>interest</U>&#8221; means any interest specified in any Security as being
payable with respect to that Security, and, with respect to any Original Issue Discount Security which by its terms bears interest only after Maturity, means interest payable after Maturity and, when used with respect to a Security which provides
for the payment of Additional Amounts pursuant to Section&nbsp;10.4, includes such Additional Amounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Interest Payment
Date</U>&#8221; means, with respect to any Security, the Stated Maturity of an installment of interest on such Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Judgment Currency</U>&#8221; has the meaning specified in Section&nbsp;1.16. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Legal Holiday</U>&#8221; has the meaning specified in Section&nbsp;1.14. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Maturity</U>&#8221; means, with respect to any Security, the date on which the principal of such Security or an installment of
principal becomes due and payable as provided in or pursuant to this Indenture, whether at the Stated Maturity or by declaration of acceleration, notice of redemption or repurchase, notice of option to elect repayment or otherwise, and includes the
Redemption Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>New York Banking Day</U>&#8221; has the meaning specified in Section&nbsp;1.16. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Office</U>&#8221; or &#8220;<U>Agency</U>&#8221; means, with respect to any Securities, an office or agency of the Company
maintained or designated as a Place of Payment for such Securities pursuant to Section&nbsp;10.2 or any other office or agency of the Company maintained or designated for such Securities pursuant to Section&nbsp;10.2 or, to the extent designated or
required by Section&nbsp;10.2 in lieu of such office or agency, the Corporate Trust Office of the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Officer</U>&#8221;
means, with respect to any Person, the Chairman of the Board of Directors, a Vice Chairman, the Chief Executive Officer, the President, any Vice President (without regard to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
qualifiers such as &#8220;Executive&#8221; or &#8220;Senior&#8221;), the Chief Operating Officer, the Chief Financial Officer, the Treasurer, an Assistant Treasurer, the Controller, the Secretary
or an Assistant Secretary of such Person, or other Person authorized by resolution of the Board of Directors of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Officer&#8217;s Certificate</U>&#8221; means a certificate signed by an Officer, that, if applicable, complies with the requirements
of Section&nbsp;314(e) of the Trust Indenture Act and is delivered to the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Opinion of Counsel</U>&#8221; means a
written opinion of counsel, who may be an employee of or counsel for the Company or other counsel that, if applicable, complies with the requirements of Section&nbsp;314(e) of the Trust Indenture Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Original Issue Discount Security</U>&#8221; means a Security issued pursuant to this Indenture that provides, at any time prior to
the final Stated Maturity of such Security, for declaration of an amount less than the principal amount thereof to be due and payable upon acceleration pursuant to Section&nbsp;5.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Outstanding</U>&#8221; means, when used with respect to any Securities, as of the date of determination, all such Securities
theretofore authenticated and delivered under this Indenture, except: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any such Security theretofore cancelled by the Trustee or
delivered to the Trustee for cancellation including Securities tendered and exchanged for other securities of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any such
Security of any series for which payment at the Maturity thereof money in the necessary amount has been theretofore deposited pursuant hereto (other than pursuant to Section&nbsp;4.2) with the Trustee or any Paying Agent (other than the Company) in
trust or set aside and segregated in trust by the Company (if the Company shall act as its own Paying Agent) for the Holders of such series of Securities, provided that, if such Securities are to be redeemed, notice of such redemption has been duly
given pursuant to this Indenture or provision therefor satisfactory to the Trustee has been made; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) any such Security of any series
with respect to which the Company has effected defeasance or covenant defeasance pursuant to the terms hereof, except to the extent provided in Section&nbsp;4.2; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) any such Security which has been paid pursuant to Section&nbsp;3.6 or in exchange for or in lieu of which other Securities have been
authenticated and delivered pursuant to this Indenture, unless there shall have been presented to the Trustee proof satisfactory to it that such Security is held by a &#8220;protected purchaser&#8221; (as such term is defined in the New York Uniform
Commercial Code) in whose hands such Security is a valid obligation of the Company; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) any such Security converted or exchanged as
contemplated by this Indenture into Common Stock or other securities, cash or other property, if the terms of such Security provide for such conversion or exchange pursuant to Section&nbsp;3.1; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">provided, however, that in determining whether the Holders of the requisite principal amount
of Outstanding Securities of any series have given any request, demand, authorization, direction, notice, consent or waiver hereunder or are present at a meeting of Holders of Securities of such series for quorum purposes, (i)&nbsp;the principal
amount of an Original Issue Discount Security that may be counted in making such determination and that shall be deemed to be Outstanding for such purposes shall be equal to the amount of the principal thereof that pursuant to the terms of such
Original Issue Discount Security would be declared (or shall have been declared to be) due and payable upon a declaration of acceleration thereof pursuant to Section&nbsp;5.2 at the time of such determination, and (ii)&nbsp;the principal amount of
any Indexed Security that may be counted in making such determination and that shall be deemed Outstanding for such purpose shall be equal to the principal face amount of such Indexed Security at original issuance, unless otherwise provided in or
pursuant to this Indenture, and (iii)&nbsp;the principal amount of a Security denominated in a Foreign Currency shall be the Dollar equivalent, determined on the date of original issuance of such Security, of the principal amount (or, in the case of
an Original Issue Discount Security, the Dollar equivalent on the date of original issuance of such Security of the amount determined as provided in (i)&nbsp;above) of such Security, and (iv)&nbsp;Securities owned by the Company or any other obligor
upon the Securities or any Affiliate of the Company or such other obligor, shall be disregarded and deemed not to be Outstanding, except that, in determining whether the Trustee shall be protected in making any such determination or relying upon any
such request, demand, authorization, direction, notice, consent or waiver, only Securities which a Responsible Officer actually knows to be so owned shall be so disregarded. Securities so owned which shall have been pledged in good faith may be
regarded as Outstanding if the pledgee establishes to the satisfaction of a Responsible Officer (A)&nbsp;the pledgee&#8217;s right so to act with respect to such Securities and (B)&nbsp;that the pledgee is not the Company or any other obligor upon
the Securities or an Affiliate of the Company or such other obligor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Participant</U>&#8221; means, with respect to the
Depositary, a Person who has an account with the Depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Paying Agent</U>&#8221; means any Person authorized by the Company
to pay the principal of, or any premium or interest on, or any Additional Amounts with respect to, any Security on behalf of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Person</U>&#8221; or &#8220;<U>person</U>&#8221; means any individual, corporation, partnership, joint venture, joint-stock company,
association, trust, unincorporated organization, limited liability company or government or any agency or political subdivision thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Place of Payment</U>&#8221; means, with respect to any Security, the place or places where the principal of, or any premium or
interest on, or any Additional Amounts with respect to such Security are payable as provided in or pursuant to this Indenture or such Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Predecessor Security</U>&#8221; of any particular Security means every previous Security evidencing all or a portion of the same
indebtedness as that evidenced by such particular Security; and, for the purposes of this definition, any Security authenticated and delivered under Section&nbsp;3.6 in exchange for or in lieu of a lost, destroyed, mutilated or stolen Security shall
be deemed to evidence the same indebtedness as the lost, destroyed, mutilated or stolen Security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Redemption Date</U>&#8221; means, with respect to any Security or portion thereof
to be redeemed, each date fixed for such redemption by or pursuant to this Indenture or such Security. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Redemption
Price</U>&#8221; means, with respect to any Security or portion thereof to be redeemed, the price at which it is to be redeemed including, if applicable, accrued and unpaid interest and Additional Amounts as determined by or pursuant to this
Indenture or such Security. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Registered Security</U>&#8221; means any Security established pursuant to Section&nbsp;2.1 which is
registered in the Security Register. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Regular Record Date</U>&#8221; for the interest payable on any Registered Security on any
Interest Payment Date therefor means the date, if any, specified in or pursuant to this Indenture or such Security as the &#8220;Regular Record Date.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Required Currency</U>&#8221; has the meaning specified in Section&nbsp;1.16. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Responsible Officer</U>&#8221; means any officer of the Trustee in its Corporate Trust Office with direct responsibility for the
administration of this Indenture, and also, with respect to a particular corporate trust matter, any other officer of the Trustee to whom such matter is referred because of such officer&#8217;s knowledge of and familiarity with the particular
subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Security</U>&#8221; or &#8220;<U>Securities</U>&#8221; means any note or notes, bond or bonds, debenture or
debentures, or any other evidences of indebtedness, as the case may be, authenticated and delivered under this Indenture; provided, however, that, if at any time there is more than one Person acting as Trustee under this Indenture,
&#8220;Securities,&#8221; with respect to any such Person, shall mean Securities authenticated and delivered under this Indenture, exclusive, however, of Securities of any series as to which such Person is not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Security Register</U>,&#8221; &#8220;<U>Security Registrar</U>&#8221; and &#8220;<U>Registrar</U>&#8221; have the respective
meanings specified in Section&nbsp;3.5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>series</U>&#8221; means a series of Securities established under this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Special Record Date</U>&#8221; for the payment of any Defaulted Interest on any Registered Security means a date fixed by the
Trustee pursuant to Section&nbsp;3.7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Stated Maturity</U>&#8221; means, with respect to any Security or any installment of
principal thereof or interest thereon or any Additional Amounts with respect thereto, the date established by or pursuant to this Indenture or such Security as the fixed date on which the principal of such Security or such installment of principal
or interest is, or such Additional Amounts are, due and payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Trust Indenture Act</U>&#8221; or &#8220;<U>TIA</U>&#8221;
means the Trust Indenture Act of 1939, as amended, and any reference herein to the Trust Indenture Act or a particular provision thereof shall mean such Act or provision, as the case may be, as amended or replaced from time to time or as
supplemented from time to time by rules or regulations adopted by the Commission under or in furtherance of the purposes of such Act or provision, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Trustee</U>&#8221; means the Person named as the &#8220;Trustee&#8221; in the
first paragraph of this instrument until a successor Trustee shall have become such with respect to one or more series of Securities pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Trustee&#8221; shall mean each Person
who is then a Trustee hereunder; provided, however, that if at any time there is more than one such Person, &#8220;Trustee&#8221; shall mean each such Person and as used with respect to the Securities of any series shall mean only the Trustee with
respect to the Securities of such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>United States</U>&#8221; means, except as otherwise provided in or pursuant to this
Indenture or any Security, the United States of America (including the states thereof and the District of Columbia), its territories and possessions and other areas subject to its jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>United States Alien</U>&#8221; means, except as otherwise provided in or pursuant to this Indenture or any Security, any Person who,
for United States federal income tax purposes, is a foreign corporation, a <FONT STYLE="white-space:nowrap">non-resident</FONT> alien individual, a <FONT STYLE="white-space:nowrap">non-resident</FONT> alien fiduciary of a foreign estate or trust, or
a foreign partnership one or more of the members of which is, for United States federal income tax purposes, a foreign corporation, a <FONT STYLE="white-space:nowrap">non-resident</FONT> alien individual or a
<FONT STYLE="white-space:nowrap">non-resident</FONT> alien fiduciary of a foreign estate or trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>U.S. Depositary</U>&#8221;
or &#8220;<U>Depositary</U>&#8221; means, with respect to any Security issuable or issued in the form of one or more Global Securities, the Person designated as U.S. Depositary or Depositary by the Company in or pursuant to this Indenture, which
Person must be, to the extent required by applicable law or regulation, a clearing agency registered under the Exchange Act and, if so provided with respect to any Security, any successor to such Person. If at any time there is more than one such
Person, &#8220;U.S. Depositary&#8221; or &#8220;Depositary&#8221; shall mean, with respect to any Securities, the qualifying entity which has been appointed with respect to such Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Vice President</U>&#8221; means, when used with respect to the Company or the Trustee, any vice president, whether or not designated
by a number or a word or words added before or after the title &#8220;Vice President.&#8221; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Compliance Certificates
and Opinions</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise expressly provided in or pursuant to this Indenture, upon any application or request by the Company
to the Trustee to take any action under any provision of this Indenture, the Company shall furnish to the Trustee an Officer&#8217;s Certificate stating that all conditions precedent, if any, provided for in this Indenture relating to the proposed
action have been complied with and an Opinion of Counsel stating that, in the opinion of such counsel, all such conditions precedent, if any, have been complied with, except that in the case of any such application or request as to which the
furnishing of such documents or any of them is specifically required by any provision of this Indenture relating to such particular application or request, no additional certificate or opinion need be furnished. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every certificate or opinion with respect to compliance with a condition or covenant or covenant provided for in this Indenture (other than a
certificate delivered pursuant to Section&nbsp;7.4(4)) shall include: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) a statement that each individual signing such certificate or opinion has read such
condition or covenant and the definitions herein relating thereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) a brief statement as to the nature and scope of the examination or
investigation upon which the statements or opinions contained in such certificate or opinion are based; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) a statement that, in the
opinion of each such individual, he or she has made such examination or investigation as is necessary to enable him or her to express an informed opinion as to whether or not such condition or covenant has been complied with; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) a statement as to whether, in the opinion of each such individual, such condition or covenant has been complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3 <U>Form of Documents Delivered to Trustee</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In any case where several matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that
all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other
such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any
certificate or opinion of an Officer of the Company may be based, insofar as it relates to legal matters, upon an Opinion of Counsel, unless such Officer knows that the opinion with respect to the matters upon which his certificate or opinion is
based are erroneous. Any such Opinion of Counsel may be based, insofar as it relates to factual matters, upon a certificate or opinion of, or representations by, an Officer or Officers of the Company stating that the information with respect to such
factual matters is in the possession of the Company unless such counsel knows that the certificate or opinion or representations with respect to such matters are erroneous. Any certificate, statement or opinion of an Officer of the Company or any
Opinion of Counsel may be based, insofar as it relates to accounting matters, upon a certificate or opinion of or representations by an accountant or firm of accountants in the employ of the Company, unless such Officer or counsel, as the case may
be, knows that the certificate or opinion or representations with respect to the accounting matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where any Person is required to make, give or execute two or more applications, requests, consents, certificates, statements, opinions or
other instruments under this Indenture or any Security, they may, but need not, be consolidated and form one instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4
<U>Acts of Holders</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Any request, demand, authorization, direction, notice, consent, waiver or other action provided by or pursuant
to this Indenture to be given or taken by Holders may be embodied in and evidenced by one or more instruments (including instruments in electronic, digital or other machine-readable form) of substantially similar tenor signed by such Holders
(whether in person or through signatures in electronic, digital or other machine-readable form) or by an agent duly appointed in writing (including writings in electronic, digital or other machine-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
readable form) or may be embodied in and evidenced by the record of Holders voting in favor thereof, either in person or by proxies duly appointed in writing, at any meeting of Holders duly
called and held in accordance with the provisions of Article 15, or a combination of such instruments or record. Except as herein otherwise expressly provided, such action shall become effective when such instrument or instruments or record or both
are delivered to the Trustee and, where it is hereby expressly required, to the Company. Such instrument or instruments or record or both (and the action embodied therein and evidenced thereby) are herein sometimes referred to as the
&#8220;Act&#8221; of the Holders signing such instrument or instruments or so voting at any such meeting. Proof of execution of any such instrument or of a writing appointing any such agent, or of the holding by any Person of a Security, shall be
sufficient for any purpose of this Indenture and (subject to Section&nbsp;315 of the Trust Indenture Act) conclusive in favor of the Trustee and the Company and any agent of the Trustee or the Company, if made in the manner provided in this
Section&nbsp;1.4. The record of any meeting of Holders of Securities shall be proved in the manner provided in Section&nbsp;15.6. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without
limiting the generality of this Section&nbsp;1.4, unless otherwise provided in or pursuant to this Indenture, a Holder, including a U.S. Depositary that is a Holder of a Global Security, may make, give or take, by a proxy or proxies, duly appointed
in writing, any request, demand, authorization, direction, notice, consent, waiver or other Act provided in or pursuant to this Indenture or the Securities to be made, given or taken by Holders, and a U.S. Depositary that is a Holder of a Global
Security may provide its proxy or proxies to the beneficial owners of interests in any such Global Security through such U.S. Depositary&#8217;s standing instructions and customary practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee may fix a record date for the purpose of determining the Persons who are beneficial owners of interests in any permanent Global
Security held by a U.S. Depositary entitled under the procedures of such U.S. Depositary to make, give or take, by a proxy or proxies duly appointed in writing, any request, demand, authorization, direction, notice, consent, waiver or other Act
provided in or pursuant to this Indenture to be made, given or taken by Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) The fact and date of the execution by any Person of
any such instrument or writing referred to in this Section&nbsp;1.4 may be proved in any reasonable manner which the Trustee deems sufficient and in accordance with such reasonable rules as the Trustee may determine; and the Trustee may in any
instance require further proof with respect to any of the matters referred to in this Section&nbsp;1.4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) The ownership, principal
amount and serial numbers of Registered Securities held by any Person, and the date of the commencement and the date of the termination of holding the same, shall be proved by the Security Register. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) If the Company shall solicit from the Holders of any Registered Securities any request, demand, authorization, direction, notice, consent,
waiver or other Act, the Company may, at its option (but is not obligated to), by Board Resolution, fix in advance a record date for the determination of Holders of Registered Securities entitled to give such request, demand, authorization,
direction, notice, consent, waiver or other Act. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other Act may be given </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
before or after such record date, but only the Holders of Registered Securities of record at the close of business on such record date shall be deemed to be Holders for the purpose of determining
whether Holders of the requisite proportion of Outstanding Securities have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other Act, and for that purpose the Outstanding Securities
shall be computed as of such record date; provided that no such authorization, agreement or consent by the Holders of Registered Securities shall be deemed effective unless it shall become effective pursuant to the provisions of this Indenture not
later than six months after the record date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) Any request, demand, authorization, direction, notice, consent, waiver or other Act by
the Holder of any Security shall bind every future Holder of the same Security and the Holder of every Security issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof in respect of anything done or suffered to be
done by the Trustee, any Security Registrar, any Paying Agent or the Company in reliance thereon, whether or not notation of such Act is made upon such Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5 <U>Notices, etc., to Trustee and Company</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any request, demand, authorization, direction, notice, consent, waiver or other Act of Holders or other document provided or permitted by this
Indenture to be made upon, given or furnished to, or filed with: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Trustee by any Holder or the Company shall be sufficient for
every purpose hereunder if made, given, furnished or filed in writing (which may be via facsimile or other electronic transmission) to or with the Trustee at its Corporate Trust Office; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Company by the Trustee or any Holder shall be sufficient for every purpose hereunder (unless otherwise herein expressly provided) if
in writing and mailed, first-class postage prepaid or airmail postage prepaid if sent from outside the United States, to the Company addressed to BioAtla, Inc., 11085 Torreyana Road, San Diego, CA 92121, Attention: Christian Vasquez, or to any other
address previously furnished in writing to the Trustee by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6 <U>Notice to Holders of Securities; Waiver</U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise expressly provided in or pursuant to this Indenture, where this Indenture provides for notice to Holders of
Securities of all or any series of any event, such notice shall be sufficiently given to Holders of Registered Securities of such series if in writing, which may be by facsimile or other electronic transmission, or mailed, first-class postage
prepaid, to each Holder of a Registered Security affected by such event, at his address as it appears in the Security Register, not later than the latest date, and not earlier than the earliest date, prescribed for the giving of such notice. In any
case where notice to Holders of Registered Securities is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder of a Registered Security shall affect the sufficiency of such notice
with respect to other Holders of Registered Securities given as provided herein. Any notice which is mailed in the manner herein provided shall be conclusively presumed to have been duly given or provided. In the case by reason of the suspension of
regular mail service or by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reason of any other cause it shall be impracticable to give such notice by mail, then such notification as shall be made with the approval of the Trustee shall constitute a sufficient
notification for every purpose hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where this Indenture provides for notice in any manner, such notice may be waived in writing by
the Person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders of Securities shall be filed with the Trustee, but such filing shall not be a
condition precedent to the validity of any action taken in reliance upon such waiver. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where this Indenture provides for notice of any
event to a Holder of a Global Security, such notice shall be sufficiently given if given to the Depositary for such Security (or its designee), pursuant to the Applicable Procedures of the Depositary, not later than the latest date, if any, and not
earlier than the earliest date, if any, prescribed for the giving of such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7 <U>Language of Notices</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any request, demand, authorization, direction, notice, consent, election or waiver required or permitted under this Indenture shall be in the
English language, except that, if the Company so elects, any published notice may be in an official language of the country of publication (with a copy in English to be provided to the Trustee). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.8 <U>Incorporation by Reference of Trust Indenture Act; Trust Indenture Act Controls</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If any provision hereof limits, qualifies or conflicts with the duties that would be imposed by any of Sections 310 to 317 of the Trust
Indenture Act through operation of Section&nbsp;318(c) thereof on any person, such imposed duties shall control. The following Trust Indenture Act terms have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>indenture securities</U>&#8221; means the Securities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>indenture security holder</U>&#8221; means a Holder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>indenture to be qualified</U>&#8221; means this Indenture; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>indenture trustee</U>&#8221; or &#8220;<U>institutional trustee</U>&#8221; means the Trustee; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>obligor</U>&#8221; on the indenture securities means the Company and any other obligor on the indenture securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All other Trust Indenture Act terms used in this Indenture that are defined by the Trust Indenture Act, defined in the Trust Indenture Act by
reference to another statute or defined by SEC Rule have the meanings assigned to them by such definitions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If any provision of this
Indenture limits, qualifies or conflicts with another provision which is required to be included in this Indenture by the Trust Indenture Act, the provision required by the Trust Indenture Act shall control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.9 <U>Effect of Headings and Table of Contents</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Article and Section headings herein and the Table of Contents are for convenience only and shall not affect the construction hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.10 <U>Successors and Assigns</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All covenants and agreements in this Indenture by the Company shall bind its successors and assigns, whether so expressed or not. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.11 <U>Separability Clause</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case any provision in this Indenture or any Security shall be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.12 <U>Benefits of Indenture</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Indenture or any Security, express or implied, shall give to any Person, other than the parties hereto, any Security
Registrar, any Paying Agent, any Authentication Agent and their successors hereunder and the Holders of Securities, any benefit or any legal or equitable right, remedy or claim under this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.13 <U>Governing Law; Waiver of Trial by Jury</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Indenture and the Securities shall be governed by and construed in accordance with the laws of the State of New York applicable to
agreements made or instruments entered into and, in each case, performed in said state. Each of the Company and the Trustee hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Indenture, the Securities or the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.14
<U>Legal Holidays</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in or pursuant to this Indenture or any Securities, in any case where any Interest
Payment Date, Stated Maturity or Maturity of any Security, or the last date on which a Holder has the right to convert or exchange Securities of a series that are convertible or exchangeable shall not be a Business Day (a &#8220;<U>Legal
Holiday</U>&#8221;) at any Place of Payment, then (notwithstanding any other provision of this Indenture or any Security other than a provision in any Security that specifically states that such provision shall apply in lieu hereof) payment need not
be made at such Place of Payment on such date, and such Securities need not be converted or exchanged on such date but such payment may be made, and such Securities may be converted or exchanged, on the next succeeding day that is a Business Day at
such Place of Payment with the same force and effect as if made on the Interest Payment Date or at the Stated Maturity or Maturity or on such last day for conversion or exchange, and no interest shall accrue on the amount payable on such date or at
such time for the period from and after such Interest Payment Date, Stated Maturity, Maturity or last day for conversion or exchange, as the case may be, to the next succeeding Business Day. If this Indenture provides for a time period that ends or
requires </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
performance of any <FONT STYLE="white-space:nowrap">non-payment</FONT> obligation by a day that is not a Business Day, then such time period shall instead be deemed to end on, and such obligation
shall instead be performed by, the next succeeding Business Day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.15 <U>Counterparts</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Indenture may be executed in several counterparts, each of which when so executed shall be deemed to be an original and all of which
taken together shall constitute one and the same instrument. The exchange of copies of this Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Indenture as to the parties
hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. The words &#8220;delivery,&#8221;
&#8220;execution,&#8221; &#8220;execute,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in or related to any document to be signed in connection with this Indenture and the transactions contemplated hereby shall be
deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Trustee, or the keeping of records in electronic form, each of which shall be of the same legal
effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal
Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act or any other similar state laws based on the Uniform Electronic Transactions Act. The Company agrees to assume all risks arising out
of the use of digital signatures and electronic methods, including without limitation the risk of the Trustee acting on unauthorized instructions, and the risk of interception and misuse by third parties. Each of the parties hereto agrees that the
transaction consisting of this Indenture may be conducted by electronic means. Each party agrees, and acknowledges that it is such party&#8217;s intent, that if such party signs this Indenture using an electronic signature, it is signing, adopting,
and accepting this Indenture and that signing this Indenture using an electronic signature is the legal equivalent of having placed its handwritten signature on this Indenture on paper. Each party acknowledges that it is being provided with an
electronic or paper copy of this Indenture in a usable format. Electronic signatures complying with the ESIGN Act of 2000 or other applicable law (including electronic images of handwritten signatures and digital signatures provided by DocuSign,
Orbit, Adobe Sign or any other digital signature provider acceptable to the Trustee and the Company) shall be deemed original signatures for all purposes of this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.16 <U>Judgment Currency</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company agrees, to the fullest extent that it may effectively do so under applicable law, that (a)&nbsp;if for the purpose of obtaining
judgment in any court it is necessary to convert the sum due in respect of the principal of, or premium or interest, if any, or Additional Amounts on the Securities of any series (the &#8220;<U>Required Currency</U>&#8221;) into a currency in which
a judgment will be rendered (the &#8220;<U>Judgment Currency</U>&#8221;), the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the requisite amount of
the Required Currency with the Judgment Currency on the New York Banking Day preceding the day on which a final unappealable judgment is given and (b)&nbsp;its obligations under this Indenture to make payments in the Required Currency (i)&nbsp;shall
not be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discharged or satisfied by any tender, or any recovery pursuant to any judgment (whether or not entered in accordance with clause (a)), in any currency other than the Required Currency, except to
the extent that such tender or recovery shall result in the actual receipt, by the payee, of the full amount of the Required Currency expressed to be payable in respect of such payments, (ii)&nbsp;shall be enforceable as an alternative or additional
cause of action for the purpose of recovering in the Required Currency the amount, if any, by which such actual receipt shall fall short of the full amount of the Required Currency so expressed to be payable and (iii)&nbsp;shall not be affected by
judgment being obtained for any other sum due under this Indenture. For purposes of the foregoing, &#8220;<U>New York Banking Day</U>&#8221; means any day except a Saturday, Sunday or a Legal Holiday in The City of New York or a day on which banking
institutions in The City of New York are authorized or obligated by law, regulation or executive order to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.17
<U>Limitation on Individual Liability</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No recourse under or upon any obligation, covenant or agreement contained in this Indenture or
in any Security, or for any claim based thereon or otherwise in respect thereof, shall be had against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor, either directly or
through the Company or any successor, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued
hereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, officers or directors, as such, of the Company or any successor, or any of
them, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any Security or implied therefrom; and that any and all such personal liability
of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, stockholder, officer or director, as such, because of the creation of the
indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any Security or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration
for, the execution of this Indenture and the issuance of such Security. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES FORMS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Forms Generally</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Registered Security and temporary or permanent Global Security or Definitive Security issued pursuant to this Indenture shall be in the
form established by or pursuant to a Board Resolution and set forth in an Officer&#8217;s Certificate, or established in one or more indentures supplemental hereto, shall have such appropriate insertions, omissions, substitutions and other
variations as are required or permitted by or pursuant to this Indenture or any indenture supplemental hereto and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as may, consistently
herewith, be determined by the Officers executing such Security as evidenced by their execution of such Security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in or pursuant to this Indenture or any Securities, the Securities
shall be issuable in registered form without coupons and shall not be issuable upon the exercise of warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Definitive Securities shall
be printed, lithographed or engraved or produced by any combination of these methods on a steel engraved border or steel engraved borders or may be produced in any other manner, all as determined by the Officers of the Company executing such
Securities, as evidenced by their execution of such Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Form of Trustee</U><U>&#8217;</U><U>s Certificate of
Authentication</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to Section&nbsp;6.12, the Trustee&#8217;s certificate of authentication shall be in substantially the
following form: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is one of the Securities of the series designated therein referred to in the
<FONT STYLE="white-space:nowrap">within-mentioned</FONT> Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">__________________________________ , as Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">_________________________________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;Authorized Signatory</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Dated: _______________________________________</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Securities in Global Form</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in or pursuant to this Indenture or any Securities, the Securities shall be issuable in permanent global form. If
Securities of a series shall be issuable in global form, any such Security may provide that it or any number of such Securities shall represent the aggregate amount of all Outstanding Securities of such series (or such lesser amount as is permitted
by the terms thereof) from time to time endorsed thereon and may also provide that the aggregate amount of Outstanding Securities represented thereby may from time to time be increased or reduced to reflect exchanges, redemptions or transfer of
beneficial interests from one Global Security to another Global Security. Any endorsement of any Global Security to reflect the amount, or any increase or decrease in the amount, or changes in the rights of Holders, of Outstanding Securities
represented thereby shall be made in such manner and by such Person or Persons as shall be specified therein or in the Company Order to be delivered pursuant to Section&nbsp;3.3 or Section&nbsp;3.4 with respect thereto. Subject to the provisions of
Section&nbsp;3.3 and, if applicable, Section&nbsp;3.4, the Trustee shall deliver and redeliver any Security in permanent global form in the manner and upon instructions given by the Person or Persons specified therein or in the applicable Company
Order. If a Company Order pursuant to Section&nbsp;3.3 or Section&nbsp;3.4 has been, or simultaneously is, delivered, any instructions by the Company with respect to a Global Security shall be in writing but need not be accompanied by or contained
in an Officer&#8217;s Certificate and need not be accompanied by an Opinion of Counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the provisions of
Section&nbsp;3.7, unless otherwise specified in or pursuant to this Indenture or any Securities, payment of principal of, any premium and interest on, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any Additional Amounts in respect of, any Security in temporary or permanent global form shall be made to the Person or Persons specified therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the provisions of Section&nbsp;3.8 and except as provided in the preceding paragraph, the Company, the Trustee and any agent
of the Company or the Trustee shall treat as the Holder of such principal amount of Outstanding Securities as is represented by a Global Security in the case of a Global Security in registered form, the Holder of such Global Security in registered
form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Global Security shall bear a legend in substantially the following form (unless otherwise specified by the Depositary): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;THIS DEBT SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A
DEPOSITARY OR A NOMINEE THEREOF. THIS DEBT SECURITY MAY NOT BE TRANSFERRED TO, OR REGISTERED OR EXCHANGED FOR SECURITIES REGISTERED IN THE NAME OF, ANY PERSON OTHER THAN THE DEPOSITARY OR A NOMINEE THEREOF AND NO SUCH TRANSFER MAY BE REGISTERED,
EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE. EVERY DEBT SECURITY AUTHENTICATED AND DELIVERED UPON REGISTRATION OF TRANSFER OF, OR IN EXCHANGE FOR OR IN LIEU OF, THIS DEBT SECURITY SHALL BE A GLOBAL SECURITY SUBJECT TO THE
FOREGOING, EXCEPT IN SUCH LIMITED CIRCUMSTANCES.&#8221; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Amount Unlimited; Issuable in Series</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may be
issued in one or more series. With respect to any Securities to be authenticated and delivered hereunder, there shall be established in or pursuant to a Board Resolution and set forth in an Officer&#8217;s Certificate, or established in one or more
indentures supplemental hereto, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the title of such Securities and the series, including CUSIP numbers in which such Securities shall
be included; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any limit upon the aggregate principal amount of the Securities of such series that may be authenticated and delivered
under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of such series pursuant to Section&nbsp;3.4, Section&nbsp;3.5, Section&nbsp;3.6,
Section&nbsp;9.6 or Section&nbsp;11.7, upon repayment in part of any Registered Security of such series pursuant to Article 13 or upon surrender in part of any Registered Security for conversion or exchange into Common Stock or other securities,
cash or other property pursuant to its terms, or pursuant to the terms of such Securities and except for any Securities, which, pursuant to Section&nbsp;3.3, are deemed never to have been authenticated and delivered hereunder); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if any of such Securities are to be issuable in global form, when any of such Securities
are to be issuable in global form and (i)&nbsp;whether such Securities are to be issued in temporary or permanent global form or both, (ii)&nbsp;whether beneficial owners of interests in any such Global Security may exchange such interests for
Securities of the same series and of like tenor and of any authorized form and denomination, and the circumstances under which any such exchanges may occur, if other than in the manner specified in Section&nbsp;3.5, and (iii)&nbsp;the name of the
Depositary or the U.S. Depositary, as the case may be, with respect to any Global Security; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the date as of which any Global Security
shall be dated (if other than the date of original issuance of the first of such Securities to be issued); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the date or dates, or the
method for determining such date or dates, on which the principal of such Securities will be payable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) the rate or rates at which such
Securities shall bear interest, if any, or the method or methods, if any, by which such rate or rates are to be determined, the date or dates, if any, from which such interest shall accrue or the method or methods, if any, by which such date or
dates are to be determined, the Interest Payment Dates, if any, on which such interest shall be payable and the Regular Record Date, if any, for the interest payable on Registered Securities on any Interest Payment Date, whether and under what
circumstances Additional Amounts on such Securities or any of them shall be payable, the notice, if any, to Holders regarding the determination of interest on a floating rate Security and the manner of giving such notice, and the basis upon which
interest shall be calculated if other than that of a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) if in addition to or other than the Borough of Manhattan, The City of New York, the place or places where the principal of, any premium
and interest on or any Additional Amounts with respect to such Securities shall be payable, any of such Securities that are Registered Securities may be surrendered for registration of transfer or exchange, any of such Securities may be surrendered
for conversion or exchange and notices or demands to or upon the Company in respect of such Securities and this Indenture may be served, the extent to which, or the manner in which, any interest payment or Additional Amounts on a Global Security on
an Interest Payment Date, will be paid and the manner in which any principal of or premium, if any, on any Global Security will be paid; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) whether any of such Securities are to be redeemable at the option of the Company and, if so, the date or dates on which, the period or
periods within which, the price or prices at which and the other terms and conditions upon which such Securities may be redeemed, in whole or in part, at the option of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) whether the Company is obligated to redeem or purchase any of such Securities pursuant to any sinking fund or analogous provision or at
the option of any Holder thereof and, if so, the date or dates on which, the period or periods within which, the price or prices at which and the other terms and conditions upon which such Securities shall be redeemed or purchased, in whole or in
part, pursuant to such obligation, and any provisions for the remarketing of such Securities so redeemed or purchased; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) the denominations in which any of such Securities that are Registered Securities shall
be issuable if other than denominations of $1,000 and any multiple of $1,000 in excess thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) whether the Securities of the series
will be convertible into shares of Common Stock and/or exchangeable for other securities, cash or other property of the Company or of any other Person, and if so, the terms and conditions upon which such Securities will be so convertible or
exchangeable, and any deletions from or modifications or additions to this Indenture to permit or to facilitate the issuance of such convertible or exchangeable Securities or the administration thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) if other than the principal amount thereof, the portion of the principal amount of any of such Securities that shall be payable upon
declaration of acceleration of the Maturity thereof pursuant to Section&nbsp;5.2 or the method by which such portion is to be determined; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) if other than Dollars, the Foreign Currency in which payment of the principal of, any premium or interest on or any Additional Amounts
with respect to any of such Securities shall be payable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) if the principal of, any premium or interest on or any Additional Amounts
with respect to any of such Securities are to be payable, at the election of the Company or a Holder thereof or otherwise, in Currency other than that in which such Securities are stated to be payable, the date or dates on which, the period or
periods within which, and the other terms and conditions upon which, such election may be made, and the time and manner of determining the exchange rate between the Currency in which such Securities are stated to be payable and the Currency in which
such Securities or any of them are to be paid pursuant to such election, and any deletions from or modifications of or additions to the terms of this Indenture to provide for or to facilitate the issuance of Securities denominated or payable, at the
election of the Company or a Holder thereof or otherwise, in a Foreign Currency; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) whether the amount of payments of principal of, any
premium or interest on or any Additional Amounts with respect to such Securities may be determined with reference to an index, formula, financial or economic measure or other method or methods (which index, formula, measure or method or methods may
be based, without limitation, on one or more Currencies, commodities, equity indices or other indices), and, if so, the terms and conditions upon which and the manner in which such amounts shall be determined and paid or be payable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) any deletions from, modifications of or additions to the Events of Default or covenants of the Company with respect to any of such
Securities, whether or not such Events of Default or covenants are consistent with the Events of Default or covenants set forth herein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) whether either or both of Section&nbsp;4.2(2) relating to defeasance or Section&nbsp;4.2(3) relating to covenant defeasance shall not be
applicable to the Securities of such series, and any covenants relating to the Securities of such series which shall be subject to covenant defeasance, and, if the Securities of such series are subject to repurchase or repayment at the option of the
Holders thereof, whether the Company&#8217;s obligation to repurchase or repay such Securities will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be subject to defeasance or covenant defeasance, and any deletions from, or modifications or additions to, the provisions of Article 4 in respect of the Securities of such series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18) whether any of such Securities are to be issuable upon the exercise of warrants or units, and the time, manner and place for such
Securities to be authenticated and delivered; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19) if there is more than one Trustee or a Trustee other than ____________________, the
identity of the Trustee and, if not the Trustee, the identity of each Security Registrar, Paying Agent or Authenticating Agent with respect to such Securities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(20) whether the Securities are senior or subordinated debt securities, and if subordinated debt securities, the terms of such subordination;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(21) whether the Securities of the series will be guaranteed by any Persons and, if so, the identity of such Persons, the terms and
conditions upon which such Securities shall be guaranteed and, if applicable, the terms and conditions upon which such guarantees may be subordinated to other indebtedness of the respective guarantors and may be released; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(22) whether the Securities of the series will be secured by any collateral and, if so, the terms and conditions upon which such Securities
shall be secured and, if applicable, upon which such liens may be subordinated to other liens securing other indebtedness of the Company or any guarantor and may be released; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(23) any other terms of such Securities and any deletions from or modifications or additions to this Indenture in respect of such Securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All Securities of any one series shall be substantially identical except as to denomination and except as may otherwise be provided by
the Company in or pursuant to the Board Resolution and set forth in the Officer&#8217;s Certificate or in any indenture or indentures supplemental hereto pertaining to such series of Securities. The terms of the Securities of any series may provide,
without limitation, that the Securities of such series shall be authenticated and delivered by the Trustee on original issue from time to time in accordance with such procedures as are acceptable to the Trustee (including authentication and delivery
by the Trustee on original issue from time to time upon telephonic or written order of persons designated in the Officer&#8217;s Certificate or supplemental indenture (telephonic instructions to be promptly confirmed in writing by such person) and
that such persons are authorized to determine, consistent with such Officer&#8217;s Certificate or any applicable supplemental indenture, such terms and conditions of the Securities of such series as are specified in such Officer&#8217;s Certificate
or supplemental indenture). All Securities of any one series need not be issued at the same time and, unless otherwise so provided by the Company, a series may be reopened for issuances of additional Securities of such series or to establish
additional terms of such series of Securities. If any of the terms of the Securities of any series shall be established by action taken by or pursuant to a Board Resolution, the Board Resolution shall be delivered to the Trustee at or prior to the
delivery of the Officer&#8217;s Certificate setting forth the terms of such series. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Currency; Denominations</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in or pursuant to this Indenture or any Security, the principal of, any premium and interest on and any Additional
Amounts with respect to, the Securities shall be payable in Dollars. Unless otherwise provided in or pursuant to this Indenture, Registered Securities denominated in Dollars shall be issuable in registered form without coupons in denominations of
$1,000 or any integral multiple of $1,000 in excess thereof. Securities not denominated in Dollars shall be issuable in such denominations as are established with respect to such Securities in or pursuant to this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Execution, Authentication, Delivery and Dating</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities shall be executed on behalf of the Company by any Officer of the Company. The signature of any such Officer on the Securities may
be manual or facsimile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities bearing the manual or facsimile signatures of individuals who were at any time the proper Officers of
the Company shall bind the Company, notwithstanding that such individuals or any of them have ceased to hold such offices prior to the authentication and delivery of such Securities or did not hold such offices at the date of such Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities, executed by the
Company, to the Trustee for authentication and, provided that the Board Resolution and Officer&#8217;s Certificate or supplemental indenture or indentures with respect to such Securities referred to in Section&nbsp;3.1 and a Company Order for the
authentication and delivery of such Securities have been delivered to the Trustee, the Trustee in accordance with the Company Order and subject to the provisions hereof and of such Securities shall authenticate and deliver such Securities. In
authenticating such Securities, and accepting the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be provided with, and (subject to Sections 315(a) through 315(d) of the Trust Indenture Act) shall
be fully protected in relying upon an Opinion of Counsel and an Officer&#8217;s Certificate that contain the statements required by Section&nbsp;1.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee shall not be required to authenticate such Securities if the issue of such Securities pursuant to this Indenture will affect the
Trustee&#8217;s own rights, duties or immunities under the Securities and this Indenture or otherwise in a manner which is not reasonably acceptable to the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the provisions of Section&nbsp;3.1 and of the preceding paragraph, if all Securities of a series are not to be originally
issued at one time, it shall not be necessary to deliver the Officer&#8217;s Certificate or Company Order otherwise required pursuant to such preceding paragraph at or prior to the authentication of each Security of such series if such documents are
delivered at or prior to the authentication upon original issuance of the first Security of such series to be issued. This paragraph shall not be applicable to Securities of a series that are issued as part of a reopening pursuant to the last
paragraph of Section&nbsp;3.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Registered Security shall be dated the date of its authentication. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Security shall be entitled to any benefit under this Indenture or be valid or obligatory
for any purpose, unless there appears on such Security a certificate of authentication substantially in the form provided for in Section&nbsp;2.2 or Section&nbsp;6.12 executed by or on behalf of the Trustee or by the Authenticating Agent by the
manual signature of one of its authorized signatories. Such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if any Security shall have been authenticated and delivered hereunder but never issued and sold by the Company,
and the Company shall deliver such Security to the Trustee for cancellation as provided in Section&nbsp;3.9, for all purposes of this Indenture such Security shall be deemed never to have been authenticated and delivered hereunder and shall never be
entitled to the benefits of this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Temporary Securities</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pending the preparation of Definitive Securities, the Company may execute and deliver to the Trustee and, upon Company Order, the Trustee
shall authenticate and deliver, in the manner provided in Section&nbsp;3.3, temporary Securities in lieu thereof which are printed, lithographed, typewritten, mimeographed or otherwise produced, in any authorized denomination, substantially of the
tenor of the Definitive Securities in lieu of which they are issued, in registered form and with such appropriate insertions, omissions, substitutions and other variations as the Officers of the Company executing such Securities may determine, as
conclusively evidenced by their execution of such Securities. Such temporary Securities may be in the form of Global Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except
in the case of temporary Global Securities, which shall be exchanged in accordance with the provisions thereof, if temporary Securities are issued, the Company shall cause Definitive Securities to be prepared without unreasonable delay. After the
preparation of Definitive Securities of the same series and containing terms and provisions that are identical to those of any temporary Securities, such temporary Securities shall be exchangeable for such Definitive Securities upon surrender of
such temporary Securities at an Office or Agency for such Securities, without charge to any Holder thereof. Upon surrender for cancellation of any one or more temporary Securities, the Company shall execute and the Trustee shall authenticate and
deliver in exchange therefor a like principal amount of Definitive Securities of authorized denominations of the same series and containing identical terms and provisions. Unless otherwise provided in or pursuant to this Indenture with respect to a
temporary Global Security, until so exchanged the temporary Securities of any series shall in all respects be entitled to the same benefits under this Indenture as Definitive Securities of such series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>Registration, Transfer and Exchange</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to the Registered Securities of each series, if any, the Company shall cause to be kept a register (each such register being
herein sometimes referred to as the &#8220;<U>Security Register</U>&#8221;) at an Office or Agency for such series in which, subject to such reasonable regulations as it may prescribe, the Company shall provide for the registration of the Registered
Securities of such series and of transfers of the Registered Securities of such series. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such Office or Agency shall be the &#8220;<U>Security Registrar</U>&#8221; or
&#8220;<U>Registrar</U>&#8221; for that series of Securities. Unless otherwise specified in or pursuant to this Indenture or the Securities, the Trustee shall be the initial Security Registrar for each series of Securities. The Company shall have
the right to remove and replace from time to time the Security Registrar for any series of Securities; provided that no such removal or replacement shall be effective until a successor Security Registrar with respect to such series of Securities
shall have been appointed by the Company and shall have accepted such appointment by the Company. In the event that the Trustee shall not be or shall cease to be Security Registrar with respect to a series of Securities, it shall have the right to
examine the Security Register for such series at all reasonable times. There shall be only one Security Register for each series of Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Global Security may not be transferred as a whole except by the Depositary to a nominee of the Depositary, by a nominee of the Depositary to
the Depositary or to another nominee of the Depositary, or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary. Notwithstanding the foregoing, except as may be provided pursuant to
Section&nbsp;3.1, any Global Security or any beneficial interest therein shall be exchangeable for Definitive Securities only if (i)&nbsp;the Depositary is at any time unwilling, unable or ineligible to continue as Depositary and a successor
Depositary is not appointed by the Company within 90 days of the date the Company is so informed in writing, (ii)&nbsp;the Depositary ceases to be a clearing agency registered under the Exchange Act, (iii)&nbsp;the Company (subject to the Applicable
Procedures) executes and delivers to the Trustee a Company Order to the effect that such Global Security shall be so exchangeable or (iv)&nbsp;an Event of Default has occurred and is continuing with respect to such Securities. If the holder of a
Global Security or the beneficial owners of interests in a Global Security are entitled to exchange such interests for Definitive Securities as the result of an event specified in clause (i), (ii), (iii) or (iv)&nbsp;of the preceding sentence, the
Company shall promptly make available to the Trustee Definitive Securities in such form and denominations as are required by or pursuant to this Indenture, and of the same series, containing identical terms and in aggregate principal amount equal to
the principal amount of such Global Security, executed by the Company. Such Global Security shall be surrendered from time to time by the U.S. Depositary or such other Depositary as shall be specified in the Company Order with respect thereto, and
in accordance with instructions given to the Trustee and the U.S. Depositary or such other Depositary, as the case may be (which instructions shall be in writing but need not be contained in or accompanied by an Officer&#8217;s Certificate or be
accompanied by an Opinion of Counsel), as shall be specified in the Company Order with respect thereto to the Trustee, as the Company&#8217;s agent for such purpose, to be exchanged, in whole or in part, for Definitive Securities as described above
without charge. The Trustee shall authenticate and make available for delivery, in exchange for each portion of such surrendered Global Security, a like aggregate principal amount of Definitive Securities of the same series of authorized
denominations and of like tenor as the portion of such Global Security to be exchanged; provided, however, that no such exchanges may occur during a period beginning at the opening of business 15 days before any selection of Securities of the same
series to be redeemed and ending on the relevant Redemption Date. Promptly following any such exchange in part, such Global Security shall be returned by the Trustee to such Depositary or the U.S. Depositary, as the case may be, or such other
Depositary or U.S. Depositary referred to above in accordance with the instructions of the Company referred to above. If a Registered portion of a Global Security is exchanged for Definitive Registered Securities after the close of business at the
Office or Agency for such Security where such exchange occurs on or after (i)&nbsp;any Regular </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Record Date for such Security and before the opening of business at such Office or Agency on the next Interest Payment Date, or (ii)&nbsp;any Special Record Date for such Security and before the
opening of business at such Office or Agency on the related proposed date for payment of interest or Defaulted Interest, as the case may be, interest shall not be payable on such Interest Payment Date or proposed date for payment, as the case may
be, in respect of such Definitive Registered Security, but shall be payable on such Interest Payment Date or proposed date for payment, as the case may be, only to the Person to whom interest in respect of such portion of such Global Security shall
be payable in accordance with the provisions of this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer and exchange of beneficial interests in the Global
Securities shall be effected through the Depositary, in accordance with the provisions of this Indenture and the Applicable Procedures. Transfers and exchanges of beneficial interests in the Global Securities also shall require compliance with
either subparagraph (1)&nbsp;or (2) below, as applicable, as well as one or more of the other following paragraphs, as applicable: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)
Beneficial interests in any Global Security may be transferred to Persons who take delivery thereof in the form of a beneficial interest in the same Global Security. No written orders or instructions shall be required to be delivered to the
Registrar to effect the transfers described in this subparagraph (1). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) In connection with the transfer or exchange of beneficial
interests in any Global Security to Persons who take delivery thereof in the form of a beneficial interest in a different Global Security, the transferor of such beneficial interest must deliver to the Registrar (i)&nbsp;an order from a Participant
or an Indirect Participant given to the Depositary in accordance with the Applicable Procedures directing the Depositary to credit or cause to be credited a beneficial interest in another Global Security in an amount equal to the beneficial interest
to be transferred or exchanged and (ii)&nbsp;instructions given in accordance with the Applicable Procedures containing information regarding the Participant account to be credited with such increase. Upon satisfaction of all of the requirements for
transfer or exchange of beneficial interests in Global Securities contained in this Indenture and such Securities or otherwise applicable under the Securities Act, the Trustee shall adjust the principal amount of the relevant Global Security(s)
pursuant to this paragraph. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Holder of a beneficial interest in a Global Security proposes to exchange such beneficial interest for
a Definitive Security or to transfer such beneficial interest to a Person who takes delivery thereof in the form of a Definitive Security in the event of the occurrence of any of the conditions set forth in the third paragraph of this
Section&nbsp;3.5, then, upon delivery to the Registrar of (i)&nbsp;an order from a Participant or an Indirect Participant given to the Depositary in accordance with the Applicable Procedures directing the Depositary to cause to be issued a
Definitive Security in an amount equal to the beneficial interest to be transferred or exchanged and (ii)&nbsp;instructions given by the Depositary to the Registrar containing information regarding the Person in whose name such Definitive Security
shall be registered to effect the transfer or exchange referred to in clause (i), the Trustee shall cause the aggregate principal amount of the applicable Global Security to be reduced accordingly as described below, and the Company shall execute
and, upon receipt of a Company Order pursuant to Section&nbsp;3.3, the Trustee shall authenticate and deliver to the Person designated in the instructions a Definitive Security in the appropriate principal amount. Any Definitive Security issued in
exchange for a beneficial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interest pursuant to this paragraph shall be registered in such name or names and in such authorized denomination or denominations as the Holder of such beneficial interest shall instruct the
Registrar through instructions from the Depositary and the Participant or Indirect Participant. The Trustee shall deliver such Definitive Securities to the Persons in whose names such Securities are so registered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Holder of a Definitive Security may exchange such Security for a beneficial interest in a Global Security or transfer such Definitive
Securities to a Person who takes delivery thereof in the form of a beneficial interest in a Global Security at any time. Upon receipt of a request for such an exchange or transfer, the Trustee shall cancel the applicable Definitive Security and
increase or cause to be increased the aggregate principal amount of the applicable Global Security. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the option of the Holder,
Definitive Securities of any series may be exchanged for other Definitive Securities of the same series, of any authorized denominations and of like tenor and aggregate principal amount, upon surrender of the Definitive Securities to be exchanged at
an Office or Agency. Whenever any Definitive Securities are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Definitive Securities which the Holder making the exchange is entitled to
receive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon request by a Holder of Definitive Securities and such Holder&#8217;s compliance with the provisions of this paragraph, the
Registrar shall register the transfer or exchange of Definitive Securities. Prior to such registration of transfer or exchange, the requesting Holder shall present or surrender to the Registrar the Definitive Securities duly endorsed or accompanied
by a written instruction of transfer in form satisfactory to the Registrar duly executed by such Holder or by its attorney, duly authorized in writing. A Holder of Definitive Securities may transfer such Securities to a Person who takes delivery
thereof in the form of a Definitive Security. Upon receipt of a request to register such a transfer, the Registrar shall register the Definitive Securities pursuant to the instructions from the Holder thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At such time as all beneficial interests in a particular Global Security have been exchanged for Definitive Securities or a particular Global
Security has been redeemed, repurchased or cancelled in whole and not in part, each such Global Security shall be returned to or retained and cancelled by the Trustee in accordance with Section&nbsp;3.9. At any time prior to such cancellation, if
any beneficial interest in a Global Security is exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Security or for Definitive Securities, the principal amount of Securities
represented by such Global Security shall be reduced accordingly and an endorsement shall be made on such Global Security by the Trustee or by the Depositary at the direction of the Trustee to reflect such reduction; and if the beneficial interest
is being exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Security, the principal amount of Securities represented by such other Global Security shall be increased
accordingly and an endorsement shall be made on such Global Security by the Trustee or by the Depositary at the direction of the Trustee to reflect such increase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All Securities issued upon any registration of transfer or exchange of Securities shall be the valid and legally binding obligations of the
Company evidencing the same debt and entitling </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Holders thereof to the same benefits under this Indenture as the Securities surrendered upon such registration of transfer or exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every Registered Security presented or surrendered for registration of transfer or for exchange or redemption shall (if so required by the
Company or the Security Registrar for such Security) be duly endorsed, signature guaranteed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar for such Security duly executed by the
Holder thereof, signature guaranteed, or his or her attorney duly authorized in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No service charge shall be made for any
registration of transfer or exchange, or redemption of Securities, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge and any other expenses (including fees and expenses of the Trustee) that may be
imposed in connection with any registration of transfer or exchange of Securities, other than exchanges pursuant to Sections 3.4, 3.6, 9.6 and 11.7 not involving any transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in or pursuant to this Indenture, the Company shall not be required (i)&nbsp;to issue, register the transfer of
or exchange any Securities during a period beginning at the opening of business 15 days before the day of selection of Securities of like tenor and the same series under Section&nbsp;11.3 for redemption and ending at the close of business on the day
of such selection, (ii)&nbsp;to register the transfer of or exchange any Registered Security so selected for redemption in whole or in part, except in the case of any Security to be redeemed in part, the portion thereof not to be redeemed, or
(iii)&nbsp;to issue, register the transfer of or exchange any Security which, in accordance with its terms, has been surrendered for repayment or purchase at the option of the Holder, except the portion, if any, of such Security not to be so repaid.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registrar shall retain copies of all certificates, notices and other written communications received pursuant to this
Section&nbsp;3.5. The Company shall have the right to inspect and make copies of all such certificates, notices or other written communications at any reasonable time upon the giving of reasonable written notice to the Registrar. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All certifications and certificates required to be submitted to the Registrar pursuant to this Section&nbsp;3.5 to effect a registration of
transfer or exchange may be submitted by facsimile, with an original of such document to be sent promptly thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6
<U>Mutilated, Destroyed, Lost and Stolen Securities</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any mutilated Security is surrendered to the Trustee, subject to the
provisions of this Section&nbsp;3.6, the Company shall execute and the Trustee shall authenticate and deliver in exchange therefor a new Security of the same series containing identical terms and of like principal amount and bearing a number not
contemporaneously outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If there be delivered to the Company and to the Trustee (i)&nbsp;evidence to their satisfaction of the
destruction, loss or theft of any Security and (ii)&nbsp;such security or indemnity as may be required by them to save each of them and any agent of either of them harmless, then, in the absence of notice to the Company or to a Responsible Officer
that such Security has been acquired by a &#8220;protected purchaser&#8221; (as such term is defined in the New York Uniform </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Commercial Code), the Company shall execute and, upon the Company&#8217;s request the Trustee shall authenticate and deliver, in exchange for or in lieu of any such destroyed, lost or stolen
Security, a new Security of the same series containing identical terms and of like principal amount and bearing a number not contemporaneously outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Section&nbsp;3.6, in case any mutilated, destroyed, lost or stolen Security has become or is
about to become due and payable, the Company in its discretion may, instead of issuing a new Security, pay such Security. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the
issuance of any new Security under this Section&nbsp;3.6, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and
expenses of the Trustee) connected therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every new Security issued pursuant to this Section&nbsp;3.6 in lieu of any destroyed, lost
or stolen Security shall constitute a separate obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and
proportionately with any and all other Securities of such series duly issued hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of this Section&nbsp;3.6, as
amended or supplemented pursuant to this Indenture with respect to particular Securities or generally, shall be exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of
mutilated, destroyed, lost or stolen Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7 <U>Payment of Interest and Certain Additional Amounts; Rights to
Interest and Certain Additional Amounts Preserved</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in or pursuant to this Indenture, any interest on and any
Additional Amounts with respect to, any Registered Security that shall be payable, and are punctually paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name such Security (or one or more Predecessor
Securities) is registered as of the close of business on the Regular Record Date for such interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in or
pursuant to this Indenture, any interest on and any Additional Amounts with respect to, any Registered Security that shall be payable, but shall not be punctually paid or duly provided for, on any Interest Payment Date for such Registered Security
(herein called &#8220;<U>Defaulted Interest</U>&#8221;) shall forthwith cease to be payable to the Holder thereof on the relevant Regular Record Date by virtue of having been such Holder; and such Defaulted Interest may be paid by the Company, at
its election in each case, as provided in clause (1)&nbsp;or (2) below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) The Company may elect to make payment of any Defaulted
Interest to the Person in whose name such Registered Security (or a Predecessor Security thereof) shall be registered at the close of business on a Special Record Date for the payment of such Defaulted Interest, which shall be fixed in the following
manner. The Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on such Registered Security and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an
amount </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit on or prior to the date of
the proposed payment, such money when so deposited to be held in trust for the benefit of the Person entitled to such Defaulted Interest as in this clause provided. Thereupon, the Trustee shall fix a Special Record Date for the payment of such
Defaulted Interest which shall be not more than 15 days and not less than 10 days prior to the date of the proposed payment and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly
notify the Company of such Special Record Date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and the Special Record Date therefor to be given in the manner provided in
Section&nbsp;1.6, not less than 10 days prior to such Special Record Date. The Trustee may, in its discretion, in the name and at the expense of the Company, cause a similar notice to be published at least once in an Authorized Newspaper of general
circulation in the Borough of Manhattan, The City of New York, but such publication shall not be a condition precedent to the establishment of such Special Record Date. Notice of the proposed payment of such Defaulted Interest and the Special Record
Date therefor having been so given, such Defaulted Interest shall be paid to the Person in whose name such Registered Security (or a Predecessor Security thereof) shall be registered at the close of business on such Special Record Date and shall no
longer be payable pursuant to the following clause (2). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) The Company may make payment of any Defaulted Interest in any other lawful
manner not inconsistent with the requirements of any securities exchange on which such Security may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of the proposed payment
pursuant to this clause, such payment shall be deemed practicable by the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in or pursuant to this
Indenture or the Securities of any particular series pursuant to the provisions of this Indenture, at the option of the Company, interest on Registered Securities that bear interest may be paid by wire transfer in immediately available funds if the
Holder of the Registered Security has provided to the Company and the Trustee wire instructions at least five Business Days prior to the applicable payment date or by check mailed to the address of that Holder as it appears on the books of the
Securities Registrar if that Holder has not provided wire instructions; provided that any payment of principal (or premium, if any) in respect of any Security will be made only upon presentation and surrender of such Security at the applicable
Office or Agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the foregoing provisions of this Section&nbsp;3.7 and Section&nbsp;3.5, each Security delivered under this
Indenture upon registration of transfer of or in exchange for or in lieu of any other Security shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of any Registered Security of any series that is convertible, which Registered Security is converted after any Regular Record Date
and on or prior to the immediately succeeding Interest Payment Date (other than any Registered Security with respect to which the Maturity is prior to such Interest Payment Date), interest on such Interest Payment Date shall be payable on such
Interest Payment Date notwithstanding such conversion, and such interest (whether or not punctually paid or duly provided for) shall be paid to the Person in whose name </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that Registered Security (or one or more predecessor Registered Securities) is registered at the close of business on such Regular Record Date. Except as otherwise expressly provided in the
immediately preceding sentence, in the case of any Registered Security which is converted, interest with respect to which the Stated Maturity is after the date of conversion of such Registered Security shall not be payable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8 <U>Persons Deemed Owners</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to due presentment of a Registered Security for registration of transfer, the Company, the Trustee and any agent of the Company or the
Trustee may treat the Person in whose name such Registered Security is registered in the Security Register as the owner of such Registered Security for the purpose of receiving payment of principal of, any premium and (subject to Section&nbsp;3.5
and Section&nbsp;3.7) interest on and any Additional Amounts with respect to, such Registered Security and for all other purposes whatsoever, whether or not any payment with respect to such Registered Security shall be overdue, and none of the
Company, the Trustee or any agent of the Company or the Trustee shall be affected by notice to the contrary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No holder of any beneficial
interest in any Global Security held on its behalf by a Depositary shall have any rights under this Indenture with respect to such Global Security, and such Depositary may be treated by the Company, the Trustee and any agent of the Company or the
Trustee as the owner of such Global Security for all purposes whatsoever. None of the Company, the Trustee, any Paying Agent or the Security Registrar will have any responsibility or liability for any aspect of the records relating to or payments
made on account of beneficial ownership interests of a Global Security or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9 <U>Cancellation</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All Securities surrendered for payment, redemption, registration of transfer, exchange or conversion or for credit against any sinking fund
payment shall, if surrendered to any Person other than the Trustee, be delivered to the Trustee, and any such Securities, as well as Securities surrendered directly to the Trustee for any such purpose, shall be cancelled promptly by the Trustee. The
Company may at any time deliver to the Trustee for cancellation any Securities previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and all Securities so delivered shall be cancelled promptly
by the Trustee. No Securities shall be authenticated in lieu of or in exchange for any Securities cancelled as provided in this Section&nbsp;3.9, except as expressly permitted by or pursuant to this Indenture. All cancelled Securities held by the
Trustee shall be disposed of by the Trustee in accordance with its customary procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10 <U>Computation of Interest</U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in or pursuant to this Indenture, or in any Security, interest on the Securities shall be computed on the
basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11 <U>CUSIP and ISIN Numbers</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company in issuing the Securities may use &#8220;CUSIP&#8221; and &#8220;ISIN&#8221; numbers (if then generally in use), and, if so, the
Trustee shall use CUSIP and ISIN numbers in notices of redemption as a convenience to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as
contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will
promptly notify the Trustee of any change in the CUSIP and ISIN numbers. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SATISFACTION AND DISCHARGE OF INDENTURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Satisfaction and Discharge</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the direction of the Company by a Company Order, this Indenture shall cease to be of further effect with respect to any series of
Securities specified in such Company Order and the Trustee, on receipt of a Company Order, at the expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture as to such series, when </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) either </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) all Securities
of such series theretofore authenticated and delivered have been delivered to the Trustee for cancellation (other than (i)&nbsp;Securities of such series that have been destroyed, lost or stolen and have been replaced or paid as provided in
Section&nbsp;3.6 and (ii)&nbsp;Securities of such series the payment of money for which has theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company or discharged from such trust, as
provided in Section&nbsp;10.3); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) all Securities of such series not theretofore delivered to the Trustee for cancellation: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) have become due and payable, or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) will become due and payable at their Stated Maturity within one year, or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) if redeemable at the option of the Company, are to be called for redemption within one year under arrangements satisfactory to the
Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and the Company, in the case of (i), (ii)
or (iii)&nbsp;above, has deposited or caused to be deposited with the Trustee as trust funds in trust for such purpose, (x)&nbsp;money in an amount or (y)&nbsp;Government Obligations that through the payment of interest and principal in respect
thereof in accordance with their terms will provide, not later than one day before the due date of any payment, in the opinion of a nationally recognized Independent Registered Public Accounting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Firm or investment bank expressed in a written certification thereof delivered to the Trustee, money in the amount, or (z)&nbsp;a combination of (x)&nbsp;and (y) in an amount in the Currency in
which such series of Securities are payable sufficient to pay and discharge the entire indebtedness on such Securities not theretofore delivered to the Trustee for cancellation, including the principal of, any premium and interest on, and any
Additional Amounts with respect to such Securities then determinable, to the date of such deposit (in the case of Securities which have become due and payable) or to the Maturity or the Redemption Date thereof, as the case may be; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Company has paid or caused to be paid all other sums payable hereunder by the Company with respect to the Outstanding Securities of
such series; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Company has delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel, each stating that
all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture as to such series have been complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event there are Securities of two or more series hereunder, the Trustee shall be required to execute an instrument acknowledging
satisfaction and discharge of this Indenture only if requested to do so with respect to Securities of such series as to which it is Trustee and if the other conditions thereto are met. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the satisfaction and discharge of this Indenture with respect to any series of Securities, the obligations of the Company to
the Trustee under Section&nbsp;6.7, the obligations of the Trustee under Section&nbsp;4.3, if money, Government Obligations or a combination thereof shall have been deposited with the Trustee pursuant to subclause (b)&nbsp;of clause (1)&nbsp;of this
Section&nbsp;4.1, the obligations of the Company and the Trustee with respect to the Securities of such series under Section&nbsp;3.4, Section&nbsp;3.5, Section&nbsp;3.6, Section&nbsp;10.2 and Section&nbsp;10.3, and the obligations of the Company
with respect to the payment of Additional Amounts, if any, with respect to such Securities as contemplated by Section&nbsp;10.4 (but only to the extent that the Additional Amounts payable with respect to such Securities exceed the amount deposited
in respect of such Additional Amounts pursuant to Section&nbsp;4.1(1)(b)), and with respect to any rights to convert or exchange such Securities into Common Stock or other securities, cash or other property shall survive such satisfaction and
discharge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Defeasance and Covenant Defeasance</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Unless pursuant to Section&nbsp;3.1, either or both of (i)&nbsp;defeasance of the Securities of a series under clause (2)&nbsp;of this
Section&nbsp;4.2 shall not be applicable with respect to the Securities of such series or (ii)&nbsp;covenant defeasance of the Securities of a series under clause (3)&nbsp;of this Section&nbsp;4.2 shall not be applicable with respect to the
Securities of such series, then such provisions, together with the other provisions of this Section&nbsp;4.2 (with such modifications thereto as may be specified pursuant to Section&nbsp;3.1 with respect to any Securities), shall be applicable to
such Securities, and the Company may at its option by Board Resolution, at any time, with respect to such Securities, elect to have Section&nbsp;4.2(2) or Section&nbsp;4.2(3) be applied to such Outstanding Securities upon compliance with the
conditions set forth below in this Section&nbsp;4.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Upon the Company&#8217;s exercise of the above option applicable to this
Section&nbsp;4.2(2) with respect to any Securities of or within a series, the Company shall be deemed to have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
been discharged from its obligations with respect to such Outstanding Securities on the date the conditions set forth in clause (4)&nbsp;of this Section&nbsp;4.2 are satisfied (hereinafter,
&#8220;<U>defeasance</U>&#8221;). For this purpose, such defeasance means that the Company shall be deemed to have paid and discharged the entire indebtedness represented by such Outstanding Securities, which shall thereafter be deemed to be
&#8220;Outstanding&#8221; only for the purposes of the Sections of this Indenture referred to in clauses (i)&nbsp;and (ii) below, and to have satisfied all of its other obligations under such Securities and this Indenture insofar as such Securities
are concerned (and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging the same), except for the following which shall survive until otherwise terminated or discharged hereunder: (i)&nbsp;the rights of Holders
of such Outstanding Securities to receive, solely from the trust fund described in clause (4)&nbsp;of this Section&nbsp;4.2 and as more fully set forth in such Section, payments in respect of the principal of (and premium, if any) and interest, if
any, on, and Additional Amounts, if any, with respect to, such Securities when such payments are due, and any rights of such Holder to convert or exchange such Securities into Common Stock or other securities, cash or other property, (ii)&nbsp;the
obligations of the Company and the Trustee with respect to such Securities under Section&nbsp;3.4, Section&nbsp;3.5, Section&nbsp;3.6, Section&nbsp;10.2 and Section&nbsp;10.3 and the obligations of the Company with respect to the payment of
Additional Amounts, if any, on such Securities as contemplated by Section&nbsp;10.4 (but only to the extent that the Additional Amounts payable with respect to such Securities exceed the amount deposited in respect of such Additional Amounts
pursuant to Section&nbsp;4.2(4)(a) below), and with respect to any rights to convert or exchange such Securities into Common Stock or other securities, cash or other property, (iii)&nbsp;the rights, powers, trusts, duties and immunities of the
Trustee hereunder and (iv)&nbsp;this Section&nbsp;4.2. The Company may exercise its option under this Section&nbsp;4.2(2) notwithstanding the prior exercise of its option under clause (3)&nbsp;of this Section&nbsp;4.2 with respect to such
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) Upon the Company&#8217;s exercise of the above option applicable to this Section&nbsp;4.2(3) with respect to any
Securities of or within a series, (i)&nbsp;the Company shall be released from its obligations to comply with any term, provision or condition under Section&nbsp;8.1 with respect to such Securities (and, to the extent specified pursuant to
Section&nbsp;3.1, any other restrictive covenant added for the benefit of such Securities) and (ii)&nbsp;unless otherwise specified pursuant to Section&nbsp;3.1, the occurrence of any event specified in Section&nbsp;5.1(7) shall not be deemed to be
an Event of Default, in each case on and after the date the conditions set forth in clause (4)&nbsp;of this Section&nbsp;4.2 are satisfied (hereinafter, &#8220;<U>covenant defeasance</U>&#8221;), and such Securities shall thereafter be deemed to be
not &#8220;Outstanding&#8221; for the purposes of any direction, waiver, consent or declaration or Act of Holders (and the consequences of any thereof) in connection with any such covenant, but shall continue to be deemed &#8220;Outstanding&#8221;
for all other purposes hereunder. For this purpose, such covenant defeasance means that, with respect to such Outstanding Securities, the Company may omit to comply with, and shall have no liability in respect of, any term, condition or limitation
set forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any covenant or by reason of reference in any such covenant to any other provision herein or in any other document and such omission to
comply shall not constitute a default or an Event of Default under Section&nbsp;5.1(4), Section&nbsp;5.1(7) or otherwise, as the case may be, insofar as it relates to Section&nbsp;8.1 and, to the extent specified pursuant to Section&nbsp;3.1, any
other restrictive covenant added for the benefit of such Security, but, except as specified above, the remainder of this Indenture and such Securities shall be unaffected thereby; provided that the obligations of the Company with respect to the
payment of Additional Amounts, if any, on such Securities as contemplated by Section&nbsp;10.4 shall remain </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unsatisfied only to the extent that the Additional Amounts payable with respect to such Securities exceed the amount deposited in respect of such Additional Amounts pursuant to
Section&nbsp;4.2(4)(a) below; provided, further, that notwithstanding a covenant defeasance with respect to Section&nbsp;8.1, any Person to whom a sale, assignment, transfer, lease, conveyance or other disposition is made pursuant to
Section&nbsp;8.1, shall as a condition to such sale, assignment, transfer, lease, conveyance or other disposition, assume by an indenture supplemental hereto in form satisfactory to the Trustee, executed by such successor Person and delivered to the
Trustee, the obligations of the Company to the Trustee under Section&nbsp;6.7 and the second to the last paragraph of this Section&nbsp;4.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) The following shall be the conditions to the application of clause (2)&nbsp;or (3) of this Section&nbsp;4.2 to any Outstanding Securities
of a series: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall irrevocably have deposited or caused to be deposited with the Trustee (or another trustee satisfying
the requirements of Section&nbsp;6.8 who shall agree to comply with the provisions of this Section&nbsp;4.2 applicable to it) as trust funds in trust for the purpose of making the following payments, specifically pledged as security for, and
dedicated solely to, the benefit of the Holders of such Securities, (1)&nbsp;an amount in Dollars or in such Foreign Currency in which such Securities are then specified as payable at Stated Maturity, or (2)&nbsp;Government Obligations applicable to
such Securities (determined on the basis of the Currency in which such Securities are then specified as payable at Stated Maturity) which through the scheduled payment of principal and interest in respect thereof in accordance with their terms will
provide, not later than one day before the due date of any payment of principal of (and premium, if any) and interest, if any, on such Securities, money in an amount, or (3)&nbsp;a combination thereof, in any case, in an amount, sufficient, without
consideration of any reinvestment of such principal and interest, in the opinion of a nationally recognized Independent Registered Public Accounting Firm or investment bank expressed in a written certification thereof delivered to the Trustee, to
pay and discharge, and which shall be applied by the Trustee (or other qualifying trustee) to pay and discharge, (y)&nbsp;the principal of (and premium, if any) and interest or Additional Amounts then determinable, if any, on such Outstanding
Securities at the Maturity of such principal or installment of principal or interest, provided that the Company shall specify whether such Outstanding Securities are being defeased to Stated Maturity or to the Redemption Date and (z)&nbsp;any
mandatory sinking fund payments or analogous payments applicable to such Outstanding Securities on the day on which such payments are due and payable in accordance with the terms of this Indenture and of such Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Such defeasance or covenant defeasance shall not result in a breach or violation of, or constitute a default under, this Indenture or any
other material agreement or instrument to which the Company is a party or by which it is bound. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) No Event of Default or event that,
with notice or lapse of time or both, would become an Event of Default with respect to such Securities shall have occurred and be continuing on the date of such deposit (other than an Event of Default resulting from
<FONT STYLE="white-space:nowrap">non-compliance</FONT> with any covenant from which the Company is released upon effectiveness of such defeasance or covenant defeasance, as applicable). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the case of an election under clause (2)&nbsp;of this Section&nbsp;4.2, the Company
shall have delivered to the Trustee an Opinion of Counsel stating that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Company has received from the Internal Revenue Service a
letter ruling, or there has been published by the Internal Revenue Service a Revenue Ruling, or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) since the date of execution of this
Indenture, there has been a change in the applicable federal income tax law, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">in either case to the effect that, and based thereon such
opinion shall confirm that, subject to customary assumptions and exclusions, the Holders of such Outstanding Securities will not recognize income, gain or loss for federal income tax purposes as a result of such defeasance and will be subject to
federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such defeasance had not occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) In the case of an election under clause (3)&nbsp;of this Section&nbsp;4.2, the Company shall have delivered to the Trustee an Opinion of
Counsel to the effect that, subject to customary assumptions and exclusions, the Holders of such Outstanding Securities will not recognize income, gain or loss for federal income tax purposes as a result of such covenant defeasance and will be
subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such covenant defeasance had not occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company shall have delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel, each stating that all conditions
precedent to the defeasance or covenant defeasance under clause (2)&nbsp;or (3) of this Section&nbsp;4.2 (as the case may be) have been complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) If the Securities are to be redeemed prior to their Stated Maturity (other than from mandatory sinking fund payments or analogous
payments), notice of such redemption shall have been duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee shall have been made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Notwithstanding any other provisions of this Section&nbsp;4.2(4), such defeasance or covenant defeasance shall be effected in compliance
with any additional or substitute terms, conditions or limitations which may be imposed on the Company in connection therewith pursuant to Section&nbsp;3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall pay and indemnify the Trustee against any tax, fee or other charge, imposed on or assessed against the Government
Obligations deposited pursuant to this Section&nbsp;4.2 or the principal or interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of such Outstanding Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Anything in this Section&nbsp;4.2 to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from time to time upon
Company Request any money or Government Obligations (or other property and any proceeds therefrom) held by it as provided in clause (4)&nbsp;of this Section&nbsp;4.2 which, in the opinion of a nationally recognized Independent Registered Public
Accounting Firm or investment bank expressed in a written certification thereof delivered to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Trustee, are in excess of the amount thereof which would then be required to be deposited to effect a defeasance or covenant defeasance, as applicable, in accordance with this Section&nbsp;4.2.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Application of Trust Money</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of the last paragraph of Section&nbsp;10.3, all money and Government Obligations (including the proceeds thereof)
deposited with the Trustee or other qualifying trustee (solely for purposes of this Section&nbsp;4.3, the Trustee and any such other trustee are referred to collectively as the &#8220;Trustee&#8221;) pursuant to Section&nbsp;4.1 or Section&nbsp;4.2
in respect of any Outstanding Securities of any series shall be held in trust and applied by the Trustee, in accordance with the provisions of the Securities and this Indenture, to the payment, either directly or through any Paying Agent (including
the Company acting as its own Paying Agent) as the Trustee may determine, to the Persons entitled thereto, of the principal, premium, if any, interest and Additional Amounts, if any, for whose payment such money has or Government Obligations have
been deposited with or received by the Trustee; but such money and Government Obligations need not be segregated from other funds except to the extent required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Qualifying Trustee</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any trustee appointed pursuant to Section&nbsp;4.2 for the purpose of holding trust funds deposited pursuant to that Section shall be
appointed under an agreement in form acceptable to the Trustee and shall provide to the Trustee a certificate of such trustee, upon which certificate the Trustee shall be entitled to conclusively rely, that all conditions precedent provided for
herein to the related defeasance or covenant defeasance have been complied with. In no event shall the Trustee be liable for any acts or omissions of said trustee. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 5 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REMEDIES
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Events of Default</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Event of Default</U>,&#8221; wherever used herein with respect to Securities of any series, means any one of the following events
(whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or
governmental body), unless such event is specifically deleted or modified in or pursuant to the supplemental indenture, Board Resolution or Officer&#8217;s Certificate establishing the terms of such series pursuant to this Indenture: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) default for 30 days in the payment when due of any interest on or any Additional Amount in respect of any Security of such series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) default in the payment of the principal of or any premium on any Security of such series when the principal or premium becomes due and
payable at Maturity; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) default in the deposit of any sinking fund payment when and as due by the terms of any
Security of such series, subject to any cure period specified in any Security of such series; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) failure on the part of the Company duly
to observe or perform any other of the covenants or agreements (other than those described in clause (1), (2) or (3)&nbsp;above) on the part of the Company with respect to that series contained in such Securities or otherwise established with
respect to that series of Securities pursuant to Section&nbsp;3.1 hereof or contained in this Indenture (other than a covenant or agreement that has been expressly included in this Indenture solely for the benefit of one or more series of Securities
other than such series) and such failure shall continue for a period of 60 days after the date on which written notice of such failure, requiring the same to be remedied and stating that such notice is a &#8220;Notice of Default&#8221; shall have
been given to the Company by the Trustee, upon direction of Holders of at least 25% in principal amount of the Outstanding Securities of that series; provided, however, that if such failure is not capable of cure within such <FONT
STYLE="white-space:nowrap">60-day</FONT> period, such <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be automatically extended by an additional 60 days so long as (i)&nbsp;such failure is subject to cure, and (ii)&nbsp;the Company is
using commercially reasonable efforts to cure such failure; and provided, further, that a failure to comply with any such other agreement in this Indenture that results from a change in GAAP shall not be deemed to be an Event of Default; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) a decree or order by a court having jurisdiction in the premises shall have been entered adjudging the Company bankrupt or insolvent, or
approving as properly filed a petition seeking liquidation or reorganization of the Company under any applicable bankruptcy, insolvency, reorganization or other similar law, and such decree or order shall have continued unvacated and unstayed for a
period of 90 days; an involuntary case shall be commenced under any applicable bankruptcy, insolvency, reorganization or other similar law in respect of the Company and shall continue undismissed for a period of 90 days or an order for relief in
such case shall have been entered and such order shall have remained in force unvacated and unstayed for a period of 90 days; or a decree or order of a court having jurisdiction in the premises shall have been entered for the appointment on the
ground of insolvency or bankruptcy of a receiver, custodian, liquidator, trustee or assignee in bankruptcy or insolvency of the Company or of its property, or for the winding up or liquidation of its affairs, and such decree or order shall have
remained in force unvacated and unstayed for a period of 90 days; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) the Company shall institute proceedings to be adjudicated a
voluntary bankrupt, shall consent to the filing of a bankruptcy proceeding against it, shall file a petition or answer or consent seeking liquidation or reorganization under any applicable bankruptcy, insolvency, reorganization or other similar law,
shall consent to the filing of any such petition or shall consent to the appointment on the ground of insolvency or bankruptcy of a receiver or custodian or liquidator or trustee or assignee in bankruptcy or insolvency of it or of its property, or
shall make a general assignment for the benefit of creditors; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) any other Event of Default provided in or pursuant to the Indenture
with respect to Securities of the series, provided that any such Event of Default that results from a change in GAAP shall not be deemed to be an Event of Default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Acceleration of Maturity; Rescission and Annulment</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default specified in clause (5)&nbsp;or (6) of the definition thereof above occurs, the principal of all Securities shall
automatically become due and payable without further action or notice, anything contained in this Indenture or the Securities of each series or established with respect to each series pursuant to Section&nbsp;3.1 to the contrary notwithstanding. If
(a)&nbsp;upon the occurrence and continuance of an Event of Default specified in clause (1)&nbsp;or (2) of the definition thereof, the Company and the Trustee receive notice in writing that Holders of not less than 25% in aggregate principal amount
of the Outstanding Securities of that series, or (b)&nbsp;upon the occurrence and continuance of any other Event of Default other than an Event of Default specified in clause (1), (2), (5) and (6)&nbsp;of the definition thereof, the Company and the
Trustee receive notice in writing that Holders of not less than a majority in aggregate principal amount of the Outstanding Securities of that series have declared the principal (or, in the case of discounted Securities, the amount specified in the
terms thereof) of all Securities of that series to be due and payable immediately, then upon any such declaration the same shall become and shall be immediately due and payable, anything contained in this Indenture or in the Securities of that
series or established with respect to that series to the contrary notwithstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time after a declaration of acceleration or
automatic acceleration with respect to the Securities of any series has been made and before a judgment or decree for payment of the money due has been obtained by the Trustee as hereafter in this Article 5 provided, the Holders of not less than a
majority in principal amount of the Outstanding Securities of such series, by written notice to the Company and the Trustee, may rescind and annul the declaration or automatic acceleration and its consequences if: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company has paid or deposited with the Trustee a sum of money sufficient to pay (A)&nbsp;all overdue installments of interest on all
Securities of such series and any Additional Amounts payable with respect thereto, (B)&nbsp;the principal of and any premium on any Securities of the series which have become due otherwise than by the declaration of acceleration or automatic
acceleration and interest thereon and any Additional Amounts with respect thereto at the rate or rates borne by or provided in such Securities, (C)&nbsp;interest upon overdue interest at the rate or rates prescribed therefor in such Securities and
(D)&nbsp;all sums paid or advanced by the Trustee hereunder and the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all Events of Default with respect to Securities of such series, other than the <FONT STYLE="white-space:nowrap">non-payment</FONT> of the
principal of, any premium and interest on, and any Additional Amounts with respect to, Securities of such series which shall have become due solely by the acceleration, shall have been cured or waived as provided in Section&nbsp;5.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Collection of Indebtedness and Suits for Enforcement by Trustee</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company covenants that if: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) default is made in the payment of any installment of interest on any Security, or any Additional Amounts payable with respect thereto,
when such interest or Additional Amounts </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall have become due and payable and such default continues for any cure period specified with respect to such Security; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) default is made in the payment of any principal of or premium, if any, on, or any Additional Amounts payable in respect of any principal
of or premium, if any, on any Security at its Maturity; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) default is made in the deposit of any sinking fund payment, when and as
due by the terms of any Security and such default continues for any cure period specified with respect to such Security; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the Company shall, upon demand
of the Trustee, pay to the Trustee, for the benefit of the Holders of such Securities, the whole amount of money then due and payable with respect to such Securities, with interest upon the overdue principal, any premium and, to the extent that
payment of such interest shall be legally enforceable, upon any overdue installments of interest and Additional Amounts at the rate or rates borne by or provided for in such Securities, and, in addition thereto, such further amount of money as shall
be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel and all other amounts due to the Trustee under Section&nbsp;6.7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company fails to pay the money it is required to pay the Trustee pursuant to the preceding paragraph forthwith upon the demand of the
Trustee, the Trustee, in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the money so due and unpaid, and may prosecute such proceeding to judgment or final decree, and may enforce the same
against the Company or any other obligor upon such Securities and collect the monies adjudged or decreed to be payable in the manner provided by law out of the property of the Company or any other obligor upon such Securities, wherever situated.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default with respect to the Securities of any series occurs and is continuing, the Trustee may, and if (A)&nbsp;an Event
of Default specified in clause (1), (2), (5) or (6)&nbsp;of the definition thereof occurs and is continuing, and Holders of not less than 25% in aggregate principal amount of the Outstanding Securities of such series direct, or (B)&nbsp;an Event of
Default other than an Event of Default specified in clause (1), (2), (5) or (6)&nbsp;of the definition thereof occurs and is continuing, and Holders of not less than a majority in aggregate principal amount of the Outstanding Securities of such
series direct, so long as such Holders shall have provided the Trustee with such indemnity as it shall require and subject to the provisions of Section&nbsp;5.12, the Trustee shall, proceed to protect and enforce its rights and the rights of the
Holders of Securities of such series by such appropriate judicial proceedings to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement in this Indenture or such Securities or in aid of the exercise of
any power granted herein or therein, or to enforce any other proper remedy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Trustee May File Proofs of Claim</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case of the pendency of any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or
other judicial proceeding relative to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company or any other obligor upon the Securities or the property of the Company or such other obligor or their creditors, the Trustee (irrespective of whether the principal of the Securities
shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand on the Company for the payment of any overdue principal, premium, interest or Additional Amounts)
shall be entitled and empowered, by intervention in such proceeding or otherwise, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to file and prove a claim for the whole amount, or
such lesser amount as may be provided for in the Securities of such series, of the principal and any premium, interest and Additional Amounts owing and unpaid in respect of the Securities and to file such other papers or documents as may be
necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents or counsel) and of the Holders of Securities allowed in such
judicial proceeding, and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) to collect and receive any monies or other property payable or deliverable on any such claims and to
distribute the same; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding
is hereby authorized by each Holder of Securities to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders of Securities, to pay to the Trustee any amount due to it
for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel and any other amounts due the Trustee under Section&nbsp;6.7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder of a
Security any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Holder of a Security in any such proceeding.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Trustee May Enforce Claims without Possession of Securities</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All rights of action and claims under this Indenture or any of the Securities may be prosecuted and enforced by the Trustee without the
possession of any of the Securities or the production thereof in any proceeding relating thereto, and any such proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery or judgment, after
provision for the payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, shall be for the ratable benefit of each and every Holder of a Security in respect of which such judgment has been
recovered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Application of Money Collected</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any money collected by the Trustee pursuant to this Article 5 with respect to Securities of any series shall be applied in the following
order, at the date or dates fixed by the Trustee and, in case of the distribution of such money on account of principal, or any premium, interest or Additional Amounts, upon presentation of such Securities, and the notation thereon of the payment if
only partially paid and upon surrender thereof if fully paid: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FIRST: To the payment of all amounts due the Trustee and any predecessor Trustee under
Section&nbsp;6.7; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECOND: To the payment of the amounts then due and unpaid upon such Securities for principal and any premium, interest
and Additional Amounts in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the aggregate amounts due and payable on such Securities for principal and any
premium, interest and Additional Amounts, respectively; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIRD: The balance, if any, to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>Limitations on Suits</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Holder of any Security of any series shall have any right to institute any proceeding, judicial or otherwise, with respect to this
Indenture, or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) such Holder has previously
given written notice to the Trustee of a continuing Event of Default with respect to the Securities of such series; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) (a) in the case
of an Event of Default specified in clause (1), (2), (5) and (6)&nbsp;of the definition thereof, Holders of not less than 25% in aggregate principal amount of the Outstanding Securities of such series, or (b)&nbsp;in the case of an Event of Default
other than as specified in clause (1), (2), (5) and (6)&nbsp;of the definition thereof, Holders of not less than a majority in aggregate principal amount of the Outstanding Securities of such series, shall have made written request to the Trustee to
institute proceedings in respect of such Event of Default in its own name as Trustee hereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) such Holder or Holders have offered
to the Trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred in compliance with such request; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the Trustee for 60 days after its receipt of such notice, request and offer of indemnity has failed to institute any such proceeding, make
such appointment or seek any other remedy; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) no direction inconsistent with such written request has been given to the Trustee
during such <FONT STYLE="white-space:nowrap">60-day</FONT> period by the Holders of a majority in principal amount of the Outstanding Securities of such series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">it being understood and intended that no one or more of such Holders shall have any right in any manner whatever by virtue of, or by availing of, any
provision of this Indenture or any Security to affect, disturb or prejudice the rights of any other such Holders or Holders of Securities of any other series, or to obtain or to seek to obtain priority or preference over any other Holders or to
enforce any right under this Indenture, except in the manner herein provided and for the equal and ratable benefit of all such Holders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Unconditional Right of Holders to Receive Principal and Any Premium,
Interest and Additional Amounts</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision in this Indenture, the Holder of any Security shall have the
right, which is absolute and unconditional, to receive payment of the principal of, any premium and (subject to Section&nbsp;3.5 and Section&nbsp;3.7) interest on, and any Additional Amounts with respect to, such Security, on the respective Stated
Maturity or Maturities therefor specified in such Security (or, in the case of redemption, on the Redemption Date or, in the case of repayment at the option of such Holder if provided in or pursuant to this Indenture, on the date such repayment is
due) and to institute suit for the enforcement of any such payment, and such right shall not be impaired without the consent of such Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>Restoration of Rights and Remedies</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Trustee or any Holder of a Security has instituted any proceeding to enforce any right or remedy under this Indenture and such
proceeding has been discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then and in every such case the Company, the Trustee and each such Holder shall, subject to any determination in such
proceeding, be restored severally and respectively to their former positions hereunder, and thereafter all rights and remedies of the Trustee and each such Holder shall continue as though no such proceeding had been instituted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>Rights and Remedies Cumulative</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities in the last
paragraph of Section&nbsp;3.6, no right or remedy herein conferred upon or reserved to the Trustee or to each and every Holder of a Security is intended to be exclusive of any other right or remedy, and every right and remedy, to the extent
permitted by law, shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall
not, to the extent permitted by law, prevent the concurrent assertion or employment of any other appropriate right or remedy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Delay or Omission Not Waiver</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No delay or omission of the Trustee or of any Holder of any Security to exercise any right or remedy accruing upon any Event of Default shall
impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article 5 or by law to the Trustee or to any Holder of a Security may be exercised from time to
time, and as often as may be deemed expedient, by the Trustee or by such Holder, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Control by
Holders of Securities</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Holders of a majority in principal amount of the Outstanding Securities of any series shall have the right
to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee with respect to the Securities of such series, provided that: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) such direction shall not be in conflict with any rule of law or with this Indenture or
with the Securities of any series and would not involve the Trustee in personal liability; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Trustee may take any other action
deemed proper by the Trustee which is not inconsistent with such direction; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) such direction is not unduly prejudicial to the
rights of the other Holders of Securities of such series not joining in such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Waiver of Past or Existing
Defaults</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Holders of not less than a majority in principal amount of the Outstanding Securities of any series by notice to the
Trustee may on behalf of the Holders of all the Securities of such series waive any past or existing default or Event of Default hereunder with respect to such series and its consequences, except: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) a continuing default or Event of Default in the payment of the principal of, any premium or interest on, or any Additional Amounts with
respect to, any Security of such series; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) a default or Event of Default in respect of a covenant or provision hereof which under
Article 9 hereof cannot be modified or amended without the consent of the Holder of each Outstanding Security of such series affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any such waiver, such default or Event of Default with respect to such series shall cease to exist, and any Event of Default with respect
to such series arising therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other default with respect to such series or impair any right with respect to such series
consequent thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Waiver of Stay or Extension Laws</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company covenants that (to the extent that it may lawfully do so) it will not at any time insist upon, or plead, or in any manner
whatsoever claim or take the benefit or advantage of, any stay or extension law wherever enacted, now or at any time hereafter in force, which may affect the covenants or the performance of this Indenture; and the Company expressly waives (to the
extent that it may lawfully do so) all benefit or advantage of any such law and covenants that it will not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power
as though no such law had been enacted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <U>Undertaking for Costs</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All parties to this Indenture agree, and each Holder of any Security by his or her acceptance thereof shall be deemed to have agreed, that any
court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of
any undertaking to pay the costs of such suit, and that such court may in its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discretion assess reasonable costs, including reasonable attorneys&#8217; fees and expenses, against any party litigant in such suit having due regard to the merits and good faith of the claims
or defenses made by such party litigant; but the provisions of this Section&nbsp;5.15 shall not apply to any suit instituted by the Trustee, to any suit instituted by any Holder, or group of Holders, holding in the aggregate more than 10% in
principal amount of Outstanding Securities of any series, or to any suit instituted by any Holder for the enforcement of the payment of the principal of (or premium, if any) or interest, if any, on or Additional Amounts, if any, with respect to any
Security on or after the respective Stated Maturities expressed in such Security (or, in the case of redemption, on or after the Redemption Date, and, in the case of repayment, on or after the date for repayment) or for the enforcement of the right,
if any, to convert or exchange any Security into Common Stock or other securities, cash or other property in accordance with its terms. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 6 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE TRUSTEE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Certain Duties and Responsibilities</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The duties and responsibilities of the Trustee shall be as provided by the Trust Indenture Act. Except during the continuance of an Event of
Default with respect to the Securities of a series of which a Responsible Officer has actual knowledge, the Trustee undertakes to perform such duties and only such duties as are specifically set forth in this Indenture with respect to such
Securities, and no implied covenants or obligations shall be read into this Indenture with respect to such Securities against the Trustee. In case an Event of Default of which a Responsible Officer has actual knowledge with respect to the Securities
of a series has occurred (which has not been cured or waived), the Trustee shall exercise the rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, with respect to such Securities, as a prudent
person would exercise or use under the circumstances in the conduct of such person&#8217;s own affairs. Notwithstanding the foregoing, no provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any
financial liability in the performance of any of its duties hereunder, or in the exercise of any of its rights or powers. Whether or not therein expressly so provided, every provision of this Indenture relating to the conduct or affecting the
liability of or affording protection to the Trustee shall be subject to the provisions of this Section&nbsp;6.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2
<U>Certain Rights of Trustee</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of Section&nbsp;6.1: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Trustee may conclusively rely and shall be fully protected in acting or refraining from acting upon any resolution, certificate,
statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, coupon, other evidence of indebtedness or other paper or document (whether in its original or facsimile form) believed by it to be genuine and
to have been signed or presented by the proper party or parties; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any request or direction of the Company mentioned herein shall be
sufficiently evidenced by a Company Request or a Company Order (in each case, other than delivery of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Security to the Trustee for authentication and delivery pursuant to Section&nbsp;3.3 which shall be sufficiently evidenced as provided therein) and any resolution of the Board of Directors of the
Company may be sufficiently evidenced by a Board Resolution; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) whenever in the administration of this Indenture the Trustee shall deem
it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence shall be herein specifically prescribed) may, in the absence of bad faith on its part, request and
conclusively rely upon an Officer&#8217;s Certificate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the Trustee may consult with counsel of its selection and the advice of such
counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the Trustee shall be under no obligation to exercise any of the rights or powers vested in it by or pursuant to this Indenture or to
institute, conduct or defend any litigation hereunder or in relation hereto at the request or direction of any of the Holders of Securities of any series pursuant to this Indenture, unless such Holders shall have offered to the Trustee security or
indemnity reasonably satisfactory to it against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement,
instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, coupon, note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may but shall not be obligated to make such
further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine, during business hours and upon reasonable notice, the
books, records and premises of the Company, personally or by agent or attorney at the expense of the Company and shall incur no liability or additional liability of any kind by reason of such inquiry or investigation; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) the Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents,
attorneys or custodians and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent, attorney or custodians appointed with due care by it hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) the Trustee shall not be liable in its individual capacity for any action taken or suffered to be taken, unless it shall be proved that
the Trustee was negligent, acted in bad faith or engaged in willful misconduct; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) the Authenticating Agent, Paying Agent, and Security
Registrar shall have the same protections as the Trustee set forth hereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) the Trustee shall not be liable in its individual
capacity with respect to any action taken, suffered or omitted to be taken by it in good faith in accordance with this Indenture, and, to the extent not so provided herein, with respect to any act requiring the Trustee to exercise its own
discretion, relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under this Indenture or any Securities, unless it shall be proved that, in connection with any such action taken, suffered or omitted or any such act, the Trustee was negligent, acted in bad
faith or engaged in willful misconduct; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) no provision of this Indenture shall require the Trustee to expend or risk its own funds or
otherwise incur any financial liability in the performance of any of its duties hereunder, or in the exercise of any of its rights or powers; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) the Trustee shall not be charged with knowledge or required to take notice of any default or Event of Default with respect to the
Securities unless either (A)&nbsp;a Responsible Officer shall have actual knowledge of such default or Event of Default or (B)&nbsp;written notice of such default or Event of Default, which references the Securities and this Indenture, shall have
been given to a Responsible Officer by the Company or other obligor on such Securities or by any Holder of such Securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) the
Trustee shall not be liable in its individual capacity for any action taken, suffered or omitted by it in good faith and reasonably believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Indenture;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) the rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be
indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian, director, officer, employee and other Person employed to act hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) the Trustee may request that the Company deliver an Officer&#8217;s Certificate setting forth the names of individuals and/or titles of
Officers authorized at such time to take specified actions pursuant to this Indenture, which Officer&#8217;s Certificate may be signed by any person authorized to sign an Officer&#8217;s Certificate, including any person specified as so authorized
in any such certificate previously delivered and not superseded; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) the permissive rights of the Trustee to take certain actions under
or perform any discretionary act enumerated in this Indenture shall not be construed as a duty unless so specified herein, and the Trustee shall not be answerable for other than its negligence or willful misconduct in the performance of such action
or act; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) the Trustee shall not be liable in its individual capacity with respect to any action taken, suffered or omitted to be taken
by it in good faith in accordance with this Indenture or at the direction of the Holders of a majority in aggregate principal amount of the Outstanding Securities relating to the time, method and place of conducting any proceeding for any remedy
available to the Trustee, or exercising or omitting to exercise any trust or power conferred upon the Trustee, under this Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18)
in no event shall the Trustee be liable for special, indirect or consequential loss or damage of any kind whatsoever (including but not limited to lost profits) even if the Trustee has been advised of the likelihood of such loss or damage and
regardless of the form of action; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19) in no event shall the Trustee be responsible or liable for any failure or delay in the
performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
beyond its control, including, without limitation strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and
interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices in the banking industry to
resume performance as soon as practicable under the circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Notice of Defaults</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within 90 days after the occurrence of any default hereunder with respect to the Securities of any series of which a Responsible Officer has
actual knowledge, the Trustee shall give the Holders of Securities of such series entitled to receive reports pursuant to Section&nbsp;7.3, notice of such default hereunder actually known to a Responsible Officer, unless such default shall have been
cured or waived; provided, however, that, except in the case of a default in the payment of the principal of (or premium, if any), or interest, if any, on, or Additional Amounts or any sinking fund or purchase fund installment with respect to, any
Security of such series, the Trustee shall be protected in withholding such notice if and so long as the board of directors, the executive committee or a trust committee of directors and/or Responsible Officers in good faith determine that the
withholding of such notice is in the best interest of the Holders of Securities of such series; and provided, further, that in the case of any default of the character specified in Section&nbsp;5.1(4) with respect to Securities of such series, no
such notice to Holders shall be given until at least 30 days after the occurrence thereof. For the purpose of this Section, the term &#8220;default&#8221; means any event that is, or after notice or lapse of time or both would become, an Event of
Default with respect to Securities of such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Not Responsible for Recitals or Issuance of Securities</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recitals contained herein and in the Securities, except the Trustee&#8217;s certificate of authentication, shall be taken as the
statements of the Company, and neither the Trustee nor any Authenticating Agent assumes any responsibility for their correctness. The Trustee makes no representations as to the validity, sufficiency or priority of this Indenture or of the
Securities. Neither the Trustee nor any Authenticating Agent shall be accountable for the use or application by the Company of the Securities or the proceeds thereof. Except with respect to the authentication of Securities pursuant to
Section&nbsp;3.3, the Trustee shall not be responsible for the legality or the validity of this Indenture or any Securities issued or to be issued hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5 <U>May Hold Securities</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee, any Authenticating Agent, any Paying Agent, any Security Registrar or any other Person that may be an agent of the Trustee or the
Company, in its individual or any other capacity, may become the owner or pledgee of Securities and, subject to Sections 310(b) and 311 of the Trust Indenture Act, may otherwise deal with the Company with the same rights it would have if it were not
the Trustee, Authenticating Agent, Paying Agent, Security Registrar or such other Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6 <U>Money Held in Trust</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Money held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by law. The Trustee shall
be under no liability for interest on any money received by it hereunder except as otherwise agreed in writing with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>Compensation and Reimbursement</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company agrees: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to pay
to the Trustee from time to time such compensation as shall be agreed upon from time to time in writing between the Company and the Trustee for all services rendered by the Trustee hereunder (which compensation shall not be limited by any provision
of law in regard to the compensation of a trustee of an express trust); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) except as otherwise expressly provided herein, to reimburse
the Trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by the Trustee in accordance with any provision of this Indenture arising out of or in connection with the acceptance or administration of the
trust or trusts hereunder (including the reasonable compensation and the expenses and disbursements of its agents and counsel), except any such expense, disbursement or advance as may be caused by the Trustee&#8217;s own negligence or willful
misconduct; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to fully indemnify each of the Trustee and any predecessor Trustee and its agents, officers, directors and employees
for, and to hold them harmless against, any loss, liability, damage, claim or expense (including reasonable legal fees and expenses), including taxes (other than taxes based on the income of the Trustee), incurred without negligence or willful
misconduct on their part, arising out of or in connection with the acceptance or administration of the trust or trusts hereunder, including the reasonable costs and expenses of defending themselves against any claim or liability (whether asserted by
the Company, a Holder of Securities, or any other Person) in connection with the exercise or performance of any of their powers or duties hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As security for the performance of the payment obligations of the Company under this Section&nbsp;6.7, the Trustee shall have a lien prior to
the Securities of any series upon all property and funds held or collected by the Trustee as such, except funds held in trust for the payment of principal of, and premium or interest on, or any Additional Amounts with respect to, particular
Securities. Such lien shall survive the resignation or removal of the Trustee and the satisfaction and discharge of this Indenture. Without prejudice to any other rights available to the Trustee under applicable law, when the Trustee incurs expenses
or renders services after a default or Event of Default specified in Section&nbsp;5.1(5) and 5.1(6) hereof occurs, the expenses and the compensation for the services (including the fees and expense of its agents and counsel) are intended to
constitute expense of administration under U.S. Code, Title 11 or any other similar foreign, federal or state law for the relief of debtors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without prejudice to any other rights available to the Trustee under applicable law, to the extent permitted by law any compensation or
expense incurred by the Trustee after a default specified in or pursuant to Section&nbsp;5.1 is intended to constitute an expense of administration </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under any then applicable bankruptcy or insolvency law. &#8220;<U>Trustee</U>&#8221; for purposes of this Section&nbsp;6.7 shall include any predecessor Trustee but the negligence or willful
misconduct of any Trustee shall not affect the rights of any other Trustee under this Section&nbsp;6.7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other
provision of this Indenture to the contrary, in no event shall the Trustee be liable for special, indirect or consequential damages of any kind whatsoever (including but not limited to lost profits) even if the Trustee had been advised of the
likelihood of such loss or damage and regardless of the form of action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of this Section&nbsp;6.7 shall survive the
satisfaction and discharge of this Indenture or the earlier resignation or removal of the Trustee and shall apply with equal force and effect to the Trustee in its capacity as Authenticating Agent, Paying Agent or Security Registrar. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8 <U>Corporate Trustee Required; Eligibility; Conflicting Interests</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There shall at all times be a Trustee hereunder that is a Corporation or a national banking association, organized and doing business under
the laws of the United States of America, any state thereof or the District of Columbia, eligible under Section&nbsp;310(a)(1) of the Trust Indenture Act to act as trustee under an indenture qualified under the Trust Indenture Act and that has a
combined capital and surplus (computed in accordance with Section&nbsp;310(a)(2) of the Trust Indenture Act) of at least $50,000,000 subject to supervision or examination by federal or state authority. If at any time the Trustee shall cease to be
eligible in accordance with the provisions of this Section&nbsp;6.8, it shall resign immediately in the manner and with the effect hereinafter specified in this Article 6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Trustee has or shall acquire a conflicting interest within the meaning of the Trust Indenture Act, the Trustee shall either eliminate
such interest or resign, to the extent and in the manner provided by, and subject to the provisions of, the Trust Indenture Act and this Indenture. To the extent permitted by such Act, the Trustee shall not be deemed to have a conflicting interest
by virtue of being a trustee under this Indenture with respect to Securities of more than one series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9 <U>Resignation and
Removal; Appointment of Successor</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) No resignation or removal of the Trustee and no appointment of a successor Trustee pursuant to
this Article 6 shall become effective until the acceptance of appointment by the successor Trustee pursuant to Section&nbsp;6.10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) The
Trustee may resign at any time with respect to the Securities of one or more series by giving written notice thereof to the Company. If the instrument of acceptance by a successor Trustee required by Section&nbsp;6.10 shall not have been delivered
to the Trustee within 30&nbsp;days after the giving of such notice of resignation, the resigning Trustee may petition, at the expense of the Company, any court of competent jurisdiction for the appointment of a successor Trustee with respect to such
series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) The Trustee may be removed at any time with respect to the Securities of any series by Act of the Holders of a majority in
principal amount of the Outstanding Securities of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such series, delivered to the Trustee and the Company. If the instrument of acceptance by a successor Trustee required by Section&nbsp;6.10 shall not have been delivered to the Trustee within
30&nbsp;days after the giving of such notice of removal, the Trustee being removed may petition, at the expense of the Company, any court of competent jurisdiction for the appointment of a successor Trustee with respect to such series. The Trustee
for one or more series of Securities may be removed by the Company, so long as no default or Event of Default has occurred and is continuing with respect to such series. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) If at any time: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the
Trustee shall fail to comply with the obligations imposed upon it under Section&nbsp;310(b) of the Trust Indenture Act with respect to Securities of any series after written request therefor by the Company or any Holder of a Security of such series
who has been a bona fide Holder of a Security of such series for at least six months; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Trustee shall cease to be eligible under
Section&nbsp;6.8 and shall fail to resign after written request therefor by the Company or any such Holder; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Trustee shall
become incapable of acting or shall be adjudged bankrupt or insolvent or a receiver of the Trustee or of its property shall be appointed or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose
of rehabilitation, conservation or liquidation, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">then, in any such case, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Company, by or pursuant to a Company Order, may remove the Trustee with respect to all Securities or the Securities of such series; or
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) subject to Section&nbsp;5.15, any Holder of a Security who has been a bona fide Holder of a Security of such series for at least six
months may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee with respect to all Securities of such series and the appointment of a successor Trustee or Trustees.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) If the Trustee shall resign, be removed or become incapable of acting, or if a vacancy shall occur in the office of Trustee for any
cause, with respect to the Securities of one or more series, the Company, by or pursuant to a Company Order, shall promptly appoint a successor Trustee or Trustees with respect to the Securities of such series (it being understood that any such
successor Trustee may be appointed with respect to the Securities of one or more or all of such series and that at any time there shall be only one Trustee with respect to the Securities of any particular series) and shall comply with the applicable
requirements of Section&nbsp;6.10. If, within one year after such resignation, removal or incapacity, or the occurrence of such vacancy, a successor Trustee with respect to the Securities of any series shall be appointed by Act of the Holders of a
majority in principal amount of the Outstanding Securities of such series delivered to the Company and the retiring Trustee, the successor Trustee so appointed shall, forthwith upon its acceptance of such appointment in accordance with the
applicable requirements of Section&nbsp;6.10, become the successor Trustee with respect to the Securities of such series and to that extent supersede the successor Trustee appointed by the Company. If no
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
successor Trustee with respect to the Securities of any series shall have been so appointed by the Company or the Holders of Securities and accepted appointment in the manner required by
Section&nbsp;6.10, any Holder of a Security who has been a bona fide Holder of a Security of such series for at least six months may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the
appointment of a successor Trustee with respect to the Securities of such series. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) The Company shall give notice of each resignation
and each removal of the Trustee with respect to the Securities of any series and each appointment of a successor Trustee with respect to the Securities of any series to all Holders of Securities of such series in the manner provided in
Section&nbsp;1.6. Each notice shall include the name of the successor Trustee with respect to the Securities of such series and the address of its Corporate Trust Office. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) In no event shall any retiring Trustee be liable for the acts or omissions of any successor Trustee hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <U>Acceptance of Appointment by Successor</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Upon the appointment hereunder of any successor Trustee with respect to all Securities, such successor Trustee so appointed shall execute,
acknowledge and deliver to the Company and the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Trustee shall become effective and such successor Trustee, without any further act,
deed or conveyance, shall become vested with all the rights, powers, trusts and duties hereunder of the retiring Trustee; but, on the request of the Company or such successor Trustee, such retiring Trustee, upon payment of its charges, shall execute
and deliver an instrument transferring to such successor Trustee all the rights, powers and trusts of the retiring Trustee and, subject to Section&nbsp;10.3, shall duly assign, transfer and deliver to such successor Trustee all property and money
held by such retiring Trustee hereunder, subject nevertheless to its lien, if any, provided for in Section&nbsp;6.7. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Upon the
appointment hereunder of any successor Trustee with respect to the Securities of one or more (but not all) series, the Company, the retiring Trustee and such successor Trustee shall execute and deliver an indenture supplemental hereto wherein each
successor Trustee shall accept such appointment and which (a)&nbsp;shall contain such provisions as shall be necessary or desirable to transfer and confirm to, and to vest in, such successor Trustee all the rights, powers, trusts and duties of the
retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor Trustee relates, (b)&nbsp;if the retiring Trustee is not retiring with respect to all Securities, shall contain such provisions as
shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series as to which the retiring Trustee is not retiring shall continue to be
vested in the retiring Trustee and (c)&nbsp;shall add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, it being understood
that nothing herein or in such supplemental indenture shall constitute such Trustees <FONT STYLE="white-space:nowrap">co-trustees</FONT> of the same trust, that each such Trustee shall be trustee of a trust or trusts hereunder separate and apart
from any trust or trusts hereunder administered by any other such Trustee and that no Trustee shall be responsible for any notice given to, or received by, or any act or failure to act on the part of any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other Trustee hereunder, and, upon the execution and delivery of such supplemental indenture, the resignation or removal of the retiring Trustee shall become effective to the extent provided
therein, such retiring Trustee shall have no further responsibility for the exercise of rights and powers or for the performance of the duties and obligations vested in the Trustee under this Indenture with respect to the Securities of that or those
series to which the appointment of such successor Trustee relates other than as hereinafter expressly set forth, and such successor Trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and
duties of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor Trustee relates; but, on request of the Company or such successor Trustee, such retiring Trustee, upon payment of its
charges with respect to the Securities of that or those series to which the appointment of such successor Trustee relates and subject to Section&nbsp;10.3 shall duly assign, transfer and deliver to such successor Trustee, to the extent contemplated
by such supplemental indenture, the property and money held by such retiring Trustee hereunder with respect to the Securities of that or those series to which the appointment of such successor Trustee relates, subject to its lien, if any, provided
for in Section&nbsp;6.7. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) Upon request of any Person appointed hereunder as a successor Trustee, the Company shall execute any and all
instruments for more fully and certainly vesting in and confirming to such successor Trustee all such rights, powers and trusts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) No
Person shall accept its appointment hereunder as a successor Trustee unless at the time of such acceptance such successor Person shall be qualified and eligible under this Article 6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11 <U>Merger, Conversion, Consolidation or Succession to Business</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Corporation or national banking association into which the Trustee may be merged or converted or with which it may be consolidated, or any
Corporation or national banking association resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any Corporation or national banking association succeeding to all or substantially all of the corporate
trust business of the Trustee by sale or otherwise, shall be the successor of the Trustee hereunder, provided such Corporation or national banking association shall otherwise be qualified and eligible under this Article 6, in each case without the
execution or filing of any paper or any further act on the part of any of the parties hereto. In case any Securities shall have been authenticated but not delivered by the Trustee then in office, any successor by merger, conversion or consolidation
to such authenticating Trustee may adopt such authentication and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12 <U>Appointment of Authenticating Agent</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee may appoint one or more Authenticating Agents acceptable to the Company with respect to one or more series of Securities which
shall be authorized to act on behalf of the Trustee to authenticate Securities of that or those series issued upon original issue, exchange, registration of transfer, partial redemption or partial repayment or pursuant to Section&nbsp;3.6, and
Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligatory for all purposes as if authenticated by the Trustee hereunder. Wherever reference is made in this Indenture to the authentication and delivery of Securities by the Trustee or the
Trustee&#8217;s certificate of authentication, such reference shall be deemed to include authentication and delivery on behalf of the Trustee by an Authenticating Agent and a certificate of authentication executed on behalf of the Trustee by an
Authenticating Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Authenticating Agent must be acceptable to the Company and, except as provided in or pursuant to this
Indenture, shall at all times be a Corporation or national banking association that would be permitted by the Trust Indenture Act to act as trustee under an indenture qualified under the Trust Indenture Act, is authorized under applicable law and by
its charter to act as an Authenticating Agent and has a combined capital and surplus (computed in accordance with Section&nbsp;310 (a)(2) of the Trust Indenture Act) of at least $50,000,000. If at any time an Authenticating Agent shall cease to be
eligible in accordance with the provisions of this Section&nbsp;6.12, it shall resign immediately in the manner and with the effect specified in this Section&nbsp;6.12. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Corporation or national banking association into which an Authenticating Agent may be merged or converted or with which it may be
consolidated, or any Corporation or national banking association resulting from any merger, conversion or consolidation to which such Authenticating Agent shall be a party, or any Corporation or national banking association succeeding to all or
substantially all of the corporate agency or corporate trust business of an Authenticating Agent, shall be the successor of such Authenticating Agent hereunder, provided such Corporation or national banking association shall be otherwise eligible
under this Section&nbsp;6.12, without the execution or filing of any paper or any further act on the part of the Trustee or the Authenticating Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Authenticating Agent may resign at any time by giving written notice thereof to the Trustee and the Company. The Trustee may at any time
terminate the agency of an Authenticating Agent by giving written notice thereof to such Authenticating Agent and the Company. Upon receiving such a notice of resignation or upon such a termination, or in case at any time such Authenticating Agent
shall cease to be eligible in accordance with the provisions of this Section&nbsp;6.12, the Trustee may appoint a successor Authenticating Agent which shall be acceptable to the Company and shall mail written notice of such appointment by
first-class mail, postage prepaid, to all Holders of Registered Securities, if any, of the series with respect to which such Authenticating Agent shall serve, as their names and addresses appear in the Security Register. Any successor Authenticating
Agent, upon acceptance of its appointment hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder, with like effect as if originally named as an Authenticating Agent. No successor Authenticating Agent shall
be appointed unless eligible under the provisions of this Section&nbsp;6.12. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company agrees to pay each Authenticating Agent from
time to time reasonable compensation for its services under this Section&nbsp;6.12 to the extent agreed in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of
Section&nbsp;3.3, Section&nbsp;6.1, Section&nbsp;6.4 and Section&nbsp;6.5 shall be applicable to each Authenticating Agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Authenticating Agent is appointed with respect to one or more series of Securities
pursuant to this Section&nbsp;6.12, the Securities of such series may have endorsed thereon, in addition to or in lieu of the Trustee&#8217;s certificate of authentication, an alternate certificate of authentication in substantially the following
form: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is one of the Securities of the series designated therein referred to in the
<FONT STYLE="white-space:nowrap">within-mentioned</FONT> Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">as
Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">As Authenticating Agent</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If all of the Securities of any series may not be originally issued at one time, and if the Trustee does
not have an office capable of authenticating Securities upon original issuance located in a Place of Payment where the Company wishes to have Securities of such series authenticated upon original issuance, the Trustee, if so requested by Company
Request (which writing need not be accompanied by or contained in an Officer&#8217;s Certificate), shall appoint in accordance with this Section&nbsp;6.12 (and subject to such procedures as shall be acceptable to the Trustee) an Authenticating Agent
having an office in a Place of Payment designated by the Company with respect to such series of Securities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 7 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HOLDERS LISTS AND REPORTS BY TRUSTEE AND COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <U>Company to Furnish Trustee Names and Addresses of Holders</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Section&nbsp;312(a) of the Trust Indenture Act, the Company shall furnish or cause to be furnished to the Trustee: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) semi-annually with respect to Securities of each series not later than 15 days after each Regular Record Date in respect of Securities of a
series, a list, in each case in such form as the Trustee may reasonably require, of the names and addresses of Holders of such Securities as of the applicable date, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) at such other times as the Trustee may request in writing, within 30 days after the receipt by the Company of any such request, a list of
similar form and content as of a date not more than 15 days prior to the time such list is furnished, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however, that so long as the Trustee is the Security Registrar no such list shall be required to
be furnished. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>Preservation of Information; Communications to Holders</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee shall comply with the obligations imposed upon it pursuant to Section&nbsp;312 of the Trust Indenture Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every Holder of Securities, by receiving and holding the same, agrees with the Company and the Trustee that neither the Company, the Trustee,
any Paying Agent or any Security Registrar shall be held accountable by reason of the disclosure of any such information as to the names and addresses of the Holders of Securities in accordance with Section&nbsp;312 of the Trust Indenture Act,
regardless of the source from which such information was derived, and that the Trustee shall not be held accountable by reason of mailing any material pursuant to a request made under Section&nbsp;312(b) of the Trust Indenture Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3 <U>Reports by Trustee</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Within 60 days after May&nbsp;15 of each year commencing with the first May&nbsp;15 following the first issuance of Securities pursuant to
Section&nbsp;3.1, if required by Section&nbsp;313(a) of the Trust Indenture Act, the Trustee shall transmit, pursuant to Section&nbsp;313(c) of the Trust Indenture Act, a brief report dated as of such May&nbsp;15 with respect to any of the events
specified in said Section&nbsp;313(a) that may have occurred since the later of the immediately preceding May&nbsp;15 and the date of this Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) The Trustee shall transmit any reports required by Sections 313(a) and (b)&nbsp;of the Trust Indenture Act at the times specified therein.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) A copy of each report, if any, described in Section&nbsp;7.3(1) and (2)&nbsp;shall, at the time of such transmission to Holders, be
filed by the Trustee with each stock exchange, if any, upon which the Securities are listed, with the Commission and with the Company. The Company will promptly notify the Trustee when the Securities are listed on any stock exchange and of any
delisting thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4 <U>Reports by Company</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, pursuant to Section&nbsp;314(a) of the Trust Indenture Act, shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) file with the Trustee, within 30 days after the Company has filed the same with the Commission, unless such reports are available on the
Commission&#8217;s EDGAR filing system (or any successor thereto), copies of the annual reports and of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time to time by rules
and regulations prescribe) which the Company may be required to file with the Commission pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act; or, if the Company is not required to file information, documents or reports pursuant to
either of Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act, then it shall file with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to time by the Commission, such of the supplementary and
periodic information, documents and reports which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may be required pursuant to Section&nbsp;13 of the Exchange Act in respect of a security listed and registered on a national securities exchange as may be prescribed from time to time in such
rules and regulations; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) file with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to time
by the Commission, such additional information, documents and reports with respect to compliance by the Company with the conditions and covenants of this Indenture as may be required from time to time by such rules and regulations; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) transmit to the Holders within 30 days after the filing thereof with the Trustee, in the manner and to the extent provided in
Section&nbsp;313(c) of the Trust Indenture Act, such summaries of any information, documents and reports required to be filed by the Company pursuant to paragraphs (1)&nbsp;and (2) of this Section&nbsp;7.4 as may be required by rules and regulations
prescribed from time to time by the Commission; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) furnish to the Trustee, within 120 days after the end of each fiscal year, a
written statement (which need not be contained in or accompanied by an Officer&#8217;s Certificate) signed by the principal executive officer, the principal financial officer or the principal accounting officer of the Company, stating that to the
best of such officer&#8217;s knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the terms, provisions and conditions
of this Indenture (or, if a default or Event of Default shall have occurred, describing all such defaults or Events of Default of which he or she may have knowledge and what action the Company is taking or proposes to take with respect thereto). For
purposes of this paragraph (4), such compliance shall be determined without regard to any period of grace or requirement of notice provided in this Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee&#8217;s receipt of such
shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company&#8217;s compliance with any of its covenants hereunder (as to which the Trustee is entitled to
rely exclusively on Officer&#8217;s Certificates). The Trustee shall have no duty to monitor the Company&#8217;s compliance with the covenants contained in this Indenture other than to receive written notices as described in paragraph (4)&nbsp;of
this Section&nbsp;7.4. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 8 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATION, MERGER AND SALES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1 <U>Company May Consolidate, etc., Only on Certain Terms</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall not directly or indirectly consolidate with or merge with or into, or sell, assign, transfer, lease, convey or otherwise
dispose of all or substantially all of its assets and properties and the assets and properties of its Subsidiaries (taken as a whole) to another Person in one or more related transactions unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) either: (A)&nbsp;the Company is the survivor; or (B)&nbsp;the Person formed by or surviving any such consolidation or merger (if other than
the Company) or to which such sale, assignment, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transfer, lease, conveyance or other disposition has been made is a Person organized or existing under the laws of the United States, any state of the United States or the District of Columbia;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Person formed by or surviving any such consolidation or merger (if other than the Company) or the Person to which such sale,
assignment, transfer, lease, conveyance or other disposition has been made shall expressly assume, by an indenture (or indentures, if at such time there is more than one Trustee) supplemental hereto, in form reasonably satisfactory to the Trustee,
executed by the successor Person and delivered to the Trustee, the due and punctual payment of the principal of, any premium and interest on and any Additional Amounts with respect to, all the Securities and the performance of every obligation in
this Indenture and the Outstanding Securities on the part of the Company to be performed or observed and shall provide for conversion or exchange rights in accordance with the provisions of the Securities of any series that are convertible or
exchangeable into Common Stock or other securities, cash or other property; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) either the Company or the successor Person shall have
delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel, each stating that such consolidation, merger, sale, assignment, transfer, lease, conveyance or other disposition and, if a supplemental indenture is required in
connection with such transaction, such supplemental indenture comply with this Article 8 and that all conditions precedent herein provided for relating to such transaction have been complied with; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) immediately after giving effect to such transaction, no Event of Default or event which, after notice or lapse of time, or both, would
become an Event of Default, shall have occurred and be continuing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2 <U>Successor Person Substituted for Company</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any consolidation by the Company with or merger of the Company into any other Person or Persons where the Company is not the survivor or
any sale, assignment, transfer, lease, conveyance or other disposition of all or substantially all of the properties and assets of the Company and the properties and assets of its Subsidiaries (taken as a whole) to any Person or Persons in
accordance with Section&nbsp;8.1, the successor Person formed by such consolidation or into which the Company is merged or to which such sale, assignment, transfer, lease, conveyance or other disposition is made shall succeed to, and be substituted
for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor Person had been named as the Company herein; and thereafter, except in the case of a lease, the predecessor Person shall be
released from all obligations and covenants under this Indenture and the Securities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 9 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUPPLEMENTAL INDENTURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1 <U>Supplemental Indentures without Consent of Holders</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without the consent of any Holders of Securities, the Company (when authorized by or pursuant to a Board Resolution) and the Trustee, at any
time and from time to time, may enter </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
into one or more indentures supplemental hereto, in form satisfactory to the Trustee, for any of the following purposes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to evidence the succession of another Person to the Company, and the assumption by any such successor of the covenants of the Company
contained herein and in the Securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) to add to the covenants of the Company for the benefit of the Holders of all or any series of
Securities (as shall be specified in such supplemental indenture or indentures) or to surrender any right or power herein conferred upon the Company; provided, that in respect of any such additional covenant, such supplemental indenture may provide
for a particular period of grace after default (which period may be shorter or longer than that allowed in the case of other defaults) or may provide for an immediate enforcement upon such a default or may limit the remedies available to the Trustee
upon an Event of Default or may limit the right of the Holders of a majority in aggregate principal amount of the Securities of such series to waive such an Event of Default; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to establish the form or terms of Securities of any series as permitted by Section&nbsp;2.1 and Section&nbsp;3.1; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more
series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, pursuant to the requirements of Section&nbsp;6.10; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) to cure any ambiguity, to correct or supplement any provision herein which may be defective or inconsistent with any other provision
herein, or to make any other provisions with respect to matters or questions arising under this Indenture; provided that no action pursuant to this clause (5)&nbsp;shall adversely affect the interests of the Holders of Securities of any series then
Outstanding in any material respect; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) to add to, delete from or revise the conditions, limitations and restrictions on the authorized
amount, terms or purposes of issue, authentication and delivery of Securities, as herein set forth; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) to add any additional Events of
Default with respect to all or any series of Securities (as shall be specified in such supplemental indenture); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) to supplement any of
the provisions of this Indenture to such extent as shall be necessary for the defeasance and discharge of any series of Securities pursuant to Article 4, provided that any such action shall not adversely affect the interests of any Holder of an
Outstanding Security of such series or any other Security in any material respect; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) to make provisions with respect to conversion or
exchange rights of Holders of Securities of any series; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) to add guarantees in respect of the Securities of one or more series and to
provide for the terms and conditions of release thereof; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) to convey, transfer, assign, mortgage or pledge to the Trustee as security for the
Securities of one or more series any property or assets and to provide for the terms and conditions of release thereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) to change or
eliminate any of the provisions of this Indenture, provided that any such change or elimination shall become effective only when there is no Outstanding Security of any series created prior to the execution of such supplemental indenture that is
entitled to the benefit of such provision; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) to provide for Definitive Securities in addition to or in place of Global Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) to qualify the Indenture under the Trust Indenture Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) with respect to the Securities of a series, to conform the text of the Indenture or the Securities of such series to any provision of the
description thereof in the Company&#8217;s offering memorandum or prospectus relating to the initial offering of such Securities, to the extent that such provision, in the good faith judgment of the Company, was intended to be a verbatim recitation
of a provision of the Indenture or such Securities; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) to make any other change that does not adversely affect the rights of Holders
of Outstanding Securities in any material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee is hereby required to join with the Company and any guarantors in the
execution of any such supplemental indenture, to make any further appropriate agreements and stipulations which may be therein contained and to accept the conveyance, transfer, assignment, mortgage or pledge of any property thereunder, but the
Trustee shall not be obligated to enter into any such supplemental indenture that affects the Trustee&#8217;s own rights, duties or immunities under this Indenture or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2 <U>Supplemental Indentures with Consent of Holders</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With the consent of the Holders of not less than a majority (or such greater amount as is provided for a particular series of Securities) in
principal amount of the Outstanding Securities of each series affected by such supplemental indenture (including consents obtained in connection with a purchase of, or tender offer or exchange offer for, Securities of such series), voting as a
single class, by Act of said Holders delivered to the Company and the Trustee, the Company (when authorized by or pursuant to a Board Resolution) and the Trustee may enter into an indenture or indentures supplemental hereto for the purpose of adding
any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of modifying in any manner the rights of the Holders of Securities of such series under this Indenture or of the Securities of such series;
provided, however, that no such supplemental indenture, without the consent of the Holder of each Outstanding Security affected thereby, shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) change the Stated Maturity of the principal of, or any premium or installment of interest on or any Additional Amounts with respect to, any
Security, or reduce the principal amount thereof or the rate (or modify the calculation of such rate in a manner that reduces such rate) of interest thereon or any Additional Amounts with respect thereto, or any premium payable upon the redemption
thereof or otherwise, or change the obligation of the Company to pay </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Additional Amounts pursuant to Section&nbsp;10.4, or reduce the amount of the principal of an Original Issue Discount Security that would be due and payable upon a declaration of acceleration of
the Maturity thereof pursuant to Section&nbsp;5.2 or the amount thereof provable in bankruptcy pursuant to Section&nbsp;5.4, change the redemption provisions (other than provisions relating to notice periods (to the extent consistent with the
Applicable Procedures of the Depositary) for redemption and conditions to redemption) or adversely affect the right of repayment at the option of any Holder as contemplated by Article 13, or change the Place of Payment for any Security or the
Currency in which the principal of, any premium or interest on, or any Additional Amounts with respect to any Security is payable, or impair the right to institute suit for the enforcement of any such payment on or after the Stated Maturity thereof
(or, in the case of redemption, on or after the Redemption Date or, in the case of repayment at the option of the Holder, on or after the date for repayment); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) reduce the percentage in principal amount of the Outstanding Securities of any series the consent of the Holders of which are required for
any such supplemental indenture, or the consent of whose Holders is required for any waiver (of compliance with certain provisions of this Indenture or certain defaults hereunder and their consequences) provided for in this Indenture, or reduce the
requirements of Section&nbsp;15.4 for quorum or voting; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) modify any of the provisions of this Section&nbsp;9.2 or Section&nbsp;5.13 or
Section&nbsp;10.5, except to increase any such percentage or to provide that certain other provisions of this Indenture cannot be modified or waived without the consent of the Holder of each Outstanding Security affected thereby; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) make any change that adversely affects the right to convert or exchange any Security into or for Common Stock or other securities, cash or
other property in accordance with the terms of such Security. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A supplemental indenture that changes or eliminates any covenant or other
provision of this Indenture that shall have been included expressly and solely for the benefit of one or more particular series of Securities, or that modifies the rights of the Holders of Securities of such series with respect to such covenant or
other provision, shall be deemed not to affect the rights under this Indenture of the Holders of Securities of any other series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It shall
not be necessary for any Act of Holders of Securities under this Section&nbsp;9.2 to approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such Act shall approve the substance thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the request of the Company, accompanied by a copy of a Board Resolution authorizing the execution of any such supplemental indenture, and
upon the filing with the Trustee of evidence of the consent of Holders of Securities as aforesaid, the Trustee shall join with the Company and any guarantors in the execution of such supplemental indenture unless such supplemental indenture affects
the Trustee&#8217;s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3 <U>Execution of Supplemental Indentures</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a condition to executing, or accepting the additional trusts created by, any supplemental indenture permitted by this Article 9 or the
modifications thereby of the trusts created by this Indenture, the Trustee shall be entitled to receive, and shall be fully protected in relying upon, an Officer&#8217;s Certificate and Opinion of Counsel stating that the execution of such
supplemental indenture is authorized or permitted by this Indenture. The Trustee may, but shall not be obligated to, enter into any such supplemental indenture that affects the Trustee&#8217;s own rights, duties or immunities under this Indenture or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4 <U>Revocation of Consents</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding clause (5)&nbsp;of Section&nbsp;1.4, any Holder of a Security or future Holder of the same Security may revoke a consent as to
its Security or portion of a Security. Any revocation of a consent by the Holder of a Security or any such future Holder shall be effective only if the Trustee receives the notice of revocation before the date on which the Trustee receives an
Officer&#8217;s Certificate from the Company certifying that the requisite number of consents have been received. If, however, a record date is fixed pursuant to Section&nbsp;1.4, then notwithstanding the second preceding sentence, those Persons who
were Holders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to revoke any consent previously given, whether or not such Persons continue to be Holders after such record date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5 <U>Effect of Supplemental Indentures</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A supplemental indenture or waiver becomes effective upon the (a)&nbsp;receipt by the Company or the Trustee of the requisite number of
consents (if required), (b) satisfaction of any conditions to effectiveness as set forth in this Indenture or any such supplemental indenture or waiver and (c)&nbsp;with respect to a supplemental indenture, execution of such supplemental indenture
by the Company and the Trustee. After a supplemental indenture or waiver becomes effective, it shall bind every Holder, unless it makes a change described in any of clauses (1)&nbsp;through (4)&nbsp;of Section&nbsp;9.2, in which case, the
supplemental indenture or waiver shall bind a Holder of a Security who is affected thereby only if it has consented to such supplemental indenture or waiver and every subsequent Holder of a Security or portion of a Security that evidences the same
debt as the consenting Holder&#8217;s Security. Upon the effectiveness of any supplemental indenture under this Article, this Indenture shall be modified in accordance therewith, and such supplemental indenture shall form a part of this Indenture
for all purposes; and, except as provided in the preceding sentence, every Holder of Securities theretofore or thereafter authenticated and delivered hereunder shall be bound thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6 <U>Reference in Securities to Supplemental Indentures</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities of any series authenticated and delivered after the execution of any supplemental indenture pursuant to this Article 9&nbsp;may, and
shall if required by the Trustee, bear a notation in form approved by the Trustee as to any matter provided for in such supplemental indenture. If the Company shall so determine, new Securities of any series so modified as to conform, in the opinion
of the Trustee and the Company, to any such supplemental indenture </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may be prepared and executed by the Company and authenticated and delivered by the Trustee in exchange for Outstanding Securities of such series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7 <U>Conformity with Trust Indenture Act</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every supplemental indenture executed pursuant to this Article 9 shall conform to the requirements of the Trust Indenture Act as then in
effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8 <U>Notice of Supplemental Indenture</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to Section&nbsp;9.2, the Company shall
transmit to the Holders of Outstanding Securities of any series affected thereby a notice setting forth the substance of such supplemental indenture; provided, that any failure to provide, or any defect in any such notice, shall not impair the
validity of any such supplemental indenture. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 10 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.1 <U>Payment of Principal, Any Premium, Interest and Additional Amounts</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company covenants and agrees for the benefit of the Holders of the Securities of each series that it will duly and punctually pay the
principal of, any premium and interest on and any Additional Amounts with respect to, the Securities of such series in accordance with the terms thereof and this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.2 <U>Maintenance of Office or Agency</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall maintain in each Place of Payment for any series of Securities an Office or Agency where Securities of such series may be
presented or surrendered for payment, where Securities of such series may be surrendered for registration of transfer or exchange, where Securities of such series that are convertible or exchangeable may be surrendered for conversion or exchange,
and where notices and demands to or upon the Company in respect of the Securities of such series relating thereto and this Indenture may be served. The Company will give prompt written notice to the Trustee of the location, and any change in the
location, of such Office or Agency. If at any time the Company shall fail to maintain any such required Office or Agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made
or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, surrenders, notices and demands. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may also from time to time designate one or more other Offices or Agencies where the Securities of one or more series may be
presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an Office or
Agency in each Place of Payment for Securities of any series for such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purposes. The Company shall give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other Office or Agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in or pursuant to this Indenture, the Company hereby designates as the Place of Payment for each series of
Securities the Borough of Manhattan, The City of New York, and initially appoints the Corporate Trust Office of ____________________, located at ____________________, as the Office or Agency of the Company in the Borough of Manhattan, The City of
New York, for such purpose. The Company may subsequently appoint a different Office or Agency in the Borough of Manhattan, The City of New York, for the Securities of any series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.3 <U>Money for Securities Payments to Be Held in Trust</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company shall at any time act as its own Paying Agent with respect to any series of Securities, it shall, on or before each due date of
the principal of, any premium or interest on or Additional Amounts with respect to any of the Securities of such series, segregate and hold in trust for the benefit of the Persons entitled thereto a sum in the currency or currencies, currency unit
or units or composite currency or currencies in which the Securities of such series are payable (except as otherwise specified pursuant to Section&nbsp;3.1 for the Securities of such series) sufficient to pay the principal or any premium, interest
or Additional Amounts so becoming due until such sums shall be paid to such Persons or otherwise disposed of as herein provided, and shall promptly notify the Trustee of its failure so to act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the Company shall have one or more Paying Agents for any series of Securities, it shall, on or prior to each due date of the
principal of, any premium or interest on or any Additional Amounts with respect to any Securities of such series, deposit with any Paying Agent a sum (in the currency or currencies, currency unit or units or composite currency or currencies
described in the preceding paragraph) sufficient to pay the principal or any premium, interest or Additional Amounts so becoming due, such sum to be held in trust for the benefit of the Persons entitled thereto, and (unless such Paying Agent is the
Trustee) the Company will promptly notify the Trustee of its failure so to act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall cause each Paying Agent for any series
of Securities (other than the Trustee) to execute and deliver to the Trustee an instrument in which such Paying Agent shall agree with the Trustee, subject to the provisions of this Section&nbsp;10.3, that such Paying Agent shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) hold all sums held by it for the payment of the principal of, any premium or interest on or any Additional Amounts with respect to
Securities of such series in trust for the benefit of the Persons entitled thereto until such sums shall be paid to such Persons or otherwise disposed of as provided in or pursuant to this Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) give the Trustee notice of any default by the Company (or any other obligor upon the Securities of such series) in the making of any
payment of principal, any premium or interest on or any Additional Amounts with respect to the Securities of such series; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) at any
time during the continuance of any such default, upon the written request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such Paying Agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may at any time, for the purpose of obtaining the satisfaction and discharge of
this Indenture or for any other purpose, pay, or by Company Order direct any Paying Agent to pay, to the Trustee all sums held in trust by the Company or such Paying Agent, such sums to be held by the Trustee upon the same terms as those upon which
such sums were held by the Company or such Paying Agent; and, upon such payment by any Paying Agent to the Trustee, such Paying Agent shall be released from all further liability with respect to such sums. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided herein or pursuant hereto, any money deposited with the Trustee or any Paying Agent, or then held by the Company,
in trust for the payment of the principal of, any premium or interest on or any Additional Amounts with respect to any Security of any series and remaining unclaimed for two years after such principal or any such premium or interest or any such
Additional Amounts shall have become due and payable shall, subject to applicable escheat law, be paid to the Company on Company Request, or (if then held by the Company) shall be discharged from such trust; and the Holder of such Security shall
thereafter, as an unsecured general creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon
cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Company either cause to be published once, in an Authorized Newspaper in each Place of Payment for such
series, or may cause to be mailed once to Holders of Registered Securities of such series, notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such publication or
mailing nor later than two years after such principal and any premium or interest or Additional Amounts shall have become due and payable, any unclaimed balance of such money then remaining will be repaid to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.4 <U>Additional Amounts</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Securities of a series provide for the payment of Additional Amounts, the Company agrees to pay to the Holder of any such Security
Additional Amounts as provided in or pursuant to this Indenture or such Securities. Whenever in this Indenture there is mentioned, in any context, the payment of the principal of or any premium or interest on, or in respect of, any Security of any
series, such mention shall be deemed to include mention of the payment of Additional Amounts provided by the terms of such series established hereby or pursuant hereto to the extent that, in such context, Additional Amounts are, were or would be
payable in respect thereof pursuant to such terms, and express mention of the payment of Additional Amounts (if applicable) in any provision hereof shall not be construed as excluding Additional Amounts in those provisions hereof where such express
mention is not made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in or pursuant to this Indenture or the Securities of the applicable series, if the
Securities of a series provide for the payment of Additional Amounts, at least 10 days prior to the first Interest Payment Date with respect to such series of Securities (or if the Securities of such series shall not bear interest prior to Maturity,
the first day on which a payment of principal is made), and at least 10 days prior to each date of payment of principal or interest if there has been any change with respect to the matters set forth in the below-mentioned Officer&#8217;s
Certificate, the Company shall furnish to the Trustee and the principal Paying Agent or Paying Agents, if other than the Trustee, an Officer&#8217;s Certificate instructing the Trustee and such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Paying Agent or Paying Agents whether such payment of principal of and premium, if any, or interest on the Securities of such series shall be made to Holders of Securities of such series who are
United States Aliens (as demonstrated by delivery of appropriate tax forms) without withholding for or on account of any tax, assessment or other governmental charge described in the Securities of such series. If any such withholding shall be
required, then such Officer&#8217;s Certificate shall specify by country the amount, if any, required to be withheld on such payments to such Holders of Securities, and the Company agrees to pay to the Trustee or such Paying Agent the Additional
Amounts required by the terms of such Securities. The Company covenants to indemnify the Trustee and any Paying Agent for, and to hold them harmless against, any loss, liability or expense reasonably incurred without negligence or bad faith on their
part arising out of or in connection with actions taken or omitted by any of them in reliance on any Officer&#8217;s Certificate furnished pursuant to this Section&nbsp;10.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.5 <U>Waiver of Certain Covenants</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may omit in any particular instance to comply with any term, provision or condition specified pursuant to Section&nbsp;3.1 with
respect to the Securities of any series if the Company shall have obtained or filed with the Trustee, prior to the time of such failure or omission, evidence (as described in Section&nbsp;1.4) of the consent of the Holders of a majority in aggregate
principal amount of the Outstanding Securities of such series, by Act of such Holders, either waiving such compliance in such instance or generally waiving compliance with such term, provision or condition, but no such waiver shall extend to or
affect such term, provision or condition except to the extent so expressly waived, and, until such waiver shall become effective in accordance with Section&nbsp;9.5, the obligations of the Company and the duties of the Trustee in respect of any such
term, provision or condition shall remain in full force and effect. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 11 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REDEMPTION OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.1 <U>Applicability of Article</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Redemption of Securities of any series at the option of the Company as permitted or required by the terms of such Securities shall be made in
accordance with the terms of such Securities and (except as otherwise provided herein or pursuant hereto) this Article 11. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.2 <U>Election to Redeem; Notice to Trustee</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The election of the Company to optionally redeem any Securities shall be evidenced by or pursuant to a Board Resolution. In case of any
redemption at the election of the Company of the Securities of any series, the Company shall, at least 60 days prior to the Redemption Date fixed by the Company (unless a shorter notice shall be satisfactory to the Trustee), notify the Trustee of
such Redemption Date and of the principal amount of Securities of such series to be redeemed. In the case of any redemption of Securities (a)&nbsp;prior to the expiration of any restriction on such redemption provided in the terms of such Securities
or elsewhere in this Indenture, or (b)&nbsp;pursuant to an election of the Company that is subject to a condition specified in the terms of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Securities or elsewhere in this Indenture, the Company shall furnish the Trustee with an Officer&#8217;s Certificate evidencing compliance with such restriction or condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.3 <U>Selection by Trustee of Securities to Be Redeemed</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated for a particular Series by a Board Resolution, an Officer&#8217;s Certificate or a supplemental indenture hereto, if
less than all of the Securities of any series with the same issue date, interest rate or formula, Stated Maturity and other terms are to be redeemed, the particular Securities to be redeemed shall be selected not more than 60 days prior to the
Redemption Date by the Trustee from the Outstanding Securities of such series not previously called for redemption on a pro rata basis or by lot (whichever is consistent with the Trustee&#8217;s customary practice); provided, however, that no such
partial redemption shall reduce the portion of the principal amount of a Registered Security of such series not redeemed to less than the minimum denomination for a Security of such series established herein or pursuant hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee shall promptly notify the Company and the Security Registrar (if other than itself) in writing of the Securities selected for
redemption and, in the case of any Securities selected for partial redemption, the principal amount thereof to be redeemed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all
purposes of this Indenture, unless the context otherwise requires, all provisions relating to the redemption of Securities shall relate, in the case of any Securities redeemed or to be redeemed only in part, to the portion of the principal of such
Securities that has been or is to be redeemed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in or pursuant to this Indenture or the Securities of any
series, if any Security selected for partial redemption is converted into or exchanged for Common Stock or other securities, cash or other property in part before termination of the conversion or exchange right with respect to the portion of the
Security so selected, the converted portion of such Security shall be deemed (so far as may be) to be the portion selected for redemption. Securities that have been converted or exchanged during a selection of Securities to be redeemed shall be
treated by the Trustee as Outstanding for the purpose of such selection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.4 <U>Notice of Redemption</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption shall be given in the manner provided in Section&nbsp;1.6, not less than 10 nor more than 60 days prior to the Redemption
Date, unless a shorter period is specified in the Securities to be redeemed, to the Holders of Securities to be redeemed. Failure to give notice by transmitting in the manner herein provided to the Holder of any Registered Securities designated for
redemption as a whole or in part, or any defect in the notice to any such Holder, shall not affect the validity of the proceedings for the redemption of any other Securities or portion thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice that is transmitted to the Holder of any Registered Securities in the manner herein provided shall be conclusively presumed to have
been duly given, whether or not such Holder receives the notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices of redemption shall state: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Redemption Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Redemption Price or if not then ascertainable, the manner of calculation thereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if less than all Outstanding Securities of any series are to be redeemed, the identification (and, in the case of partial redemption, the
principal amount) of the particular Security or Securities to be redeemed; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) in case any Security is to be redeemed in part only, the
notice which relates to such Security shall state that on and after the Redemption Date, upon surrender of such Security, the Holder of such Security will receive, without charge, a new Security or Securities of authorized denominations for the
principal amount thereof remaining unredeemed; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) that, on the Redemption Date, the Redemption Price shall become due and payable upon
each such Security or portion thereof to be redeemed, and, if applicable, that interest thereon shall cease to accrue on and after said date, subject to such conditions as may be specified pursuant to Section&nbsp;3.1 with respect to such Security;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) the place or places where such Securities are to be surrendered for payment of the Redemption Price and any accrued interest and
Additional Amounts pertaining thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) that the redemption is for a sinking fund, if such is the case; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) in the case of Securities of any series that are convertible or exchangeable into Common Stock or other securities, cash or other property,
the conversion or exchange price or rate, the date or dates on which the right to convert or exchange the principal of the Securities of such series to be redeemed will commence or terminate and the place or places where such Securities may be
surrendered for conversion or exchange; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) the CUSIP number (or any other numbers used by a Depositary to identify such Securities).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A notice of redemption published as contemplated by Section&nbsp;1.6 need not identify particular Registered Securities to be redeemed.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption of Securities to be redeemed at the election of the Company shall be given by the Company or, upon Company Request,
by the Trustee in the name and at the expense of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.5 <U>Deposit of Redemption Price</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to 10:00 a.m., New York City time, on any Redemption Date, the Company shall deposit, with respect to the Securities of any series
called for redemption pursuant to Section&nbsp;11.4, with the Trustee or with a Paying Agent (or, if the Company is acting as its own Paying Agent, segregate and hold in trust as provided in Section&nbsp;10.3) an amount of money in the applicable
Currency sufficient to pay the Redemption Price of, and (except if the Redemption Date shall be an Interest Payment Date, unless otherwise specified pursuant to Section&nbsp;3.1 or in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Securities of such series) any accrued interest on and Additional Amounts with respect to such accrued interest, all such Securities or portions thereof which are to be redeemed on that date.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.6 <U>Securities Payable on Redemption Date</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption having been given as aforesaid and all conditions specified pursuant to Section&nbsp;3.1 having been satisfied, the
Securities so to be redeemed shall, on the Redemption Date, become due and payable at the Redemption Price therein specified, and from and after such date (unless the Company shall default in the payment of the Redemption Price and accrued interest)
such Securities shall cease to bear interest. Upon surrender of any such Security for redemption in accordance with said notice, such Security shall be paid by the Company at the Redemption Price, together with any accrued interest and Additional
Amounts to the Redemption Date; provided, however, that, except as otherwise specified in or pursuant to this Indenture or the Registered Securities of such series, installments of interest on Registered Securities whose Stated Maturity is on or
prior to the Redemption Date shall be payable to the Holders of such Securities, or one or more Predecessor Securities, registered as such at the close of business on the Regular Record Dates therefor according to their terms and the provisions of
Section&nbsp;3.7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in or pursuant to this Indenture or the Securities of any series, if any Security called for
redemption shall not be so paid upon surrender thereof for redemption, the principal and any premium, until paid, shall bear interest from the Redemption Date at the rate prescribed therefor in the Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.7 <U>Securities Redeemed in Part</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Registered Security which is to be redeemed only in part shall be surrendered at any Office or Agency for such Security (with, if the
Company or the Trustee so requires, due endorsement by, or a written instrument of transfer in form satisfactory to the Company and the Trustee duly executed by, the Holder thereof or his attorney duly authorized in writing) and the Company shall
execute and the Trustee shall authenticate and deliver to the Holder of such Security without service charge, a new Registered Security or Securities of the same series, containing identical terms and provisions, of any authorized denomination as
requested by such Holder in aggregate principal amount equal to and in exchange for the unredeemed portion of the principal amount of the Security so surrendered. If a Global Security is so surrendered, the Company shall execute, and the Trustee
shall authenticate and deliver to or on behalf of the U.S. Depositary or other Depositary for such Global Security as shall be specified in the Company Order with respect thereto to the Trustee, without service charge, a new Global Security in a
denomination equal to and in exchange for the unredeemed portion of the principal of the Global Security so surrendered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.8 <U>Repurchases on the Open Market</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company or any Affiliate of the Company may at any time or from time to time repurchase any of the Securities in the open market or
otherwise. Such Securities may, at the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
option of the Company or the relevant Affiliate of the Company, be held, resold or surrendered to the Trustee for cancellation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 12 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SINKING
FUNDS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.1 <U>Applicability of Article</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of this Article 12 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise
permitted or required in or pursuant to this Indenture or any Security of such series issued pursuant to this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The minimum
amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a &#8220;mandatory sinking fund payment,&#8221; and any payment in excess of such minimum amount provided for by the terms of
Securities of such series is herein referred to as an &#8220;optional sinking fund payment.&#8221; If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in
Section&nbsp;12.2. Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms of Securities of such series and this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.2 <U>Satisfaction of Sinking Fund Payments with Securities</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may, in satisfaction of all or any part of any sinking fund payment with respect to the Securities of any series to be made
pursuant to the terms of such Securities (1)&nbsp;deliver Outstanding Securities of such series (other than any of such Securities previously called for redemption or any of such Securities in respect of which cash shall have been released to the
Company) and (2)&nbsp;apply as a credit Securities of such series which have been redeemed either at the election of the Company pursuant to the terms of such series of Securities or through the application of permitted optional sinking fund
payments pursuant to the terms of such Securities, provided that such Securities have not been previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the Redemption Price specified in such
Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly. If as a result of the delivery or credit of Securities of any series in lieu of cash payments pursuant to this
Section&nbsp;12.2, the principal amount of Securities of such series to be redeemed in order to satisfy the remaining sinking fund payment shall be less than $100,000, the Trustee need not call Securities of such series for redemption, except upon
Company Request, and such cash payment shall be held by the Trustee or a Paying Agent and applied to the next succeeding sinking fund payment, provided, however, that the Trustee or such Paying Agent shall at the request of the Company from time to
time pay over and deliver to the Company any cash payment so being held by the Trustee or such Paying Agent upon delivery by the Company to the Trustee of Securities of that series purchased by the Company having an unpaid principal amount equal to
the cash payment requested to be released to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.3 <U>Redemption of Securities for Sinking Fund</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not less than 60 days (unless otherwise indicated in the Board Resolution, Officer&#8217;s Certificate or supplemental indenture in respect of
a particular series of Securities) prior to each sinking fund payment date for any series of Securities, the Company shall deliver to the Trustee an Officer&#8217;s Certificate specifying the amount of the next ensuing mandatory sinking fund payment
for that series pursuant to the terms of that series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting of Securities of that series
pursuant to Section&nbsp;12.2, and the basis for such credit and the optional amount, if any, to be added in cash to the next ensuing mandatory sinking fund payment, and will also deliver to the Trustee any Securities to be so credited and not
theretofore delivered. If such Officer&#8217;s Certificate shall specify an optional amount to be added in cash to the next ensuing mandatory sinking fund payment, the Company shall thereupon be obligated to pay the amount therein specified. Not
less than 30 days (unless otherwise indicated in the Board Resolution, Officer&#8217;s Certificate or supplemental indenture in respect of a particular series of Securities) before each such sinking fund payment date the Trustee shall select the
Securities to be redeemed upon such sinking fund payment date in the manner specified in Section&nbsp;11.3 and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in
Section&nbsp;11.4. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Section&nbsp;11.6 and Section&nbsp;11.7. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 13 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPAYMENT
AT THE OPTION OF HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13.1 <U>Applicability of Article</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities of any series which are repayable at the option of the Holders thereof before their Stated Maturity shall be repaid in accordance
with the terms of the Securities of such series. The repayment of any principal amount of Securities pursuant to such option of the Holder to require repayment of Securities before their Stated Maturity, for purposes of Section&nbsp;3.9, shall not
operate as a payment, redemption or satisfaction of the indebtedness represented by such Securities unless and until the Company, at its option, shall deliver or surrender the same to the Trustee with a directive that such Securities be cancelled.
Notwithstanding anything to the contrary contained in this Section&nbsp;13.1, in connection with any repayment of Securities, the Company may arrange for the purchase of any Securities by an agreement with one or more investment bankers or other
purchasers to purchase such Securities by paying to the Holders of such Securities on or before the close of business on the repayment date an amount not less than the repayment price payable by the Company on repayment of such Securities, and the
obligation of the Company to pay the repayment price of such Securities shall be satisfied and discharged to the extent such payment is so paid by such purchasers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 14 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES IN FOREIGN CURRENCIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14.1 <U>Applicability of Article</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever this Indenture provides for (i)&nbsp;any action by, or the determination of any of the rights of, Holders of Securities of any series
in which not all of such Securities are denominated in the same Currency, or (ii)&nbsp;any distribution to Holders of Securities, in the absence of any provision to the contrary pursuant to this Indenture or the Securities of any particular series,
any amount in respect of any Security denominated in a Foreign Currency shall be treated for any such action or distribution as that amount of Dollars that could be obtained for such amount on such reasonable basis of exchange and as of the record
date with respect to Registered Securities of such series (if any) for such action, determination of rights or distribution (or, if there shall be no applicable record date, such other date reasonably proximate to the date of such action,
determination of rights or distribution) as the Company may specify in a written notice to the Trustee or, in the absence of such written notice, as the Trustee may determine. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 15 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEETINGS OF
HOLDERS OF SECURITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.1 <U>Purposes for Which Meetings May Be Called</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A meeting of Holders of Securities of any series may be called at any time and from time to time pursuant to this Article 15 to make, give or
take any request, demand, authorization, direction, notice, consent, waiver or other Act provided by this Indenture to be made, given or taken by Holders of Securities of such series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.2 <U>Call, Notice and Place of Meetings</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) The Trustee may at any time call a meeting of Holders of Securities of any series for any purpose specified in Section&nbsp;15.1, to be
held at such time and at such place in the Borough of Manhattan, The City of New York as the Trustee may select and as shall be acceptable to the Company. Notice of every meeting of Holders of Securities of any series, setting forth the time and the
place of such meeting and in general terms the action proposed to be taken at such meeting, shall be given, in the manner provided in Section&nbsp;1.6, not less than 21&nbsp;nor more than 180 days prior to the date fixed for the meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) In case at any time the Company (by or pursuant to a Board Resolution) or the Holders of at least 25% in principal amount of the
Outstanding Securities of any series shall have requested the Trustee to call a meeting of the Holders of Securities of such series for any purpose specified in Section&nbsp;15.1, by written request setting forth in reasonable detail the action
proposed to be taken at the meeting, and the Trustee shall not have transmitted notice of such meeting within 21 days after receipt of such request or shall not thereafter proceed to cause the meeting to be held as provided herein, then the Company
or the Holders of Securities of such series in the amount above specified, as the case may be, may determine the time and the place in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Borough of Manhattan, The City of New York for such meeting and may call such meeting for such purposes by giving notice thereof as provided in clause (1)&nbsp;of this Section&nbsp;15.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.3 <U>Persons Entitled to Vote at Meetings</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be entitled to vote at any meeting of Holders of Securities of any series, a Person shall be (1)&nbsp;a Holder of one or more Outstanding
Securities of such series, or (2)&nbsp;a Person appointed by an instrument in writing as proxy for a Holder or Holders of one or more Outstanding Securities of such series by such Holder or Holders. The only Persons who shall be entitled to be
present or to speak at any meeting of Holders of Securities of any series shall be the Persons entitled to vote at such meeting and their counsel, any representatives of the Trustee and its counsel and any representatives of the Company and its
counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.4 <U>Quorum; Action</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Persons entitled to vote a majority in principal amount of the Outstanding Securities of a series shall constitute a quorum for a meeting
of Holders of Securities of such series; provided, however, that if any action is to be taken at such meeting with respect to a consent or waiver which this Indenture expressly provides may be given by the Holders of a different percentage in
principal amount of the Outstanding Securities of a series, the Persons entitled to vote such percentage in principal amount of the Outstanding Securities of such series shall constitute a quorum. In the absence of a quorum within 30 minutes after
the time appointed for any such meeting, the meeting shall, if convened at the request of Holders of Securities of such series, be dissolved. In any other case the meeting may be adjourned for a period of not less than 10 days as determined by the
chairman of the meeting prior to the adjournment of such meeting. In the absence of a quorum at any such adjourned meeting, such adjourned meeting may be further adjourned for a period of not less than 10 days as determined by the chairman of the
meeting prior to the adjournment of such adjourned meeting. Notice of the reconvening of any adjourned meeting shall be given as provided in Section&nbsp;15.2(1), except that such notice need be given only once not less than five days prior to the
date on which the meeting is scheduled to be reconvened. Notice of the reconvening of an adjourned meeting shall state expressly the percentage, as provided above, of the principal amount of the Outstanding Securities of such series which shall
constitute a quorum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as limited by the proviso to Section&nbsp;9.2, any resolution presented to a meeting or adjourned meeting
duly reconvened at which a quorum is present as aforesaid may be adopted only by the affirmative vote of the Holders of a majority in principal amount of the Outstanding Securities of that series; provided, however, that, except as limited by the
proviso to Section&nbsp;9.2, any resolution with respect to any consent or waiver which this Indenture or any supplemental indenture expressly provides may be given by the Holders of at least <FONT STYLE="white-space:nowrap">66-2/3%</FONT> in
principal amount of the Outstanding Securities of a series may be adopted at a meeting or an adjourned meeting duly convened and at which a quorum is present as aforesaid only by the affirmative vote of the Holders of
<FONT STYLE="white-space:nowrap">66-2/3%</FONT> in principal amount of the Outstanding Securities of that series; and provided, further, that, except as limited by the proviso to Section&nbsp;9.2, any resolution with respect to any request, demand,
authorization, direction, notice, consent, waiver or other Act which this Indenture or any supplemental indenture expressly provides may be made, given or taken by the Holders of a different specified percentage, which is less than a majority, in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
principal amount of the Outstanding Securities of a series, may be adopted at a meeting or an adjourned meeting duly reconvened and at which a quorum is present as aforesaid by the affirmative
vote of the Holders of such specified percentage in principal amount of the Outstanding Securities of such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any resolution passed
or decision taken at any meeting of Holders of Securities of any series duly held in accordance with this Section&nbsp;15.4 shall be binding on all the Holders of Securities of such series, whether or not such Holders were present or represented at
the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.5 <U>Determination of Voting Rights; Conduct and Adjournment of Meetings</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Notwithstanding any other provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any
meeting of Holders of Securities of such series in regard to proof of the holding of Securities of such series and of the appointment of proxies and in regard to the appointment and duties of inspectors of votes, the submission and examination of
proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall deem appropriate. Except as otherwise permitted or required by any such regulations, the holding of Securities
shall be proved in the manner specified in Section&nbsp;1.4 and the appointment of any proxy shall be proved in the manner specified in Section&nbsp;1.4. Such regulations may provide that written instruments appointing proxies, regular on their
face, may be presumed valid and genuine without the proof specified in Section&nbsp;1.4 or other proof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) The Trustee shall, by an
instrument in writing, appoint a temporary chairman of the meeting, unless the meeting shall have been called by the Company or by Holders of Securities as provided in Section&nbsp;15.2(2), in which case the Company or the Holders of Securities of
the series calling the meeting, as the case may be, shall in like manner appoint a temporary chairman. A permanent chairman and a permanent secretary of the meeting shall be elected by vote of the Persons entitled to vote a majority in principal
amount of the Outstanding Securities of such series represented at the meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) At any meeting, each Holder of a Security of such
series or proxy shall be entitled to one vote for each $1,000 principal amount of Securities of such series held or represented by him; provided, however, that no vote shall be cast or counted at any meeting in respect of any Security challenged as
not Outstanding and ruled by the chairman of the meeting to be not Outstanding. The chairman of the meeting shall have no right to vote, except as a Holder of a Security of such series or proxy. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Any meeting of Holders of Securities of any series duly called pursuant to Section&nbsp;15.2 at which a quorum is present may be adjourned
from time to time by Persons entitled to vote a majority in principal amount of the Outstanding Securities of such series represented at the meeting; and the meeting may be held as so adjourned without further notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.6 <U>Counting Votes and Recording Action of Meetings</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The vote upon any resolution submitted to any meeting of Holders of Securities of any series shall be by written ballots on which shall be
subscribed the signatures of the Holders of Securities of such series or of their representatives by proxy and the principal amounts and serial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
numbers of the Outstanding Securities of such series held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the
meeting for or against any resolution and who shall make and file with the permanent secretary of the meeting their verified written reports in triplicate of all votes cast at the meeting. A record, at least in triplicate, of the proceedings of each
meeting of Holders of Securities of any series shall be prepared by the permanent secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits
by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that said notice was given as provided in Section&nbsp;15.2 and, if applicable, Section&nbsp;15.4. Each copy shall be signed and
verified by the affidavits of the permanent chairman and secretary of the meeting and one such copy shall be delivered to the Company, and another to the Trustee to be preserved by the Trustee, the latter to have attached thereto the ballots voted
at the meeting. Any record so signed and verified shall be conclusive evidence of the matters therein stated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page
Intentionally Left Blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of
the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BIOATLA, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>____________________</B>,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">as Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d31173dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g31173g0116091810846.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">January&nbsp;16, 2026</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Orrick, Herrington&nbsp;&amp; Sutcliffe LLP</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Orrick Building</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">405 Howard
Street</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">San Francisco, CA 94105-2669</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-415-773-5700</FONT></FONT></FONT></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BioAtla, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11085 Torreyana Road</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>orrick.com</B></P></TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">BioAtla, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At your request, we have examined the
Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (the &#8220;Registration Statement&#8221;), filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) relating to the offering from time to time,
pursuant to Rule 415 of the General Rules and Regulations of the Commission promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), by BioAtla, Inc., a Delaware corporation (the &#8220;Company&#8221;), of the
following securities in an indeterminate amount: (i)&nbsp;common stock of the Company, $0.0001 par value per share (&#8220;Common Stock&#8221;), including Common Stock that may be issued upon conversion of the Debt Securities (as defined below) or
the exercise of Warrants (as defined below); (ii) preferred stock of the Company, $0.0001 par value per share (&#8220;Preferred Stock&#8221;), including Preferred Stock that may be issued upon conversion of the Debt Securities or the exercise of
Warrants; (iii)&nbsp;debt securities of the Company which may be senior or subordinated, and which may be issued in one or more series (&#8220;Debt Securities&#8221;); (iv) warrants to purchase Common Stock, Preferred Stock or Debt Securities or
other securities, currencies or commodities (&#8220;Warrants&#8221;); and (v)&nbsp;units consisting of Common Stock, Preferred Stock, Debt Securities or Warrants, in any combination (&#8220;Units&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offering of Common Stock, Preferred Stock, Debt Securities, Warrants and Units (collectively, the &#8220;Securities&#8221;) will be as set forth in the
prospectus contained in the Registration Statement (the &#8220;Prospectus&#8221;), as supplemented by one or more supplements to the Prospectus (each, a &#8220;Prospectus Supplement&#8221;). The Debt Securities will be issued pursuant to an
indenture between the Company and a trustee to be appointed in the future (a &#8220;Trustee&#8221;) in the form filed as Exhibit 4.6 to the Registration Statement, as such indenture may be supplemented from time to time (the
&#8220;Indenture&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have examined the originals, or copies identified to our satisfaction, of such corporate records of the Company,
certificates of public officials, officers of the Company and other persons, and such other documents, agreements and instruments as we have deemed relevant and necessary for the basis of our opinions hereinafter expressed. In such examination, we
have assumed the following: (a)&nbsp;the authenticity of original documents and the genuineness of all signatures; (b)&nbsp;the conformity to the originals of all documents submitted to us as copies; (c)&nbsp;the legal competence of all signatories
to such documents; and (d)&nbsp;the truth, accuracy and completeness of the information, representations and warranties contained in the records, documents, instruments and certificates we have reviewed. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g31173g0116091810846.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BioAtla, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January 16,
2026 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on and subject to the foregoing, and assuming that: (i)&nbsp;the Registration Statement and any
amendments thereto (including post-effective amendments) will have become effective and comply with all applicable laws; (ii)&nbsp;the Registration Statement will be effective and will comply with all applicable laws at the time the Securities are
offered or issued as contemplated by the Registration Statement; (iii)&nbsp;one or more Prospectus Supplements will have been prepared and filed with the Commission describing the Securities offered thereby and will comply with all applicable laws;
(iv)&nbsp;the Board of Directors of the Company, or a duly authorized committee thereof, shall have taken such action as may be necessary to authorize the issuance and sale of such Securities, and if applicable, establish the relative rights and
preferences of such Securities, or other terms of such Securities, in each case as set forth in or contemplated by the Registration Statement and any Prospectus Supplements relating to such Securities; (v)&nbsp;all Securities will be issued and sold
in compliance with applicable federal and state securities laws and in the manner stated in the Registration Statement and the appropriate Prospectus Supplement; (vi)&nbsp;a definitive purchase, underwriting or similar agreement with respect to any
Securities offered or issued will have been duly authorized and validly executed and delivered by the Company and the other parties thereto; (vii)&nbsp;any Securities issuable upon conversion, exchange or exercise of any Security being offered or
issued will be duly authorized, created and, if appropriate, reserved for issuance upon such conversion, exchange or exercise; (viii)&nbsp;there shall not have occurred any change in law affecting the legality or enforceability of such Security; and
(ix)&nbsp;none of the terms of any Security to be established subsequent to the date hereof, nor the issuance and delivery of such Security, nor the compliance by the Company with the terms thereof, will violate any applicable law or will result in
a violation of any provision of any instrument or agreement then binding upon the Company, or any restriction imposed by any court or governmental body having jurisdiction over the Company; we are of opinion that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. The Common Stock will be validly issued, fully paid and nonassessable at such time as: (a)&nbsp;the terms of the issuance and sale of the Common Stock have
been duly authorized by appropriate action of the Company; and (b)&nbsp;the Common Stock has been duly issued and sold as contemplated by the Registration Statement, the Prospectus and any Prospectus Supplement relating thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. The Preferred Stock will be validly issued, fully paid and nonassessable at such time as: (a)&nbsp;the terms of the issuance and sale of the Preferred
Stock have been duly authorized by appropriate action of the Company; (b)&nbsp;a statement with respect to the shares establishing the Preferred Stock shall have been filed with the Secretary of State of the State of Delaware in the form and manner
required by law; and (c)&nbsp;the Preferred Stock has been duly issued and sold as contemplated by the Registration Statement, the Prospectus and any Prospectus Supplement relating thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. The Debt Securities (including any Debt Securities duly issued upon the exchange or conversion of any Debt Securities that are exchangeable or convertible
into another series of Debt Securities) will constitute valid and binding obligations of the Company at such time as: (a)&nbsp;the Indenture, in substantially the form filed as an exhibit to the Registration Statement, has been duly authorized,
executed and delivered by the Company and the Trustee; (b)&nbsp;the Trustee is qualified to act as trustee under the Indenture; (c)&nbsp;the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g31173g0116091810846.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BioAtla, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January 16,
2026 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
forms and the terms of the Debt Securities and their issuance and sale have been approved by appropriate action of the Company, and the Debt Securities have been duly executed and delivered by
the Company and authenticated by the Trustee, in accordance with the Indenture or a supplemental indenture thereto; (d)&nbsp;the Indenture has been duly qualified under the Trust Indenture Act of 1939, as amended; and (e)&nbsp;the Debt Securities
have been issued and sold as contemplated by the Registration Statement, the Prospectus and any Prospectus Supplement relating thereto and the Indenture or a supplemental indenture thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. The Warrants will constitute valid and binding obligations of the Company at such time as: (a)&nbsp;the warrant agreement relating to the Warrants has been
duly authorized, executed and delivered by the Company and the applicable warrant agent; (b)&nbsp;the forms and the terms of the Warrants and their issuance and sale have been approved by appropriate action of the Company, and the Warrants have been
duly executed and delivered by the Company and authenticated by the applicable warrant agent in accordance with the applicable warrant agreement; and (c)&nbsp;the Warrants have been issued and sold as contemplated by the Registration Statement, the
Prospectus and any Prospectus Supplement relating thereto and the applicable warrant agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Units will constitute valid and binding
obligations of the Company at such time as: (a)&nbsp;the terms of the Units (including the Securities underlying the Units) and their issuance and sale have been approved by appropriate action of the Company, and the Units (and the Securities
underlying the Units) have been duly executed and delivered by the Company and authenticated by the applicable units agent in accordance with the applicable units agreement; (b)&nbsp;the units agreement relating to the Units has been duly
authorized, executed and delivered by the Company and the applicable units agent; and (c)&nbsp;the Units have been issued and sold as contemplated by the Registration Statement, the Prospectus and any Prospectus Supplement relating thereto and the
applicable units agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinions set forth in paragraphs (3)&nbsp;through (5) above are subject, as to enforcement, to (a)&nbsp;the effect of
bankruptcy, insolvency, liquidation, receivership, moratorium, reorganization, fraudulent conveyance or similar laws relating to or affecting the rights of creditors generally; (b)&nbsp;general principles of equity, including, without limitation,
concepts of materiality, reasonableness, good faith, fair dealing, and the rules governing the availability of specific performance or injunctive relief, whether enforcement is sought in a proceeding in equity or at law; and (c)&nbsp;provisions of
law that require that a judgment for money damages rendered by a court in the United States be expressed only in United States dollars. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We express no
opinion as to any laws other than the law of the State of New York with respect to the opinions set forth in paragraphs (3)&nbsp;through (5) above and the General Corporation Law of the State of Delaware (including the statutory provisions, all
applicable provisions of the Delaware constitution and reported judicial decisions interpreting the foregoing) with respect to the opinions set forth in paragraphs (1)&nbsp;and (2) above, and we express no opinion with respect to the applicability
thereto, or the effect thereon, of the laws of any other jurisdiction or, in the case of Delaware, any other laws, or as to any matters of municipal law or the laws of any local agencies within any state. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g31173g0116091810846.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BioAtla, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January 16,
2026 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the reference to us under the heading &#8220;Legal Matters&#8221; in the Prospectus and
to the filing of this opinion as Exhibit 5.1 to the Registration Statement. By giving this consent, we do not admit that we are included in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and
regulations of the Commission promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ ORRICK, HERRINGTON&nbsp;&amp; SUTCLIFFE LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ORRICK,
HERRINGTON&nbsp;&amp; SUTCLIFFE LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>4
<FILENAME>d31173dex52.htm
<DESCRIPTION>EX-5.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g31173g0116091810846.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Orrick,&nbsp;Herrington&nbsp;&amp;&nbsp;Sutcliffe&nbsp;LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Orrick Building</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">405 Howard Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94105-2669</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-415-773-5700</FONT></FONT></FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>orrick.com</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;16, 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BioAtla,
Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11085 Torreyana Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">BioAtla, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Securities Being Registered under Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel for BioAtla,
Inc., a Delaware corporation (the &#8220;Company&#8221;), in connection with the offering by the Company of (i)&nbsp;up to $3.75&nbsp;million of shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common
Stock&#8221;), pursuant to <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements, dated as of November&nbsp;20, 2025 (the <FONT STYLE="white-space:nowrap">&#8220;Pre-Paid</FONT> Advance Agreements&#8221; and such shares of Common
Stock, the &#8220;PPA Shares&#8221;), between the Company and each of YA II PN, Ltd., a Cayman Islands exempt limited company (the &#8220;Yorkville&#8221;), Anson Investments Master Fund LP and Anson East Master Fund LP, and (ii)&nbsp;up to an
aggregate of $15,000,000 of shares of Common Stock pursuant to a Standby Equity Purchase Agreement, dated as of November&nbsp;20, 2025 (the &#8220;Standby Equity Purchase Agreement&#8221; and such shares of Common Stock, the &#8220;SEPA
Shares&#8221;), between the Company and Yorkville, in each case pursuant to a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (the &#8220;Registration Statement&#8221;), filed by the Company with the Securities and
Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), on the date hereof; the base prospectus, which forms a part of and is included in the Registration Statement (the &#8220;Base
Prospectus&#8221;); the prospectus supplement, which forms a part of and is included in the Registration Statement (the &#8220;Prospectus Supplement&#8221;), relating to the issuance and sale of the PPA Shares and the SEPA Shares (collectively, the
&#8220;Shares&#8221;). Except where the context requires otherwise, the Base Prospectus and the Prospectus Supplement are collectively referred to as the &#8220;Prospectus.&#8221; The Shares are to be sold by the Company in the manner described in
the Registration Statement and the Prospectus and in accordance with the terms of the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements and the Standby Equity Purchase Agreement, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with rendering this opinion, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of
(i)&nbsp;the Amended and Restated Certificate of Incorporation of the Company, as amended through the date hereof, (ii)&nbsp;the Amended and Restated Bylaws of the Company, as amended through the date hereof, (iii)&nbsp;certain resolutions of the
Board of Directors of the Company, or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BioAtla, Inc.&#8195; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;16, 2026 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a committee thereof, relating to the issuance, sale and registration of the Shares, (iv)&nbsp;the Registration Statement, (v)&nbsp;the Prospectus and (vi)&nbsp;such corporate records of the
Company, certificates of public officials, officers of the Company and other persons, and such other documents, agreements and instruments as we have deemed relevant and necessary or appropriate as a basis for the opinion set forth below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In our examination, we have assumed the legal capacity of all natural persons, the
genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified or photostatic copies, and the authenticity of
the originals of such copies. In making our examination of documents executed or to be executed, we have assumed that the parties thereto, other than the Company, had or will have the power, corporate or other, to enter into and perform all
obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and the execution and delivery by such parties of such documents and the validity and binding effect thereof on such parties. As to any
facts material to the opinions expressed herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the Company and others and of public officials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and subject to the limitations, qualifications and assumptions set forth herein, and assuming that: (i)&nbsp;the Registration
Statement and any amendments thereto (including post-effective amendments) will have become effective and comply with all applicable laws and (ii)&nbsp;the Registration Statement will be effective and will comply with all applicable laws at the time
the Shares are offered or issued as contemplated by the Registration Statement, we are of the opinion that the Shares have been duly authorized and, upon issuance, delivery and payment therefor in the manner contemplated by the Registration
Statement and the Prospectus and in accordance with the terms of the <FONT STYLE="white-space:nowrap">Pre-Paid</FONT> Advance Agreements and the Standby Equity Purchase Agreement, as applicable, will be validly issued, fully paid and <FONT
STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinion expressed herein is limited to the General Corporation Law of the State of Delaware and the
federal laws of the United States of America, and we express no opinion as to the effect on the matters covered by this letter of the laws of any other jurisdictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the reference to us under the heading &#8220;Legal Matters&#8221; in the Prospectus Supplement and to the filing of this opinion as
Exhibit 5.2 to the Registration Statement. By giving this consent, we do not admit that we are included in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Commission promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ ORRICK,
HERRINGTON&nbsp;&amp; SUTCLIFFE LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ORRICK, HERRINGTON&nbsp;&amp; SUTCLIFFE LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>5
<FILENAME>d31173dex233.htm
<DESCRIPTION>EX-23.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 23.3 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Consent of Independent Registered Public Accounting Firm </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#8220;Experts&#8221; in the Registration Statement (Form
<FONT STYLE="white-space:nowrap">S-3)</FONT> and related Prospectus of BioAtla, Inc. for the registration of common stock, preferred stock, debt securities, warrants and units and to the incorporation by reference therein of our report dated
March&nbsp;27, 2025, with respect to the financial statements of BioAtla, Inc. included in its Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended December&nbsp;31, 2024, filed with the Securities and Exchange
Commission. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Ernst&nbsp;&amp; Young LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">San Diego, California</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">January&nbsp;16, 2026</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>d31173dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025q4">
<head>
<title>EX-FILING FEES</title>
</head>
  <body>
  <div style="display: none"> <ix:header> <ix:hidden> <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-564">S-3</ix:nonNumeric> <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-565">S-3</ix:nonNumeric> <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-566">EX-FILING FEES</ix:nonNumeric> <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-567">0001826892</ix:nonNumeric> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-568">BioAtla, Inc.</ix:nonNumeric> <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"></ix:nonNumeric> <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ix:nonNumeric> <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ix:nonNumeric> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-572">0.0001381</ix:nonFraction> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-573">0.0001381</ix:nonFraction> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_3" id="ixv-574">0.0001381</ix:nonFraction> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_4" id="ixv-575">0.0001381</ix:nonFraction> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-576">0.0001381</ix:nonFraction> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_6" id="ixv-577">0.0001381</ix:nonFraction> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_7" id="ixv-578">0.0001381</ix:nonFraction> </ix:hidden> <ix:references> <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025q4/ffd-2025q4.xsd" xlink:type="simple"/> </ix:references> <ix:resources> <xbrli:context id="rc"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_1"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>1</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_2"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>2</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_3"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>3</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_4"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>4</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_5"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>5</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_6"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>6</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_7"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>7</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_8"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>8</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_9"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>9</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>10</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_11"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>11</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_12"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>12</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_13"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>13</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_14"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>14</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>15</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_16"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001826892</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>16</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-01-16</xbrli:startDate> <xbrli:endDate>2026-01-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> </ix:resources> </ix:header> </div> <div>
<table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
<tr>
<td colspan="4" style="padding-bottom: .5em"> <p> <b>Calculation of Filing Fee Tables</b> </p> </td> </tr>
<tr>
<td style="padding-bottom: .25em"> <p> <b> <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-738">S-3</ix:nonNumeric> </b> </p> </td> </tr>
<tr>
<td style="padding-bottom: .25em"> <p> <b> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-739">BioAtla, Inc.</ix:nonNumeric> </b> </p> </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left; ">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: left; word-wrap: break-word"> <b>Table 1: Newly Registered and Carry Forward Securities</b> </th>
<th style="vertical-align: bottom; word-wrap: break-word; text-align: right;"> <span style="-sec-ix-hidden: hiddenrcOfferingTableNa">&#9744;Not Applicable</span> </th> </tr> </table>
<table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
<tr style="background-color:#9ADAF6">
<th style="width: 12%;">
 </th>
<th style="width: 2%;">
 </th>
<th style="width: 12%;"> <p style="margin: 0pt; text-align: center;"> <b>Security Type</b> </p> </th>
<th style="width: 14%;"> <p style="margin: 0pt; text-align: center;"> <b>Security Class Title </b> </p> </th>
<th style="width: 2%;"> <p style="margin: 0pt; text-align: center;"> <b>Fee Calculation or Carry Forward Rule</b> </p> </th>
<th style="width: 5%;"> <p style="margin: 0pt; text-align: center;"> <b>Amount Registered</b> </p> </th>
<th style="width: 15%;"> <p style="margin: 0pt; text-align: center;"> <b>Proposed Maximum Offering Price Per Unit</b> </p> </th>
<th style="width: 10%;"> <p style="margin: 0pt; text-align: center;"> <b>Maximum Aggregate Offering Price</b> </p> </th>
<th style="width: 5%;"> <p style="margin: 0pt; text-align: center;"> <b>Fee Rate</b> </p> </th>
<th style="width: 6%;"> <p style="margin: 0pt; text-align: center;"> <b>Amount of Registration Fee</b> </p> </th>
<th style="width: 1%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward Form Type</b> </p> </th>
<th style="width: 7%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward File Number</b> </p> </th>
<th style="width: 6%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward Initial Effective Date</b> </p> </th>
<th style="width: 7%;"> <p style="margin: 0pt; text-align: center;"> <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b> </p> </th> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Newly Registered Securities</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-740">Equity</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-741">Common Stock, par value $0.0001 per share</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-742">457(o)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_2" id="ixv-743">Equity</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_2" id="ixv-744">Preferred Stock, par value $0.0001 per share</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_2" format="ixt:booleantrue" id="ixv-745">457(o)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_3" id="ixv-746">Debt</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_3" id="ixv-747">Debt Securities</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_3" format="ixt:booleantrue" id="ixv-748">457(o)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_4" id="ixv-749">Debt Convertible into Equity</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_4" id="ixv-750">Debt Securities</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_4" format="ixt:booleantrue" id="ixv-751">457(o)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_5" id="ixv-752">Non-Convertible Debt</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_5" id="ixv-753">Debt Securities</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_5" format="ixt:booleantrue" id="ixv-754">457(o)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_6" id="ixv-755">Other</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_6" id="ixv-756">Warrants</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_6" format="ixt:booleantrue" id="ixv-757">457(o)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_7" id="ixv-758">Other</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_7" id="ixv-759">Units</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_7" format="ixt:booleantrue" id="ixv-760">457(o)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_8" format="ixt:booleanfalse" id="ixv-761">Fees to be Paid</ix:nonNumeric> </td>
<td style="text-align: center;"> 1 </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_8" id="ixv-762">Unallocated (Universal) Shelf</ix:nonNumeric> </td>
<td style="text-align: left;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_8" format="ixt:booleantrue" id="ixv-763">457(o)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-764">4,050,000.00</ix:nonFraction> </td>
<td style="text-align: right;"> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-765">0.0001381</ix:nonFraction> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-766">559.30</ix:nonFraction> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fees Previously Paid </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Carry Forward Securities</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_9" id="ixv-767">Equity</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_9" id="ixv-768">Common Stock, par value $0.0001 per share</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_9" format="ixt:booleantrue" id="ixv-769">415(a)(6)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_9" id="ixv-770">S-3</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_9" id="ixv-771">333-269148</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_9" id="ixv-772">01/17/2023</ix:nonNumeric> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_10" id="ixv-773">Equity</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_10" id="ixv-774">Preferred Stock, par value $0.0001 per share</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_10" format="ixt:booleantrue" id="ixv-775">415(a)(6)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_10" id="ixv-776">S-3</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_10" id="ixv-777">333-269148</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_10" id="ixv-778">01/17/2023</ix:nonNumeric> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_11" id="ixv-779">Debt</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_11" id="ixv-780">Debt Securities</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_11" format="ixt:booleantrue" id="ixv-781">415(a)(6)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_11" id="ixv-782">S-3</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_11" id="ixv-783">333-269148</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_11" id="ixv-784">01/17/2023</ix:nonNumeric> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_12" id="ixv-785">Debt Convertible into Equity</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_12" id="ixv-786">Debt Securities</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_12" format="ixt:booleantrue" id="ixv-787">415(a)(6)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_12" id="ixv-788">S-3</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_12" id="ixv-789">333-269148</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_12" id="ixv-790">01/17/2023</ix:nonNumeric> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_13" id="ixv-791">Non-Convertible Debt</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_13" id="ixv-792">Debt Securities</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_13" format="ixt:booleantrue" id="ixv-793">415(a)(6)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_13" id="ixv-794">S-3</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_13" id="ixv-795">333-269148</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_13" id="ixv-796">01/17/2023</ix:nonNumeric> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_14" id="ixv-797">Other</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_14" id="ixv-798">Warrants</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_14" format="ixt:booleantrue" id="ixv-799">415(a)(6)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_14" id="ixv-800">S-3</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_14" id="ixv-801">333-269148</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_14" id="ixv-802">01/17/2023</ix:nonNumeric> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> <span style="text-indent: 0px; display:inline-block; padding-left: 20px;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_15" id="ixv-803">Other</ix:nonNumeric> </span> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_15" id="ixv-804">Units</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_15" format="ixt:booleantrue" id="ixv-805">415(a)(6)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_15" id="ixv-806">S-3</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_15" id="ixv-807">333-269148</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_15" id="ixv-808">01/17/2023</ix:nonNumeric> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> 2 </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_16" id="ixv-809">Unallocated (Universal) Shelf</ix:nonNumeric> </td>
<td style="text-align: left;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_16" format="ixt:booleantrue" id="ixv-810">415(a)(6)</ix:nonNumeric> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_16" id="ixv-811">195,950,000.00</ix:nonFraction> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_16" id="ixv-812">S-3</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_16" id="ixv-813">333-269148</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_16" id="ixv-814">01/17/2023</ix:nonNumeric> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:CfwdPrevslyPdFee" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_16" id="ixv-815">21,593.69</ix:nonFraction> </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p> </td>
<td>
 </td>
<td style="vertical-align: top; width: 16%;"> <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-816">200,000,000.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td style="vertical-align: top; border-bottom: 1px black; width: 16%;"> <p id="TotalFeeAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-817">559.30</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Total Fees Previously Paid: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-818">0.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Total Fee Offsets: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-819">0.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Net Fee Due: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="NetFeeAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-820">559.30</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr> </table> </div> <div>
<table style="width: 100%; text-indent: 0px;"> <tbody>
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td> <p style="margin:0pt;text-align:left; margin-bottom: 5px;"> <b>Offering Note</b> </p> </td>
<td/> </tr> </tbody> </table> </div> <div style="padding-bottom: 20px;">
<table style="width: 100%; text-indent: 0px;">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td style="width:10pt;"> <p style="margin:0pt;text-align:left;"> <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup> </p> </td>
<td colspan="7" style="white-space: pre-line;"> <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_8" id="ixv-821">(1) BioAtla, Inc. (the "Registrant") is registering under this registration statement such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock, and such indeterminate number of units as may be sold by the Registrant from time to time, which together shall have an aggregate initial offering price not to exceed $200,000,000. If the Registrant issues any debt securities at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $200,000,000, less the aggregate dollar amount of all securities previously issued hereunder. The Registrant may sell any securities the Registrant is registering under this registration statement separately or as units with one or more of the other securities the Registrant is registering under this registration statement. The Registrant will determine, from time to time, the proposed maximum offering price per unit in connection with its issuance of the securities the Registrant is registering under this registration statement. The securities the Registrant is registering under this registration statement also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as the Registrant may issue upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares the Registrant is registering under this registration statement include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares the Registrant is registering as a result of stock splits, stock dividends or similar transactions. (2) The proposed maximum offering price per security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b of the Instructions to the Calculation of Filing Fee Tables and Related Disclosure of Form S-3. (3) Calculated pursuant to Rule 457(o) under the Securities Act based on the proposed maximum aggregate offering price of all securities listed.</ix:nonNumeric> </td> </tr>
<tr>
<td colspan="7"> <hr style="width:100%;text-align:left;margin-left:0"/> </td> </tr>
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td style="width:10pt;"> <p style="margin:0pt;text-align:left;"> <sup style="vertical-align:top;line-height:120%;font-size:10px">2</sup> </p> </td>
<td colspan="7" style="white-space: pre-line;"> <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_16" id="ixv-822">Pursuant to Rule 415(a)(6) under the Securities Act, securities with a maximum aggregate price of $195,950,000 registered hereunder are unsold securities (the "Unsold Securities") previously covered by the Registrant's registration statement on Form S-3 (File No. 333-269148), which became effective on January 17, 2023 (the "Prior Registration Statement"), and are included in this registration statement. The Registrant paid a filing fee of $21,593.69 (calculated at the filing fee rate in effect at the time of the filing of the Prior Registration Statement) relating to the Unsold Securities under the Prior Registration Statement, and no additional filing fee is due with respect to the Unsold Securities in connection with the filing of this registration statement. During the grace period afforded by Rule 415(a)(5) under the Securities Act, the Registrant may continue to offer and sell under the Prior Registration Statement the Unsold Securities being registered hereunder. To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the Registrant sells any Unsold Securities under the Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this registration statement the updated number of Unsold Securities from the Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6) and the updated amount of new securities to be registered on this registration statement. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement.</ix:nonNumeric> </td> </tr>
<tr>
<td colspan="7"> <hr style="width:100%;text-align:left;margin-left:0"/> </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left; ">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: left; word-wrap: break-word"> <b>Table 2: Fee Offset Claims and Sources</b> </th>
<th style="vertical-align: bottom; word-wrap: break-word; text-align: right;"> <span style="-sec-ix-hidden: hiddenrcOffsetTableNa">&#9745;Not Applicable</span> </th> </tr> </table>
<table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center; border: 1px solid black;">
<tr style="background-color:#9ADAF6">
<th style="width: 10%; text-align: left;">
 </th>
<th style="width: 8%; text-align: left;">
 </th>
<th style="width: 16%;"> Registrant or Filer Name </th>
<th style="width: 6%;"> Form or Filing Type </th>
<th style="width: 7%;"> File Number </th>
<th style="width: 6%;"> Initial Filing Date </th>
<th style="width: 6%;"> Filing Date </th>
<th style="width: 6%;"> Fee Offset Claimed </th>
<th style="width: 6%;"> Security Type Associated with Fee Offset Claimed </th>
<th style="width: 8%;"> Security Title Associated with Fee Offset Claimed </th>
<th style="width: 6%;"> Unsold Securities Associated with Fee Offset Claimed </th>
<th style="width: 9%;"> Unsold Aggregate Offering Amount Associated with Fee Offset Claimed </th>
<th style="width: 6%;"> Fee Paid with Fee Offset Source </th> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Rules 457(b) and 0-11(a)(2)</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fee Offset Claims </td>
<td> N/A </td>
<td style="text-align: left;"> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: left;"> N/A </td>
<td style="text-align: left;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fee Offset Sources </td>
<td> N/A </td>
<td style="text-align: left;"> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: left;"> N/A </td>
<td style="text-align: left;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Rule 457(p)</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fee Offset Claims </td>
<td> N/A </td>
<td style="text-align: left;"> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: left;"> N/A </td>
<td style="text-align: left;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fee Offset Sources </td>
<td> N/A </td>
<td style="text-align: left;"> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: left;"> N/A </td>
<td style="text-align: left;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left; ">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: left; word-wrap: break-word"> <b>Table 3: Combined Prospectuses</b> </th>
<th style="vertical-align: bottom; word-wrap: break-word; text-align: right;"> <span style="-sec-ix-hidden: hiddenrcCombinedProspectusTableNa">&#9745;Not Applicable</span> </th> </tr> </table>
<table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; border: 1px solid black;">
<tr style="background-color:#9ADAF6">
<th style="width: 4%">
 </th>
<th style="width: 14%"> <p style="margin: 0pt; text-align: center;"> <b>Security Type</b> </p> </th>
<th style="width: 25%"> <p style="margin: 0pt; text-align: center;"> <b>Security Class Title</b> </p> </th>
<th style="width: 14%"> <p style="margin: 0pt; text-align: center;"> <b>Amount of Securities Previously Registered</b> </p> </th>
<th style="width: 18%"> <p style="margin: 0pt; text-align: center;"> <b>Maximum Aggregate Offering Price of Securities Previously Registered</b> </p> </th>
<th style="width: 6%"> <p style="margin: 0pt; text-align: center;"> <b>Form Type</b> </p> </th>
<th style="width: 10%"> <p style="margin: 0pt; text-align: center;"> <b>File Number</b> </p> </th>
<th style="width: 8%"> <p style="margin: 0pt; text-align: center;"> <b>Initial Effective Date</b> </p> </th> </tr>
<tr style="background-color:#E7E7E2;">
<td style="text-align: center;"> N/A </td>
<td> N/A </td>
<td> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: right;"> N/A </td>
<td style="text-align: center;"> N/A </td>
<td style="text-align: center;"> N/A </td>
<td style="text-align: center;"> N/A </td> </tr> </table> </div> </body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g31173g0116091810846.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g31173g0116091810846.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !* (0# 2(  A$! Q$!_\0
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M@D.@>*9!A@",CKV]C7-IX2UW2W8:;?0RPMUCD& WU4@BNLT+_D7]-_Z]8O\
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0%1%& JC %.J1B4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g31173g01n31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g31173g01n31.jpg
M_]C_X  02D9)1@ ! 0 #YP/G  #_[1HZ4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &AT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MO^P_^93^4^Z_0K?]A_\ ,@[#J'>$U#O"X\/"==OH=O\ L/\ YD_*==?H5O\
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M,UKR#[3D#GE4/Y4;O]$H/LO_ )D'847'AX4;O]$H/LO_ )E/Y4;O]$H/LO\
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MAWA-0[PN/?E/NOT*W_8?_,GY3[KTHK?]A_\ ,@[#J'>$U#O"X[^4^[?0K?\
M8?\ S*?RGW7Z';_L/_F0=AU#O":AWA<>_*?=?H5O^P_^9/RG77/]BM_V'_S(
M.PAP[PFH=X7'ORGW;Z';_L/_ )E'Y3[M]#M_V'_S(.Q:AWA-0[PN/#PGW7Z'
M;_L/_F3\IUU^AV_[#_YD'8=0[PFH=X7'ORG77Z';_L/_ )D_*==OH=O^P_\
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M*K9X9()#',W2\<PM^MM?+</"!4U5HUNIY,'5IP,8:#S5EX9#2NHZ0M<TU8D
M(!WT8?\ YH.;4MNJJJ/73PE[,XSD+ZFRW  DTSL#_>'Q6\6._57#7#5+%24/
MC3Y97DC?88!Z+W4>$>YMC<);,(VD8RXN&/P0<U>US'N8\8<TX(4>Q?>NJ'5=
M9-4.:&F1Y>0.F5\!WH(YJ4Y)E 0'F@P @YH'?E$1 3HB(').B!,('11W*=L(
M.Y 0;C9.B('J1 @YE 3ELH4CF@(F40 B="HZ(-NX4X@BBC=;KN#-12;#/ZI]
MO/JL'BNP/M$[98?/H9MX9!W'.!OOR"H!NMOX+O':?]BU[#-0U!T@ '+2<#.V
M_)!I_0J0KSBZS"S71T4;PZ%_GLW&0#G PJ/V!  3JA49P@E$3"!T3*="F2@(
M4Z($ )A,;)A ">U,;($$!3T12@A"G)1A!*)CUH@=$"<T""!S4]"G+*=/6@84
M J0G)!"D=43H@!?6EIY:J414["^0\AE?)=&X)OMIMO"]5#4/+*I[2'X:3JW=
MI_B@TV?A^YT\9DEI'-8!DG4WXJL((R#S"ZGX)'U?8SF7+:34XY<,#.&JHXEM
M])=?")%1TI!BF'GEISYWG$_P0:=;[965Y(HX#+CG@@?Q/J7JOM-=0#-9 8@>
M\@_P*Z=X2I/DCAREH*/\W%)G(&_(M/7VE?#P55#KA:ZZ@K/SD7H@';#=.,;>
MU!RI6-#9+A71ZZ6F=(WO#@/XE6MSHZ6S<9B.H'^B-F+RW?9FH[;;JZ\(5ZI;
MK-:V69[Y)(0\. 8=LZ<<_84&DUUOJ:%VFJB,9/>0?X+ZV.U5%XKF4M*,N=S/
M<.]=DX@,9X)G;='-[?L'D G!UZ78Y*G\#E'&+355F/SIF=%GU:6%!17>ELW"
MK!3NA-3<P/.(<<-S@C8[<BM)KJIU9523N#6N><D-  ]P6_4]38+CQ3)3U]&V
M<R.(,SB]IV!Z XZ86!X1.%8;(Z.IH06TSS@M_9/=SST0:1T0(G39 W1.F$0
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MX<N:?6@H1P;PY^ZV?>/^*#@WAS]UL^\?\5?>I$%#Y&\.?NMGWC_BGD;PZ/\
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MLIXA(,:I7ZO1&#TQWA2(WV=KY*X]<WKT7J+0(>/JNHFGCIK*9>R=I)$_K/\
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MY[IME/!J>=<1[0Z_Y;6??_2!]EWP0<;6?I4#W.^"Y!M]:)X-3SKB/:/]_5V
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MHZ9_YO#Y)- ](]5IXZ[*TI+F(;/64?9N+Y].' [##LK5HW#S\->,=^:?:?\
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M/ [\$*U@,#::Z5,U,R65KW%FK.WG%69TQCP\]=[_ -AJX&.;<*6@D\LD\EN
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MX!)(!T\^6V1S5G;;';[=(Z2DIQ&\[9+B[^)5DN=\G-TA]'@/AD<//B9.MO\
M"0B!%R?70 OA7/FCI9#3,URX.D>O&RR B),;C3E=TX9OERJI)ZD$N<20,D@
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M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B#'E](KPO<OI%>
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MW\]#]T$\&QYUP_M/T_MU],87(?+N]_.P_=!;7P;Q:;G(:6X%HJ?U7 8U<SR
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M9MEG:]L[QYKM.QV'7ZUZXAXKHK)<Z*@J ]U15%H8&C/,D?Y+5/#';G0BVW^
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MC1AC:B0 =WGE:I>TZWZN'$\+@K7)&.)B:3'JWCCF[?(O#-96 9< &#VN./\
M-:=PK120>":\UT[RZHKJ&>:1WK$;A_DK#PV!_D:\C]&)H]7WC5D4Y:?!#5EG
MH_)E1C[+UJW6\_*'/#'+PU9C_P!K]?T<T\'7!-MXBL!K:^Y=A+VSF:2[H,?[
MP[U8\$=OP[X39+);ZQU9;RS4XZ1@GLRX;[\B3U5?P%P%'Q'P9/6PU<T5:)7L
MC:" PXQC/FD]5=>!F>AH+G66JX4C(+PS9DKFX<X>>3S.>6.G5<*1_P >FOF^
MKQ.3<9OO<T1TY==OG^CS?Y:[CKCZ>PQ5)@MU+YSL '4!IR>_DX]4XJ\';^&+
M7)>;%<)&STC=;@6\P.NY/J7RLE9%PGX5[@+L>QIZD:(Y7;-).@9R<;<UMWA+
MXMM$?"-=!!6P5$]3&61LBD:X[[Y._+9:B*S%K6[N$WS8\F+'AC[DQ'ITG??:
MGOU_?Q!X$:VND\V<A@=CU5#6_P"2HN$/!]:;OPQ1U]7=NQGFC+G-)]$Y(_:]
M2R/DR>W^ >O-4TLEDT$L((('C((_ JOMW@\-R\']'=K?53>..C,CX7'S"!JR
M!AI.=@I.YF)F-]'3'-<6.]:7Y(YYC??T[+?P2U-;1<4WRRTTYJZ*F#Q$YP !
M(>UN<^P=Z^H\'MRNDM?7<6US8WMWA,9! &3W8]2SO I<;8*"HH_%HZ2ZP$B?
M(#2X -!)WSS]2IN,^,G<5746.UUL-#;\XFJ)GZ <;X)!(YM[NJL<O)'-U<YG
M-/$WC%'+VW.O;U_5>^ J[UURM-?#6R&2.F=&V(D ;'43R"Z>M/X>H[=0\,U%
M%PG5T]1/''I[1CPXEV#IU:5JGCO&5DI:JNOE3 :>*(N#0Y^7$;X&0.@*ZUGD
MK$3U>#-ACBLU[TU7KVGI+6O"E4U?$7%%1#;R704#6G8]3L?_ $KJ/@MOIOO"
ME-+*[-2S4)?K>['X!<IX+FXE@^4KC;+(RLBN+SJ?-%(?UB=M/_$K'P05E5P]
MQ74V.YQ.IC. [2\%H!#<@;X_:[EQQVU?FGU_V'TN+X>+</.*NON:U[_-76WA
MV+BKPK<2T%5.^*..2HF!;D[B4#O'[2R^)[17>#.NHZZU5SYJ:5SM3', ]$>O
M/[2R>!JVEH/#-Q3+73Q01GQEH?(X-!/;MVW]A61X;+Y17>*W6ZT3QUE07/R(
M7!^,AI'(^HJ1%8I-O7;ISY9XBF*>N.:QOIT[+7PI<353VVFTVJ4Q.N1TO?@'
M U =1_O+$J?!%V=I=-3W"0W5C=;21LYP!P.>,9QT5?X1;?-9+OPU7S NIHGC
MM7CDSSV]=O6NBW'CJR4UBEN,5?3R$1ES(A(TN<<$@8SSV[UTU%K3SO'SY<.+
M''"]IWOIWG?JJOD.[5G@[GMM^+'5H;I8]C@=M0QRQT"S_!7?'WOA:%U0[54P
MES9#M^V['+U!67!_$ XCLK:\T\D#'$C$C=/(^TK1_  '"WW@X/9F5FG_ )LK
M<3JU=>L/->)M@RQDC4UF)^O275D5+Q7'>9;?&WAU]*RK[4%QJ'.#=&#GT03G
M.E:H:7PA_2+)]Y-_*MS;7H\>/AXR5YN:(_-T5%0\)Q7Z.*?RB?1O>=/9^+.>
M1USG4!_NJ^6HG<;<KUY+37>V-)Z1]J\#=?27TBO"U#FCHM%XVX3;4=I74#</
MP72,WWYG/XK>TRK6TUG<.'$</3B*<EWYZ<TL>YI&"-CE0=BNE<;\(]NUU=;6
M 2#=\8Z\MP /:5S9['-<0]I#ASRO76T6C</QW%<+?AK\EOT>1OG!W0]W52!A
M6UIL[JZCJ*HU%/!%#IR97%O,D=WJ6NSC2EKSRU[JH=5&,%7%58GQ4[:B"IIJ
MB$O$9,3R[23RSLL*NH):5X:[#@Y@?ENX R?@D3M;8K4CK#$VRI"F.-S_ $6.
M=CN"-#G.P!G/3JCF\^SVH>]2YCFD@MP>XJ7,<P9<",\LJCSG=.8*S+90/N$I
M:U\<8:"2^0X:/KPOI<;4^DI65#)H9Z=S]&N)Q< [&<$XYX4W#<8[37FB.BO;
MR3&<]Z@<U(WRJYP@8ZJ1S*=/P3&R*>M0>A4\OZ)D=-U '(J/:IW*=?:J:3L.
M2CF@Y[[H,@E0.A3(Y)GO"8ZA4.B],<6/$C3APW![EYY9PJ&^45UKI9&4]6VF
MI6MRUT3B)"<==B.8_%29;QUBUM3.G;N">+!7AM'6N'; #2_;#E\O"?)KJ^%*
M1NXGO$3'_P# 6/7#. +U/+"ZCJWEM?0D-)/I$C?*Z#9N(C>^/K7;K@]H?1QQ
MU+'$^D0[2.O/<KS7ITYH?I^!XRT7GA\T]8[3[P[6QH9&UHY-& I&PP@W"PKK
M<Z:UP=M6/T19QJ. ![RN,S$1N7V:4M>>6L;EG853Q/=VV2S5%<YHD,8&&$XS
MEP'^:KQQS8?IT7VV_%:5QU?J;B:KI+9;I2Z .)D>T@@C3D;@GJ%Y\O$5K2>2
M>OH^IP/PO+DSUC-28K'6?RAU2@JHZRECJ(3F-XR#]>%]\+F/@_XLI+7:3;KO
M,V&2E.ENH@9!R>I]:VCRYL)_VZ+[;?BKCXBEJQ,SU<^)^%Y\66U*4F8B>DZ]
M/1LIV4KX4=3'5P-FAR6.Y%?9>B.KYTQ-9U*<HH"E$,=R?Q0*,("E A00%*C9
M2@83FB H &Z>Q$00 I^M0I0!^*<E 4H(Z*44 [( 4CFF$R@(@1 0>I.J8YE
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M@CORM/XLX4NMCC;XL7U=#&\.8_#001OR&3WKJ?!EP-QX=HY7DF8,:V3(QAV
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MKO\ 5L5PMU+<JUU937"BB@DP=$TNE[<#!R ".AZKU&Z@DAJK=2U#(ANX32N
M:\\L9'PZ+7!!,,^:<>U.PEZ,(37S:\;K-HKW[MB?+3T-OHJ(U4,TC9G2.=&_
M4QH+>_;?99<M50RF5LE3'H<6<G#?'^2U+Q>4GT2H%/+^R5.5J.)M'3EZ?[#=
MF3TD#+G^>M<8?32L9V$AU.);MS54ZGAN%IHXV7"DB?&?.;-)IQL/45KY@E_8
M)^M!!-OYA]Z15;<3-NDUZ-MO5737J-\$%5#"Z(,:'3/#0_EG&,YQC\5\IJZF
MBJ+9 VHC>:6'LWR!P+<@]#W+5Q3RYSI/U)V$N?0*<OH6XJTS-ICK+8[8ZD>^
MN>^2D=,Y[R!4NPPC5L1C?*]W^JIC2V=D<U,]T1FUM@=D-R6X6LB"7]DCZT-/
M+OAA3EZ[9^T3R33E[_SMMG$-52LE[2.J@GQ4LDQ$_5L.:\0MIA>*6Z&OIA#&
M!(Z/M/S@W)T@<L[]ZU8T\I/H%/%Y<>B<)R]&IXF9MS37YKOB"MAJ8Z7LI6.#
M9'' /+)6+Q7-'4\15TL$C9(G/!:YAR#L%7""3(\PH*>0?J'WJQ&G+)EMDB8F
M.^OV_P#K8[1<:>*PS&25K:Z)Q[')&<8&,?BLN[7&B<ZE=22L!F&)]QM@;9^M
M:CV$F<Z"GB\N=FJ<L.D<5>*\NFU5$U-4T-<UM53M=XPQS0]^-0'/"Q/&X?*:
MTS&9G8QF+4_5LW#CG*H13R_LE!3R_L%.4GB+3J=?[O;-U0/OTSY7X@=,\ZFD
M;C)Q_DMJ@FHZ>HK'=K:HV&![6F&0ZG$M]?K6C^+RG]0IV,QYL/O2:[3%Q$X]
MSR_-G<-S,IKQ3RR/;&UK@=1. -POM<+]<)*BH8VME,)>=@[8C.RJ^PESLPH(
M)1G##E743.W.N6]:\D=&P64TIMA)=1&?4-3:IV,;GT<*TO-=2^(MCBJJ=SA1
MNC(C?D9R=@M+$$HY-*=C*0?,*G+N=NU>*M6G+%5M9'Q/MMP@DGAA>^,!O:.T
M@G4.2FZ543Y+;HE8X1DZL'.GS@J@4\V?0*CL)=_,*NG+Q;13EU_N]M[NMPI*
M^:I;!+;7:9]G5#R X8YC'M5:;C#\M1O?/"&Q0MBU,=YHQG8'N6KBGD'ZI0T\
MN=F%2*1#M?B[VGFTN.$WB"Z253S^9B8\./=J:X#\519]N5FQ/J(:6:!C,-ET
MZCUV.0O@*>0CT#E:]=O/:TS2*QZ;_?\ ^/@>7/=3[3NOJ*>0?J%1XO*>;%7+
M4OEC?*D?4OJ*>7/H%#3R8] J+J7RPH"^PIY1^H?>GBTG[!3:<LOESY=.J <\
MKZFGE V:4%/*1Z!1=2^0Y+8.$^'9[U4Y<"RE:?/DW&>6P.",[J>%N&Y[O5CM
M&EE,P@O=W[\EUJV4$%NI6T],QK&-]0R>F3WG9<LF372'U?AWPZ<\QDR?\?\
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M#KNB% @(-BB902T;K);Z(6,WFLIO(*$"(B*+&?Z3EDK%?Z92!"'UJ%*J">I
MGK0 BA2.2 $&R@%2$#HG>B;]$!$Z)S00I3H4"!T4*5!/<@<PI3FH02GMYHB
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MQ1T%4)F3/>0",$#J@MU77JY_)D4;^Q[76[&-6G'X*Q6!=K:RY1QL?(Y@8<Y
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M\^_W!17R\I.ZD_Q/Z*[HI_&:6.;3IUC.,YPJGR<B^?D]P5O1P"FIF0AQ<&#
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ML@(B(("GVH$00I"A.B"44(@GFF$]B("8")A 1$" BA ,%!*!$&Z!GH$3.Z!
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MA^":X0Q,AK(6G&LR  $9/+9?&ZV6F905$]/'4Q/ISC\]@!_G8VP-U,G% C?
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MZ$**ZDBK*2."1HEC=@%Q&2!CF/6M=IZJ6QUCJ2M=KIL^9(=](W.Y. .8"#9
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MNDL-5P]>IHNWD<ZJ%8!!I<XEI[+/J71N!N%[I;ZSCN2NH):5E<(A2N=C\YB
MM(&/7LNPL_3R>9C8>=WKYOR*9NH]N<\^6=_4@_.!X/XHMO W"CH;!4U%?;+E
M!524S2T.TL8_.^<<R!]:_05EFEFLL4L].X3.:"^!Q!+3@9;]2LM^V_2#&GT,
M>OFODS)IY-)$!U'SN>/7N@_-/%'#7%E=>[[3UEEN]:^I+#33PU79P8:P9S'G
M??;VK8?!)PA?+7Q9;:N[VF:BIH.'_%'ROTD-E[=KL;'G@$KO#_[1'YF=CYV>
M2AV1'-EW:\\-Y8]2#\Z7+@3B&?A7CJGCM4[YJZOGEI1YN96.G#@X;]1NKSCB
MU\1<8^#>FA%BJJ:X^,,[2C<]KG1M$S=\\O1;E=P&=,.'B,8W9SSMR1OZ68!N
MG8>=WH/S[:J;C+@P7:SVSAJ:LBN%<9XJPZ#''J:&#4TG+@-.3WC9;1?>'[_6
M\7\!5LEO[3Q,:ZV:)C6,C<8' C&=AJ.-EUAV1%%G$IU#SN7U[+Z#(E<3(-./
M1VV]:#\TV:XWF@X]X[98[%+>VS,IHY1&YH,9,;PTY=[3[E[GX'XJL_"EH;34
MU9422U$-164-*_L90!G4 _.!MM]87<[!8[+0U-QN=FCC@JK@Y@J9F3.D#^SU
M!NQ) YN&V.:OS_:&^9GS3YR#\K0< \32'C"?Y KZ6&LM;F0-J)6R/<\R-.DN
MSN<=?4MOXWX7X@XR\&=ES9ZJDN5%J8:0O!<1K:,Y!QR9GZUW=V>PEU.$VYVY
M?5LO>^N/#PT8.68]+_\ "#\U4G %TXB;>ZI]ENUMJ&4DK(&UU5XRZ1Q9LW.>
MI61=J3C*_P!HX3M%1PG54D=GGB:Z9SF$2".(LR .0.<K]%M_U^!V9_:^KFL6
MLN%+2344-3/$)9WAD>IP:7.P>0Z\B@^%;2R5-FFI>RT/,+6ZOVB -E^<[;PQ
MQ97<#<-VF7AJKB=:[E3N<YSVG7&'N<Y^,[ 97Z<?(V(RR2S-[, >:<#3]:Q[
M=5P5]MIZFAJ(^PDW:]C@\.&3L"@Y7QEPU=JSPK4]?1T$DE$RRQ0&1N,!XF>2
MWGW$+WX->#:^#P2W"S7F!]MK)ZJ5^7@:@WM0YIV/7'XKK@_M)\W]3TOKY+YN
MR*9VIPG.?9U]2#\[4]JXQJN#[;P1/PM/%#32QZKD=!;I#]1.G.1S[^BMI+'Q
M#P3Q[%762SU%]I7VN.WN?&YK0QXE<XYU'?8#WKNY![9N) !CT,#?UKRW>.;'
MYHZCAW/Z]T'$N .$[G%PIQ#!Q%!):7U]3).T2;\Y2_&Q]BYU65-\I?!3;;'4
M6PLME-71::_#0V4NG<[8<Q@DCZE^L)XV3"..5G:M<""[..GJ6B4G@?X*H[@:
MR"U.,L;FOC::R<ACAN-B_!W&=P@U+@?ANZQ>%.WWF6VR/M1L+*=M2<:1)VP=
M[<Z=U?\ @6L-RLE9Q)\J4LE-XQ6RRQ!^/.:97D$8[P0NE,&((0QPA QYO/(_
M9W7MGZ>3S<;#SL\T'&_"%:+[9^/*#BRQ6F:Y@Q2124L9:TL)#6C<[;X)Y*BO
M5EXSO+K=Q-4V,,KJ"X1U,5NCB8UYC8"[!<#@G.V?6N^NSV#=1$QU#?EU]2^N
M_;?I!IT^ACU\T' ;=P[Q'Q5Q37<272RSVWLX6MBI7EKG2.:=)&H'N.<*XX;L
ME98? 924-VIG4=PC;4=I"_&K>61PSCU$'ZUV%F33OTGL3D^=SQOSW7QNE!37
M*+Q2N@[:"1I#O.+?X(/S/PW3<2\3^#OA7A^+AZ:&V,GAJ#= 6%G9 .:3CGGS
MLY]2VN&Q<1>#WBDW"R62?B&FJ:&* F,M86.!))RXGU>]=GLMIH[%9F6VUQ!E
M%3,[.&'47:&C]7)))^LK/&2V'#A&-LMYYVY(/S9+X-+]%P-I91R5%SJ:B&2>
MD8T#L0R?/?C=N^RW?PW6R_U5)8OD.BJYJ..IB=/2T<@BD(&O(#\[;8'M(*ZV
MS]-/YNGEYW?LO+P>RASB8ZAYW+Z]D'$/!'PI>J'BOB*JKK/6V^CK:1C8G54H
ME=J[0NTEV<D@<RM'M_ _%-?X/ODJ:Q5L,MKJ#+%A[0:D23:G:<'8M#1N>]?J
MP9[8_G 1CT,<O6OC&#XMYI$!S[>OK0<9\$_#M<.-I+M<+)=K7HA?&SQ^K\8<
MX$@[.^I=H)S!+J;V0R=^_P!:]G^T-\S]4^=W+R[(AER[M=SMRQZMD'K/GQ ,
MU#!\_P#9_P#RO(P.W(/:'JSZN2];ZHL/TC!RS'I?_A>6\Y\#LS^WSZ<T!V"V
M#)[,Y'F_5R7RJJ2&M$T-1 "S \\@9/\ UA?5V=,.1VAR/.Y=.:]MSVDF9 X;
M8;CT?_R@U*CJ)K/4LI:IYDI9#B.4_P#7?E;&TAS0YIR#N%4<2U,)MK*4,S42
M'#8QN1S"^G#E+44MN:RI?J<=PW'HC V2$6OL7J/TEY4Q^DJ,H(@111$1 1$0
M$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0
M$1$!$1!#G!K2YQ :-R3T7Q?64S&M<^HB:'<B7@951QV]\?"%X?&YS'MI)2'-
M."#H<N.VFQU-Q\'-7>ZFXUAJ83IB J'@#=HW&>XKE?)-9U$/=PW!US4Y[6UU
MB/J[W+4P0Z>UFC9J]'4X#/L6L^$CB>?A;AQMQHH89Y#.V+3)G3@AQSL?4N6V
M:SUMYX&J+Q67*L,T7Z'%0\ 8<X'(S_NA?&[W"HK_  ,0&KE=*^.LC:'/))/F
MOYDK$YIFO;T>S%\-I7)&[<T1;4PZQ7<8TMLX1I+Q<71LEGIV2B%I&7.<T.P
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MNE))5TIBKHVN;&X$G.D'/4(-8N%J=2OC:R:&8OV#8W:B#OSV]2S#PW/V8Q/
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MA(8H8"*=I_;;YWK[U0_(-QQ_9_\ G;\5%5BCO5H+#<?H_P#SM^*?(-R^C_\
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MKR5*((4]$WQMR3.R AY*%/1 1%',H)48P@4H("*0%""4">Q.801T13T]2=Z
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M>M^*#*[U"QOE"B^ETWWK?BGRA1?2Z?[UOQ097M18ORA1=*RG^];\4%PHM_\
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M-:VOE#J6%N,;N8W&_P!2X;Q[X3KO=/!S<G4]O=07*AJI*6KTU =V18YK2[(
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M53'TLWG,DA=YKMR,(-!XKX+NMT\)D-WI1!XFRTQTI+GX=K$KW';'+#@O7 G
M57:_!?7<.W\QLEGJ9)287:QI,@<WN[@NG>=XP?-&G3SQOG*^0QXJ[L'=MO\
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M< W<G8*8V.D<&QM<YQV  RMZX7L#:1HJ:D9F/HC]GG\4'*/"%P[4<,S6;C"
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M.MK7%I.'!PW'K 51<.!['7V6EM533/=1TOZ)HE<"-R>?,\RO7@SUQUBMO?\
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M@]BHI76$/&'7&O(]<@^"GY"V_P"\KA]X/@KA2>2"E;80T'3<:\9.3B0?!/D
M%P<;C7DMY'M!M^"ND""E=8<@M-RN!!&_YP?!2VPZ0 +E7@#8?G!\%<A$%(+
M \N%QK]1YG6/@C[ 'C#KC7D YWD'P5UC*=Z"G^0O_P#)5_W@^"AE@#&D-N->
M!SP'CX*Z3O04GR "X/-QK]0V![0?!>G6(.!:ZY5Y!'+M!\%<=<*4%*+%@8%R
MN&!_\0?!!80'.(N->"[F>T&_X*Z^I$%*;"'8U7&O.#D?G!S]RGY"/[RN'W@^
M"N.:D(*5E@#& ,N5>&CIV@^"?( U:OE&OU8QGM!R]RNN_N3""E=8 YI#KE7D
M'F#(/@I%B/2Y7#[P?!7)PH04S;"!JQ<:\$G)_.#?\$=802TFXUY(Y'M!M^"N
M@B"F^0N>;E<,?^8/@H98 UH:VXUX Y 2#X*Z"8V04HL(#M7RC7ZB,9[0?!0Z
MP!PPZY5Y'KD'P5T#T1!3_(9_>=P^\'P4,L :#IN->,G.T@Y^Y72#=!2&P9<'
M&XUY(Y'M!M^"DV'((-QKR#L1V@^"ND05]LM4%O![+4]YYO?C4?\ K"L%"D("
MA3T3F$#VJ8_24+U'Z2#)')$"**(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B#'D](Y[UX7J3F5Y]BL((H"GUH 3FH W4]$$*1L
MH"=$$C\$"($!!ZT4#KL@E$3"" -E*(@(B'F@A2G1/>@C?"*40/8F4Z)[4$>U
M2$P% 02@]J*$$XPH&ZE1ZD$H/4FRCJ@#JI0*,[()&=U"9RI0!R3O3H@01T1/
MX(@E%"D((4]"B((V4\TR$0%"=<*0@81%&4$A.GL4>Q2@#ENHPI6D^%>MN=%P
MZ/D28PULK]+' D=/5N@W9%R+C?CFLFX,MLUDE,-35R]FZ4$@LT2,U;@]1D*Y
MO5_EAJ*F.EJ*L2QU4<;@YPT 'F!C=0=$*@+GM=X3+=;WOBD9+(VFCS42-#2,
MC9P!U<]NJ^U!X1J6XW!M-0T57)JCUX:QI<WS203YW7"#?>I3.ZYM8>/:J5U1
M#54%3-6O<WL88F9);C=V"[D#C*N#QS3BSOK#15?:Q53J*2 ,&OM&C)P-7+IS
M5&X@9RGK7/YO";14;ZJGKZ*K@K86L>(7,:"\.W& 7=W-7O"'%=)Q+XZRF:YL
M]&YK)0<8RX9&-ST0;&$'/9 HZH);S66WD%BMYK*;Z(4($1$46,_9Y]JR5BO]
M,H(10 I'55 (#[D"@!!(Y*$"D'F@?4G1$0%&5/).B" I 0Y1!"GFFW-/K00B
MGV% @(H3D@E$ [E',Y03SRH4]Z@>I!* J%S'PJ\0W&SWNT0T%0^*.9S \-<1
MG)?GKZ@@Z?S*;+\W_E1O%-PEQ=35\\L5P@E<ZAJ22"X&4#2TEV=F@[ =5MU^
MK;Y=^.[79J&\55#%-%*YQAE+<EL;7#//KGIU4'8@BY[X+[_<JNLO-EO4C9ZJ
MVU;Z=LS229&M:W<DG<Y)Z!=""H*!U4H@=$3IZT0%&05)W0("A8MUKHK9;Y:N
MH#C%$ 7:<9W./\U44?&%KJN$V<0L>YM"Z-T@#B-6V=N>,^:>J#85*URFXNHZ
MBS4]TCIZKQ2>F;5-=I;LUW('?FK>EN,%12-J [1&[EJV09@. H[U\WS11N:Q
M\C6N=R!.Y6+3W:CJ*Z>DBE:9H 3(,C;!P4&>$7S9-&]A>Q[2S.,Y1DT;G/:U
M[26^E@\D'T"GFOG%)'*'&-X< <'!ZKV#A 4*?8B!U4!2H" GM4H@A I1 4<U
M*80 BA2@=Z=%'(*0@#N0J$YH)3KLGK4>Q!*],&Z\#UKVP><@R1R1!R111$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!%X;-$Z9T39&&5
MH!<P.&1GED+V@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MV%,?I(,H<D1%%$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$) &3R0:%P@35>$CBRN!S$Z&EC9W M#P<+?5H7@@!J+/<*^3]++75$9[\,E
M< M]0$55=.(;7:J@07"K;#*6AP:6N.QSOL/45CP\7V*9X9'<&.<>0T/^"O+/
MLXSQ&*L\LWC?YPO40$$9')5M5?;;2UK*2>J:RH><-9I<<[X[N\)$;[.EKUI&
M[3I9(@((!'(JGJN)[12U)@J*UK)1L6Z'?!(B9[)?)2D;O,0N$7SCGCD@$S'9
MB(U!WJ52.*;,:CL!7-[7.-.AWP2(F4MEI37-:(VND4.>UK"]QPT#)*IXN*+/
M+5"FCK6NF)#0W0[GG'<D1,]EMDI37-,1M<HL"YWB@MC&NKJ@0M=R):3GW!+7
M=Z&ZM<ZWU F#>>&D8Y]X]134ZVGBTYN3FC?MZL]$6%/<Z:"OAHWR8J)?1;@[
M[9_R4UMNUHKUF6:BKI;W;XKE\GR5+16?-Z3GEGGC')?>Y7&EME-V]=,(8=6G
M403O]7L5U+/B4U,[CIW^3*1>()63P1S1.U1R-#VN[P1D%>U&XG?6!$1 1?*2
MHBCFCB>\"23.D=^!DK&ANU#/<I:"*H#JN(9?'I.1RZXQU"NF9O6.DRSD1%&A
M%YE>V*-\CSAC 7$]P"Q+7=:.Z,>^AF$K6.+7$ C!'M]H33,WK$\LSU9J+XUE
M3#1TSYZEXCA9C4X@G&3CHJ4<9V#]XL^[?\%8B9[,WS8\<ZO:(_.6P(JBV\26
MFY5/B]%6-EFQG2&N&V0.H]87VNMZH+6!X]4"(GD"TG/N"<L]DC-CFO/%HU[[
M6**HM7$5LNDG9T=2U\G[.EP_B%]+K?K;:IF17"J;#(YNIH+7'(SCH/4G+/8\
M?'R\_-&O?:S1:]Y:6#]XL^P_X*P9>J%]5% V8%\K2YFQW Y]%>6?9*\1BM_Q
MM$_JL41%EV$1$&/)Z17CDO4GI'VKSS5010/P4H"*.JE! &%*@;J>2 AY*%*
M$V0[>M$!!R3^" H"#JH1!*#JH4H"A%*"%/M1 @!!ZE"! '7*GH@4=4$Y)494
MA1U]2"=L*/X*0GL0$4 ]ZGF@(HZ*4$=ZE0I0$4*4 =>283O3H@A3T0;IU00I
M0H$#V(G+FB H0>I3T0#R08P43F@!0I .Z(&V40*$'.[U!>7\>5)LS*32Z)K7
MNJ@_&"PCS=/U_@IJ>#KQ#9+/14%72N%)'V<T4SG]G(<YS@-W_!=!$4?:&0,9
MVA_6QO[U[0<.NG!];:[7';WSTK+G6W>6J8*%SL-8\>:"",X!!Z?6NA6SA>:E
MN#ZD.@;&^F;'IWU:^S+23MWE;2^FIY)FS201/E9Z+W,!</85]E-#G-JX#K:>
MSVBAJ:BF/BM)/33&-SM^T>2"W+>X]553>#FYR0LHC!8S3P2:H9R).UP!AI)Q
MC5CGCJNG7.YTEKACEKYA#')*V%I()R]QPT;=Y68UP+01N#NJ-,=PG5_*?"M2
M)J;1:7S.F&3EVM@:-.WJZX6?P?9J^SSW%E6^E?32/:8#'JUX WU9 '/N6RIA
M ^M,(HQ]2#TWFLIO(+%9S62WT0H0E$1%%C/])W)9*QG^F4'A3U1!OT501$0.
M]$4()"(.1V3" @484CER0%"GIS1!"D; IT4#EN@GFF-U"()10B"0JSB&AJ;C
M:I:>BJY*2<[MDC=I.=]B<'96:@H.)0^#'B*Z72CFX@?8X12 'QF@[43SD'.'
ME[<$')SC&X"^M!X-N*FOM]/4U=E^3Z.NFJVF-TO:N#VZ0#EN.Y=I4=4'&'>#
MKBV**Z4%+56,V^X30RR.D=-VC1'C9N&XWWYY5C-X,J]M+Q'!35-)HN%LFH8#
M(YV6N>0078;RVZ975^2*#D\G@TNCH;(UM50@T-%#32><_P YS&:21YO+*]5_
M@[NC^ *"RQBSU-93/D<757:.C\Z0.&,-SG'JYX75@BHX<?!;Q(; ZGGJ+-65
M1G$D?C+I7-@8!Z+,-R,'<>TJY'@[OLW C+/57&FFK14/E#Y)'EC&$-PQOFY
M&#MA=7')3WX4'&I/!OQ+315MKMM5:#9ZQT#I'3ND[9O9[G&&Z=R3SZ85K#X.
M*RFK;FZ"II33U%MJ*&'6YVH.D&&EV&XQWX74.]%10<#6:>P<.TMOJGQ22Q-
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MFMINK;957>?QNI,99YN6L+LD$]Q5O$(*:CHVT<Q;$XOSB#7K]IZ(.?-:YV<
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M9Z[\L=%K7#US;PO=JZ&YQ.8'N.EVV^7$K-X49+=N,*N]LC='2N;I&>OFAO\
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MDIZ('>H"81!**.BE!"D)T1 4*<83*!T4!3R4()1 B".B)S4Y0"G10GJ0.:E
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M$@#S#R"1CW&VK<=:M^2:_P#W6W3Q64I<UHJ8=3N0UC)7TEFBA;JED8QO>YP
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MN9Y8ZJ\V>D-VCN1:[QI@(!U'&[=)V]BL$13>W2M*UWJ.['D](KQSV7J3TBO
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MQ4!V67@=P4:1W!#3%3WK+P.X)@=P08:E96D=P3 [@AIB!2LO [@F!W!#3$4
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M0 )<8R$'5F^B/8I4,]$>Q2@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MR]S=RLNBL]OH8YXZ2DBA9.,2!K<:AOS]Y]ZN,#N"8'<$%?0T=/04S*>CB9#
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M^0YH.QHN579URGX2MM-6^;,9XV/<,><TR;\N6RO>);?;[7;:&W-F>R&6=H[
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BB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g31173g03a03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g31173g03a03.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( $< C0,!$0 "$0$#$0'_Q  >   " P$! 0 #            " <)"@8+
M!0$" __$ $$0  $$ @$# P$%! <$"P    0" P4& 0<(  D1$A,A% H5(C%!
M.%%XMQ8S-F%Q=K47(Y&A&!DD)3(T.4*VP='_Q  = 0 " P$! 0$!
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M!P='!P='!P='!P='!P='!P='!QD)^T3\O#[#L:E<-ZG*.LUN@ QNQMKLBO\
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MZ^TH=!<<6@8G(<@1].[A%BRW+V3P<<$E](O3L$JDD,OJ!9 .XQ2;52'[=D$
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M&'N369/"O'J]GW7@&(?+OG\/G[V]GU8\X=]/XNK8.1>8%3O"5"VM^D+(]3\
M2@B!W_YNC]HX5,G5SDJ24Q"3)*F]"P] ^EK[=+*TY7[C!W:_9WXXGGA"N^:E
MY+)UAL*ORU5F+15)V.7%2S7MH*7&L9L(L@ 0VIP*3'PW"'L,'QY!0CF'24-/
MJ5A>,2/*0N8OF 4+L$E>2S6FC*2#08H/75T(VD@U"P#(S*=MH^XX@>H[8S/\
MF?EC%6H+L%&]5F$T!V4$S?"/%(K!9(6[K43/%*B."L991X)NTZ;7&<>#HX.#
MHX.#HX.$;Y>]P_C9P>E*/$;ZE[7&&[# G)*MIK=3.LC;PM>(C19+);@;B,"+
M0[*AX:0YYRZE2U)^&\]0>7YAQN$>!+[RJUA7:/TXFD!$94-L@C7EQK[>&CT\
MZ/\ .G5"#*6.5*^/GCP\M6&Z;M^*D5>XD[P>F)%/J K7D[B/T2 #[CAKM:;
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$5 __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Jan. 16, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001826892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BioAtla, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Jan. 16, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt Convertible into Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Non-Convertible Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 4,050,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 559.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">(1) BioAtla, Inc. (the "Registrant") is registering under this registration statement such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock, and such indeterminate number of units as may be sold by the Registrant from time to time, which together shall have an aggregate initial offering price not to exceed $200,000,000. If the Registrant issues any debt securities at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $200,000,000, less the aggregate dollar amount of all securities previously issued hereunder. The Registrant may sell any securities the Registrant is registering under this registration statement separately or as units with one or more of the other securities the Registrant is registering under this registration statement. The Registrant will determine, from time to time, the proposed maximum offering price per unit in connection with its issuance of the securities the Registrant is registering under this registration statement. The securities the Registrant is registering under this registration statement also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as the Registrant may issue upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares the Registrant is registering under this registration statement include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares the Registrant is registering as a result of stock splits, stock dividends or similar transactions. (2) The proposed maximum offering price per security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b of the Instructions to the Calculation of Filing Fee Tables and Related Disclosure of Form S-3. (3) Calculated pursuant to Rule 457(o) under the Securities Act based on the proposed maximum aggregate offering price of all securities listed.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=9', window );">Offering: 9</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-269148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=10', window );">Offering: 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-269148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=11', window );">Offering: 11</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-269148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=12', window );">Offering: 12</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt Convertible into Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-269148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=13', window );">Offering: 13</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Non-Convertible Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-269148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=14', window );">Offering: 14</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-269148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=15', window );">Offering: 15</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-269148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=16', window );">Offering: 16</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 195,950,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-269148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 21,593.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Pursuant to Rule 415(a)(6) under the Securities Act, securities with a maximum aggregate price of $195,950,000 registered hereunder are unsold securities (the "Unsold Securities") previously covered by the Registrant's registration statement on Form S-3 (File No. 333-269148), which became effective on January 17, 2023 (the "Prior Registration Statement"), and are included in this registration statement. The Registrant paid a filing fee of $21,593.69 (calculated at the filing fee rate in effect at the time of the filing of the Prior Registration Statement) relating to the Unsold Securities under the Prior Registration Statement, and no additional filing fee is due with respect to the Unsold Securities in connection with the filing of this registration statement. During the grace period afforded by Rule 415(a)(5) under the Securities Act, the Registrant may continue to offer and sell under the Prior Registration Statement the Unsold Securities being registered hereunder. To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the Registrant sells any Unsold Securities under the Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this registration statement the updated number of Unsold Securities from the Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6) and the updated amount of new securities to be registered on this registration statement. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdFormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdFormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:formTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrevslyPdFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrevslyPdFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFctvDt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFctvDt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule415a6Flg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule415a6Flg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=9">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=9</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=11">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=11</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=12">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=12</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=13">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=13</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=14">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=14</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=15">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=15</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=16">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=16</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Jan. 16, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 200,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">559.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 559.30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>17</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="d31173dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d31173dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d31173dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="d31173dexfilingfees.htm">d31173dexfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="97">http://xbrl.sec.gov/ffd/2025q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d31173dexfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "d31173dexfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025q4/ffd-2025q4.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 15,
    "http://xbrl.sec.gov/ffd/2025q4": 13,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 17,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025q4": 97,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457oFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d31173dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457oFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d31173dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d31173dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d31173dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal8ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-26-015344-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-015344-xbrl.zip
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M6N='42_K,V]NC/X?4$L! A0#%     @ IH P7 =FPES3$@  \K8  !<
M         ( !     &0S,3$W,V1E>&9I;&EN9V9E97,N:'1M4$L%!@     !
-  $ 10    @3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>d31173dexfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025q4/ffd-2025q4.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>9</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>10</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>11</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>12</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>13</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>14</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>15</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <context id="offrl_16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826892</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>16</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-16</startDate>
            <endDate>2026-01-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-564">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-565">S-3</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-566">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-567">0001826892</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-568">BioAtla, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="7"
      id="ixv-572"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_2"
      decimals="7"
      id="ixv-573"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_3"
      decimals="7"
      id="ixv-574"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_4"
      decimals="7"
      id="ixv-575"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_5"
      decimals="7"
      id="ixv-576"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_6"
      decimals="7"
      id="ixv-577"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_7"
      decimals="7"
      id="ixv-578"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FormTp contextRef="rc" id="ixv-738">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-739">BioAtla, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-740">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-741">Common Stock, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_1" id="ixv-742">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_2" id="ixv-743">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_2" id="ixv-744">Preferred Stock, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_2" id="ixv-745">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_3" id="ixv-746">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_3" id="ixv-747">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_3" id="ixv-748">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_4" id="ixv-749">Debt Convertible into Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_4" id="ixv-750">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_4" id="ixv-751">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_5" id="ixv-752">Non-Convertible Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_5" id="ixv-753">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_5" id="ixv-754">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_6" id="ixv-755">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_6" id="ixv-756">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_6" id="ixv-757">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_7" id="ixv-758">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_7" id="ixv-759">Units</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_7" id="ixv-760">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_8" id="ixv-761">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_8" id="ixv-762">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule457oFlg contextRef="offrl_8" id="ixv-763">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_8"
      decimals="2"
      id="ixv-764"
      unitRef="USD">4050000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_8"
      decimals="7"
      id="ixv-765"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_8"
      decimals="2"
      id="ixv-766"
      unitRef="USD">559.30</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="offrl_9" id="ixv-767">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_9" id="ixv-768">Common Stock, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_9" id="ixv-769">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_9" id="ixv-770">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_9" id="ixv-771">333-269148</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_9" id="ixv-772">2023-01-17</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_10" id="ixv-773">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_10" id="ixv-774">Preferred Stock, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_10" id="ixv-775">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_10" id="ixv-776">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_10" id="ixv-777">333-269148</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_10" id="ixv-778">2023-01-17</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_11" id="ixv-779">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_11" id="ixv-780">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_11" id="ixv-781">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_11" id="ixv-782">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_11" id="ixv-783">333-269148</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_11" id="ixv-784">2023-01-17</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_12" id="ixv-785">Debt Convertible into Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_12" id="ixv-786">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_12" id="ixv-787">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_12" id="ixv-788">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_12" id="ixv-789">333-269148</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_12" id="ixv-790">2023-01-17</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_13" id="ixv-791">Non-Convertible Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_13" id="ixv-792">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_13" id="ixv-793">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_13" id="ixv-794">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_13" id="ixv-795">333-269148</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_13" id="ixv-796">2023-01-17</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_14" id="ixv-797">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_14" id="ixv-798">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_14" id="ixv-799">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_14" id="ixv-800">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_14" id="ixv-801">333-269148</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_14" id="ixv-802">2023-01-17</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_15" id="ixv-803">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_15" id="ixv-804">Units</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_15" id="ixv-805">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_15" id="ixv-806">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_15" id="ixv-807">333-269148</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_15" id="ixv-808">2023-01-17</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_16" id="ixv-809">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule415a6Flg contextRef="offrl_16" id="ixv-810">true</ffd:Rule415a6Flg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_16"
      decimals="2"
      id="ixv-811"
      unitRef="USD">195950000.00</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="offrl_16" id="ixv-812">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_16" id="ixv-813">333-269148</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_16" id="ixv-814">2023-01-17</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee
      contextRef="offrl_16"
      decimals="2"
      id="ixv-815"
      unitRef="USD">21593.69</ffd:CfwdPrevslyPdFee>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="2" id="ixv-816" unitRef="USD">200000000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="2" id="ixv-817" unitRef="USD">559.30</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="2" id="ixv-818" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="2" id="ixv-819" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="2" id="ixv-820" unitRef="USD">559.30</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_8" id="ixv-821">(1) BioAtla, Inc. (the "Registrant") is registering under this registration statement such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock, and such indeterminate number of units as may be sold by the Registrant from time to time, which together shall have an aggregate initial offering price not to exceed $200,000,000. If the Registrant issues any debt securities at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $200,000,000, less the aggregate dollar amount of all securities previously issued hereunder. The Registrant may sell any securities the Registrant is registering under this registration statement separately or as units with one or more of the other securities the Registrant is registering under this registration statement. The Registrant will determine, from time to time, the proposed maximum offering price per unit in connection with its issuance of the securities the Registrant is registering under this registration statement. The securities the Registrant is registering under this registration statement also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as the Registrant may issue upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares the Registrant is registering under this registration statement include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares the Registrant is registering as a result of stock splits, stock dividends or similar transactions. (2) The proposed maximum offering price per security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b of the Instructions to the Calculation of Filing Fee Tables and Related Disclosure of Form S-3. (3) Calculated pursuant to Rule 457(o) under the Securities Act based on the proposed maximum aggregate offering price of all securities listed.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_16" id="ixv-822">Pursuant to Rule 415(a)(6) under the Securities Act, securities with a maximum aggregate price of $195,950,000 registered hereunder are unsold securities (the "Unsold Securities") previously covered by the Registrant's registration statement on Form S-3 (File No. 333-269148), which became effective on January 17, 2023 (the "Prior Registration Statement"), and are included in this registration statement. The Registrant paid a filing fee of $21,593.69 (calculated at the filing fee rate in effect at the time of the filing of the Prior Registration Statement) relating to the Unsold Securities under the Prior Registration Statement, and no additional filing fee is due with respect to the Unsold Securities in connection with the filing of this registration statement. During the grace period afforded by Rule 415(a)(5) under the Securities Act, the Registrant may continue to offer and sell under the Prior Registration Statement the Unsold Securities being registered hereunder. To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the Registrant sells any Unsold Securities under the Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this registration statement the updated number of Unsold Securities from the Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6) and the updated amount of new securities to be registered on this registration statement. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
